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ABSTRACT 
 
Osteoarthritis is a complex multifactorial degenerative disease that is characterised by 
progressive loss of articular cartilage and inflammation of the synovium resulting pain 
and loss of mobility. HuR is a ubiquitously expressed RNA binding protein involved in 
the post-transcriptional regulation of target mRNAs and can reduce their rate of 
turnover. Previously published data suggests that HuR is spatially regulated within 
developing cartilage and is involved in the regulation of chondrocyte genes and 
osteoarthritis. Furthermore, knockout of HuR in mice at pre-implantation stage leads a 
skeletal dysplasia, among other phenotypes. This project aimed to determine whether 
HuR activity is important for maintaining cartilage and skeletal phenotype 
appropriately. 
An inducible, cartilage-specific HuR knockout mouse model and a non-inducible limb 
bud and mesenchyme-specific HuR knockout mouse model were generated utilising the 
Cre/LoxP system, were Cre expression is driven by an aggrecan promotor and a Prx1 
enhancer, respectively. Using these novel transgenic mouse models of HuR knockout, 
the role of HuR in embryonic development, during osteoarthritis and in chondrocytes 
was characterised. 
Induced aggrecan-driven knockout of HuR leads to severe dysregulation of skeletal 
development during embryogenesis, resulting in a lack of mineralisation of axial 
components including the ribs and spine, and craniofacial structures. Similarly, Prx1-
driven knockout of HuR during embryonic development leads to altered mineralisation 
of the skeleton, most strikingly in the developing limbs. This is similar in many respects 
to the phenotype observed following a broader knockout of HuR at an earlier 
developmental stage and suggests a role for HuR during endochondral ossification. In 
vitro assays using murine primary chondrocytes suggest that HuR may be required for 
the appropriate regulation of a number of known chondrocyte marker genes including 
Sox9, Runx2 and Mmp13, of which the latter two are known to be critically involved in 
the regulation of chondrocyte hypertrophy and endochondral ossification.  
The roles of RNA binding protein-mediated post transcriptional gene control is still not 
well understood in orthopaedic tissues. This study indicates that spatial and temporal 
mis-control of the protein HuR can lead to impaired skeletal mineralisation, suggesting 
that it performs an important function in chondrogenesis and /or osteogenesis. 
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1.1 Background 
Osteoarthritis is the most common and chronic form of joint disease associated 
with age and mechanical wear (Sulzbacher, 2013). Osteoarthritis affects weight-
bearing joints, predominately the knees, hips and hands, and leads to joint pain, 
stiffness and loss of function. Other risk factors for osteoarthritis include 
obesity, joint trauma and co-morbidities such as diabetes and metabolic and 
endocrine diseases (Mobasheri et al., 2014). 
Our laboratory is interested in the post-transcriptional regulation of messenger 
RNAs (mRNAs) in cartilage biology and during osteoarthritis progression. 
Previous work has identified RNA binding proteins as regulators of anabolic and 
catabolic gene expression in chondrocytes (McDermott et al. 2016). In 
particular, siRNA-mediated knockdown of the RNA binding protein HuR in 
SW1353 chondrosarcoma cells and human articular chondrocytes led to a 
significant increase in the expression of matrix metalloproteinase 13 (MMP13), 
a collagenase implicated in the destruction of the articular surface and known 
to be elevated in osteoarthritic cartilage (Karsdal and Madsen, 2008). 
This thesis expands upon these observations, examining how HuR influences 
chondrocyte function in vivo during development and disease as well as 
determining its importance in regulating chondrocytic molecular markers in 
vitro.  
 
1.2 Structure and function of synovial joints  
1.2.1 Cartilage structure and function 
Articular hyaline cartilage is an aneural, avascular and alymphatic specialised 
form of connective tissue that covers the articular ends of subchondral bone in 
diarthroidial joints and acts to reduces joint stress by providing a low-friction 
gliding surface and distributing load (Yu and Urban, 2010). Articular cartilage is 
composed of the extracellular matrix (ECM) with a sparse distribution of highly 
specialised cells called chondrocytes (Dijkgraaf et al., 1995). The ECM is mainly 
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composed of water, collagen and proteoglycans and lesser amounts of other 
non-collagenous proteins and glycoproteins. This chemical composition allows 
the ECM to retain water and allows the articular cartilage to withstand the 
pressures of repetitive loading (Clouet et al., 2009, Fox et al., 2009). 
Articular cartilage is split into four zones: the superficial zone, the middle zone, 
the deep zone and the calcified zone (Figure 1.1) (Clouet et al., 2009). These 
zones differ according to the type and orientation of the collagen fibres, the 
shape and activity of the chondrocytes, the amount of proteoglycans present 
and, consequently, the water content (García-Carvajal, 2013).  
The superficial zone contains an outer surface that is in contact with the 
synovial fluid to provide a low friction surface and contains low levels of 
proteoglycans and collagen fibres types I, II and III that are tightly packed 
parallel to the articular surface. This zone contains a relatively high number of 
chondrocytes that have a flattened morphology. Surface zone chondrocytes 
contribute to low friction articulation of the joint by secreting lubricating 
molecules such as hyaluronic acid and lubricin (Rhee et al., 2005). This 
contributes to the unique tribological properties of articular cartilage and 
enables low friction articulation of synovial joints (Greene et al., 2011).  
The middle zone contains a less dense and less organised structure of types II, 
VI, IX and XI collagen fibres. This zone makes up 40-60% of total cartilage 
volume and deforms the most during compressive loading (Grogan et al. 2013). 
Chondrocytes in the middle zone have a rounded morphology and synthesise 
large amounts of the proteoglycan aggrecan. They differ in their synthesis of 
other small proteoglycans compared to chondrocytes in other parts of the 
tissue (Goldring et al., 2006). 
The deep zone represents approximately 30% of articular cartilage volume and 
contains collagen fibres types II, IX and XI that are organised perpendicular to 
the articular surface; this provides the greatest resistance to compressive force. 
Chondrocytes of this zone are rounded and form columns that align parallel to 
the collagen fibres, perpendicular to the joint surface (Fox et al. 2009). 
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The calcified zone contains a sparse population of hypertrophic chondrocytes 
and acts as an interface between tissues by anchoring collagen fibrils of the 
deep zone to the subchondral bone (Fox et al., 2009, Clouet et al., 2009).  
 
 
 
 
 
Figure 1.1. Organisation of healthy articular cartilage and the zones of the ECM. 
Each zone is characterised by different morphology and function of chondrocytes 
and the orientation of collagen fibres (red). In the superficial zone the fibres are 
horizontal and chondrocytes secrete lubricant. The fibres of the middle zone run 
obliquely and chondrocytes are rounded. Fibres run perpendicular to the articular 
cartilage in the deep zone and chondrocytes align parallel to the collagen fibres. 
The ECM is divided into zones based on the distance from chondrocytes. The 
pericellular zone immediately surrounds the chondrocyte, the territorial zone is 
next to the pericellular zone and the interterritorial zone is the furthest. The 
expression of different molecules differ between each zone of the ECM (Adapted 
from García-Carvajal, 2013).  
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1.2.2 Extracellular matrix 
The biomechanical properties of cartilage and the physical function of joints are 
critically dependent on the integrity of the ECM. In normal articular cartilage, 
water constitutes up to 60% to 80% of the total weight, this water is drawn in 
by the high concentration of negatively charged glycosaminoglycans and gives 
cartilage its ability to withstand loading. The remaining dry weight is made up of 
type II collagens and the proteoglycan aggrecan (Fox et al., 2009; van der Kraan 
et al., 2002). 
The ECM can be divided into the pericellular matrix, the territorial matrix and 
the interterritorial matrix based on distance to the chondrocytes (Figure 1.1) 
(van der Kraan et al., 2002). The pericellular matrix (PCM) immediately 
surrounds the chondrocytes and contains type VI collagen fibrils in a cross-
linked network around the cells. Combined, the chondrocyte and its 
surrounding pericellular microenvironment have been termed the ‘chondron’ 
(Poole, 1997).  The territorial matrix surrounds the pericellular matrix and 
contains high concentrations of proteoglycans including aggrecan, hyaluronan 
and decorin. The territorial matrix also contains large amounts of collagen type 
VI which help the chondrocytes to attach to the macromolecular framework of 
the matrix. (Fox et al.,2009). The interterritorial matrix is the most distant from 
the chondrocytes and the largest of the 3 regions. Type II, XI and IX collagen 
fibrils are arranged perpendicular to the joint surface in the middle zone, which 
allows the retention of proteoglycans in the interterritorial matrix (Guilak et al., 
1999). 
1.2.2.1 Collagens 
Collagens are a family of glycoproteins that are present in the ECM with 
different suprastructural organisations and account for up to 60% of the dry 
weight of cartilage (Table 1.1) (Eyre, 2002; Birk and Bruckner, 2005). All 
collagens are trimers and contain three polypeptide α chains folded into triple 
helices and subsequently collagen fibrils, forming the structural framework of 
the articular cartilage ECM. In developing cartilage, the fibril network is a 
copolymer of collagens type II, IX and XI, with type II being the most abundant. 
Collagens type III, VI, XII and XIV are also found in small amounts in cartilage 
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(Eyre, 2002). Collagen fibrils are organised in a unique cross-linked network 
with anchoring proteins including chondronectin and fibronectin (Dijkgraaf et 
al., 1995). This fibrillar architecture, which changes between the zones of 
articular cartilage, is critical to the integrity of the articular cartilage (Eyre, 
2004). 
 
 
Table 1.1. The functions of different collagen types and their relative abundance 
within the extracellular matrix (Adapted from Eyre, 2004 and Luo, 2017). 
Collagen Function % of total 
collagen 
Distribution in 
cartilage 
Type II Major fibrillar collagen 
Forms the main scaffold by cross-
linking with collagen type XI to 
provide integrity and strength to 
the tissue 
90% (75% 
foetal) 
Broadly 
distributed in 
articular cartilage 
Type III Fibrillar collagen 
Involved in matrix repair and 
remodelling 
10% Broadly 
distributed in 
articular cartilage 
Type VI Microfibrillar collagen  
Forms a network that aids in the 
attachment and integrity of 
chondrocytes to the PCM by 
interacting with ECM proteins 
including collagen II and XIV and 
decorin  
<1% Found in the 
pericellular 
matrix of 
articular cartilage 
Type IX Fibril-forming collagen 
Crucial for maintenance of 
cartilage matrix and aids in 
tensile properties by forming a 
stable collagen network  
Found at the surface of 
chondrocytes and interacts with 
1% (10% 
foetal) 
 
Mainly found in 
type II collagen-
containing 
tissues including 
the growth plate 
and adult 
articular cartilage 
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cartilage proteoglycans to aid in 
the organisation of the 
pericellular matrix 
Type X Network-forming collagen 
Homotrimeric collagen and plays 
a key role in modifying the 
cartilage matrix during 
endochondral ossification for 
calcification 
 
1% Found exclusively 
in the 
hypertrophic 
zone of growth 
plate  
Type XI Fibril-forming collagen 
Found in the centre of collagen 
fibrils and regulates collagen fibril 
formation 
 
3% (10% 
foetal) 
 
Broadly 
distributed in 
articular cartilage 
Type XII Interacts with microfibrils and 
contributes to mechanical 
stability 
 
<1% Expressed at the 
junction between 
synovial fluid and 
articular cartilage 
surface 
Type XIII Fibril associated collagen 
Transmembrane protein involved 
in cell-matrix and cell-cell 
adherence junctions; also 
contributes to the differentiation 
of osteoblasts 
<1% Localised to the 
plasma 
membrane 
Type XIV Large non-fibrillar ECM protein 
Maintains the integrity and 
mechanical properties of the 
tissue 
 
<1% Found uniformly 
throughout the 
articular cartilage 
Absent from 
growth plate 
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1.2.2.2 Proteoglycans 
Proteoglycans are a family of complex glycoproteins that consist of a central 
core protein with one or more covalently linked glycosaminoglycan (GAG) side 
chains such as keratin sulphate, chondroitin sulphate, dermatan sulphate or 
heparin sulphate (Iozzo and Schaefer, 2015). Proteoglycans make up 20 to 30% 
of the dry weight of cartilage and, together with the collagen network, provide 
the cartilage with the abilities to withstand compressive load (Kiani et al., 2002; 
Hunziker et al., 2002). Prominent proteoglycans found within articular cartilage 
include aggrecan, decorin, biglycan and fibromodulin (Roughley and Lee, 1994). 
1.2.2.2.1 Aggrecan 
Aggrecan, a member of the lectican family (also known as hyalectins due to 
their interaction with hyaluronic acid (HA)), is the most abundant proteoglycan 
in the ECM and the most crucial for the proper function of articular cartilage 
(Kiani et al., 2002). The aggrecan core protein consists of three globular 
domains (G1, G2 and G3) and an inter-globular domain (IGD) that connects G1 
and G2. Between G2 and G3 is a large sequence modified with ~100 chondroitin 
sulfate (CS) and ~30 keratin sulfate (KS) GAG side chains (Figure 1.2A) (Kiani et 
al., 2002). Aggrecan within the extracellular matrix occurs in the form of 
proteoglycan aggregates (Muir, 1978). Each aggregate contains a central 
filament of HA with multiple aggrecan molecules non-covalently attached to its 
N-terminal G1 domain. Link proteins (LP) stabilise the interaction between the 
aggrecan core proteins and HA (Figure 1.2A) (Wight et al., 1992). 
GAG attachment regions are highly polyanionic and hydrophilic so when packed 
at high density, proteoglycans are able to draw water into the tissue by 
generating a large osmotic swelling potential (Figure 1.2B). This causes the 
aggrecan-matrix network to swell and expand, while being resisted by the 
collagen fibril network (Kiani et al., 2002). When force is loaded upon the 
articular cartilage, the equilibrium is disrupted and the water is displaced. 
Aggrecan molecules are therefore brought into closer proximity which increases 
the swelling potential of the aggrecan. Aggrecan will rehydrate upon removal of 
the force and restore normal equilibrium (Roughley and Mort, 2014).  
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Aside from its structural role in the ECM, aggrecan is involved in the control and 
modification of normal bone growth by regulating the expression of key growth 
factors and signalling molecules (Lauing et al., 2014). Postnatal morphogen 
gradient formation in the growth plate is also reliant on the proper sulfation 
patterns of the GAG chains attached to aggrecan (Cortes et al., 2009). 
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Figure 1.2. Aggrecan structure and function. A) The structure of proteoglycan 
aggregates. A central hyaluronan (HA) filament with aggrecan and link proteins (LP) 
attached. G1, G2 and G3 domains are indicated, keratin sulfate (KS) and 
chondroitin sulfate-rich domains (CS1, CS2). B) The function of aggrecan in 
articular cartilage. Aggregates are surrounded by collagen fibrils. Aggregates swell 
as CS and KS chains draw in water in a relaxed state. During compression, the water 
is displaced and CS and KS chains are brought closer. (Taken from Roughley and 
Mort, 2014). 
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1.2.2.3 Articular chondrocytes 
Articular chondrocytes are the only cellular component of articular cartilage 
and, when joint development is complete, maintain a stable phenotype 
throughout adulthood (Goldring, 2012). Chondrocytes arise during 
development from the differentiation of condensed mesenchymal progenitor 
cells and are critically involved in the growth and patterning of the embryonic 
skeleton, while in adult articular cartilage they proliferate and secrete 
extracellular matrix in order to maintain the cartilage (Goldring, 2012; Akkiraju 
and Nohe, 2015). The main role of chondrocytes in the superficial and middle 
zone is the synthesis and turnover of ECM components including collagen, 
proteoglycans and glycoproteins. Chondrocytes function in a low oxygen 
environment and rely on diffusion of nutrients and metabolites from the 
articular surface due to the avascular nature of articular cartilage (Archer and 
Francis-West, 2003).  
1.2.3 Cartilage and skeletal development 
The multiple types of cartilage that contribute to the primary skeleton are 
formed from the differentiation or chondrogenesis of cells from three 
mesenchymal lineages (sclerotome, somatopleure and neural crest 
ectomesenchyme) (Bobick and Kulyk, 2008). Bones of the axial and 
appendicular skeletons develop through endochondral ossification. This begins 
with mesenchymal condensation of osteo- chondroprogenitors which is 
necessary for the subsequent formation of cartilage templates by chondrocyte 
differentiation (Tsang et al., 2015; Long and Ornitz, 2013). These osteo-
chondroprogenitors undergo lineage restriction toward either chondrocytes or 
osteoblasts (Tsang et al., 2014). 
There are defined stages of cartilage and bone formation which include the 
commitment to a specialist cell lineage, mesenchymal condensation, 
proliferation, disposition of the extracellular matrix (ECM), mineralisation and 
maintenance (de Crombrugghe et al. 2001). 
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1.2.3.1 Mesenchymal condensation/chondrogenesis 
Bone growth is mediated and controlled by the vertebrate growth plate. The 
growth plate is formed via defined stages of a differentiation process were 
chondrocytes differentiate, proliferate and undergo hypertrophy resulting in an 
increase in cell size (Figure 1.3) (Tsang et al., 2015).  
Chondrogenesis starts at embryonic day 9 (E9) in murine embryonic 
development (Cheah et al., 1991). Hox genes, in particular Hoxa13 and Hoxd13, 
have been shown to control mesenchymal condensation, while bone 
morphogenetic proteins (BMPs) are essential for the formation of chondrogenic 
mesenchymal condensations (Long and Ornitz, 2013). Other extracellular 
signals involved in mesenchymal condensation include TGFβ (transforming 
growth factor-β), FGFs (fibroblast growth factors), IGF (insulin-like growth 
factor) and EGF (epidermal growth factor) (Bobick and Kulyk, 2008). 
More mesenchymal progenitors are recruited to the primordial cartilage and 
once committed to the chondrocyte lineage, chondroprogenitors differentiate 
into chondrocytes. The transcription factor Sox9, from the SRY-related high 
mobility family, is essential for the onset and regulation of the chondrocyte 
lineage (Bi et al., 1999). Sox9 recruits Sox5 and Sox6 and forms a trio that are 
required for the regulation of subsequent chondrocyte differentiation by 
binding and activating genes for cartilage-specific extracellular matrix 
components such as collagen type II and XI and aggrecan, and specifying cell 
fate (Han and Lefebvre, 2008). 
 
1.2.3.2 Endochondral ossification 
Fibroblast-like chondrocytes proliferate and organise into columns, at which 
point proliferation ceases and chondrocytes differentiate into rounded 
prehypertrophic chondrocytes, synthesising molecules such as collagens type II, 
IX and XI and aggrecan. A cartilage template is then formed surrounded by the 
perichondrium (Bobick and Kulyk, 2008). Msx1 and 2 (Msh homeobox 1 and 2), 
β-catenin, Lef1 (Lymphoid enhancer binding factor 1), AP1 and 2 (Activator 
protein 1 and 2) and Runx2 are also implicated in chondrogenic differentiation 
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and skeletal patterning (Bobick and Kulyk, 2008). Cartilage calcification is 
mediated by the secretion of matrix vesicles by mature hypertrophic 
chondrocytes (Tsang et al., 2015). A bone collar is formed around the 
hypertrophic zone by the secretion of bone matrix from perichondrial cells that 
have differentiated into osteoblasts. Osteoblasts and bone matrix organise into 
a periosteum which later forms the diaphysis of the bone (Figure 1.3) (Tsang et 
al., 2014). 
Vascularisation of the calcified cartilage occurs at E14.5 in mice with the 
development of the primary ossification centre (POC). This brings osteoblasts 
and chondroclasts which produce proteolytic enzymes that degrade the 
mineralised cartilage ECM and replace it with bone matrix to form trabecular 
bone (Tsang et al., 2015, Akkiraju and Nohe, 2015). The chondro-osseous 
junction forms and divides the cartilage template into two epiphyses 
encompassing the growth plate (Tsang et al., 2015). The epiphyseal growth 
plate is therefore divided into four different anatomical zones based on the 
morphological and biochemical properties of the cells each zone inhabits 
(Ballock and O'Keefe, 2003).  
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Figure 1.3. The process of endochondral ossification. Endochondral bone 
formation begins with mesenchymal cells aggregating at the site of future bone. 
Mesenchymal cells at the centre of the condensation differentiate into 
chondrocytes and synthesis cartilage matrix. Chondrocytes then undergo 
proliferation and hypertrophy, while adjacent perichondrial cells differentiate into 
osteoblasts and deposit bone matrix. Vascularisation of the calcified cartilage 
occurs which brings osteoclasts/chondroclasts and degrade the cartilage matrix, 
which is replaced with bone. (Adapted from Tsang et al. 2014). 
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1.2.3.3 ATDC5 cells 
Our understanding of the underlying mechanisms of chondrogenesis and 
endochondral ossification has been facilitated by utilising chondrocytic cell lines 
(Newton et al., 2012). ATDC5 cells are a commonly used model for in vitro 
research of chondrocyte development as Atsumi (1990) reported they undergo 
a well-characterised cellular condensation stage, sequential chondrogenic 
differentiation and mineralisation when treated with insulin (Figure 1.4) 
(Shukunami et al., 1997).  
 
 
 
Figure 1.4. Schematic diagram depicting ATDC5 differentiation during 
chondrogenesis. ATDC5 cells treated with insulin undergo condensation and 
express collagen type II and aggrecan. As cells become hypertrophic during 
differentiation collagen type X is expressed, followed by matrix mineralisation 
(Taken from Yoa and Wang, 2013). 
 
 
ATDC5 cells rapidly proliferate meaning large amounts of cells can be obtained 
for in vitro culture systems and during expansion are maintained in an 
undifferentiated state. Upon treatment of ATDC5 cells with insulin, cells 
undergo condensation and then exhibit a chondrocyte phenotype with the 
expression of collagen type II and aggrecan. Collagen type X is then expressed 
as the chondrocytes become hypertrophic, followed by mineralisation (Yao and 
Wang, 2013). This cell line is therefore an ideal model to study the molecular 
mechanisms occurring during chondrogenesis. 
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1.2.3.4 Transcription Factors 
Endochondral ossification and skeletal development is regulated by several 
transcription factors including Sox9 and Runx2 (Amano et al., 2009; Yoshida et 
al., 2004). Transcription factors control the transcriptional rate of target genes 
from DNA to mRNA by binding to specific DNA sequences. Abnormal expression 
of these transcription factors has also been implicated in the development of 
cartilage pathology such as osteoarthritis (Zhang and Wang, 2015).  
1.2.3.4.1 Sox9 
SRY-box 9 (Sox9) is a HMG-box-containing transcription factor that is critical for 
the differentiation of mesenchymal progenitor cells into chondrocytes during 
cartilage morphogenesis (Bi et al., 1999). Sox9 is a master transcription factor 
during chondrogenesis and acts on cis-elements within many genes encoding 
cartilage matrix proteins promoting their transcription (Lefebvre and Dvir-
Ginzberg 2017). Genes regulated by Sox9 include aggrecan, collagen XI and 
Col2a1, often via cartilage specific enhancer elements such as that located 
within the first intron of the mouse Col2a1 gene (de Crombrugghe et al., 2000, 
Lefebvre et al., 1997, Sekiya et al., 2000). Haploinsufficiency of Sox9 results in 
an autosomal dominant human disease called campomelic dysplasia, were 
inadequate chondrocyte differentiation causes severe skeletal malformations 
such as shortening and bowing of the long bones and scoliosis (Wagner et al., 
1994, Foster et al., 1994). It has also been demonstrated that Sox9 is required 
for cartilage formation in mouse embryonic stem cell chimeras in which Sox9-
deficient cells were unable to express chondrocyte-specific extracellular matrix 
genes and therefore were unable to differentiate down the chondrogenic 
lineage (Bi et al., 1999). Furthermore, mouse embryos containing a conditional 
homozygous deletion of Sox9 present with defective joint formation and severe 
generalised chondrodysplasia (Akiyama et al., 2002). Sox9 overexpression also 
resulted in skeletal disorder as a result of a suppression of chondrocyte 
hypertrophy, a delay in terminal differentiation and subsequently a delay in 
ossification (Kim et al. 2011). Together these studies indicate that dosage of 
Sox9 is important for normal chondrocyte function. A previous study also 
demonstrated that retroviral transduction of Sox9 could improve the 
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phenotype of dedifferentiated human articular chondrocytes from 
osteoarthritis patients (Tew et al. 2005). 
Decreased Sox9 expression is a hallmark of human osteoarthritis (Lee and Im, 
2011). Interestingly, an inducible cartilage-specific deletion of Sox9 in postnatal 
mice did not result in the onset of osteoarthritis by 18 months of age. These 
mice did, however, present with disruptions to cartilage homeostasis of the 
growth plate, the articular cartilage and the intervertebral discs of the spine 
(Henry et al., 2012). Sox9 is also subject to post-transcriptional regulation and 
its mRNA has been reported to be unstable with a short half-life in chondrocytic 
cells (Tew and Hardingham 2006). The micro RNA, mi-145, has been shown to 
directly target Sox9 and inhibit its expression in human chondrocytes (Martinez-
Sanchez et al., 2012). Inhibiting Sox9 via mi-145 results in reduced expression of 
Col2a1 and aggrecan, and an increase in the expression levels of MMP13 - a 
known marker of osteoarthritis (Martinez-Sanchez et al., 2012). These studies 
highlight the importance of Sox9 as an essential transcription factor during the 
sequential steps of the chondrocyte differentiation pathway.  
1.2.3.4.2 Runx2 
Runx2 is an essential transcription factor that regulates hypertrophic 
chondrocyte differentiation in late stage endochondral ossification and bone 
formation, and has been shown to regulate markers of endochondral 
ossification including Indian hedgehog (Ihh), Col10a1 and MMP13 (Komori, 
2010). Total Runx2 deficiency in mice results in neonatal lethality due to a 
complete lack of bone formation as a result of an absence of osteoblast 
differentiation and a delay in chondrocyte maturation (Komori et al. 1997). 
Runx2 expression levels are increased in human osteoarthritis cartilage (Zhong 
et al. 2016), and an overexpression of Runx2 in chondrocytes has been shown 
to increase expression levels of the matrix-degrading enzymes including 
MMP13 and ADAMTS5 via a direct interaction with their promoters (Tetsunaga 
et al. 2011). 
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1.2.3.4.3 Nfat1 
Recent studies suggest that NFAT1, a member of the Nuclear Factor of 
Activated T-cells (NFAT) transcription factor family, regulates chondrocyte 
functions through its age-dependant expression in articular cartilage and plays 
an important role in maintaining the permanent cartilage phenotype in mice 
(Zhang and Wang, 2015). Epigenetic studies have also suggested that dynamic 
histone methylation regulates the age-dependant NFAT1 expression in articular 
chondrocytes (Rodova et al., 2011). Nfat-deficient mice present with a 
phenotype that is comparable to osteoarthritis with phenotypes including 
articular cartilage degradation and chondrocyte clustering, chondro-osteophyte 
formation and thickening of the subchondral bone (Wang et al., 2009). 
1.2.3.4.4 Prx1 
The paired-related homeobox genes Prx1 and Prx2 are expressed in the early 
limb bud mesenchyme and function as transcriptional coactivators (Martin et 
al., 1995). Prx1 plays a major role in chondrogenesis and patterning of the 
developing skeleton in mice and chick embryos, with expression studies 
revealing that Prx1 is primarily expressed in undifferentiated mesenchyme and 
regulates skeletal development of the limb via bone morphogenetic protein 
(BMP) signalling pathways (Kuratani et al., 1994, Nohno et al., 1993, Cserjesi et 
al., 1992). Prx1-null mice display severe defects in the developing skeleton 
including deformities in the craniofacial, appendicular and axial structures, 
supporting the idea that Prx1 plays a role in the regulation of skeletal primordia 
growth (Martin et al., 1995).  
1.2.3.5 Hox genes in axial skeleton development 
Transcription factors are vital to the process of pattern formation throughout 
the axial and appendicular skeleton. During embryonic development, members 
of the homeobox (Hox) transcription family are expressed in distinct spatial and 
temporal patterns prior to mesenchymal differentiation. Hox genes are a family 
of 39 highly conserved transcription factors that control axial patterning and 
integration of the musculoskeletal tissues and one of the major functions of 
these genes is to provide a specific identity to segmental units of the embryo.  
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(Mallo et al. 2010). The genes in each cluster are further subdivided into 13 
paralogous groups based on sequence similarity and the similarity in expression 
domains  The co-linear arrangement of these genes along the chromosome, 
arranged on four chromosomal clusters HoxA-D, reflect their spatial and 
temporal expression along the anterior-posterior (AP) axis of the body, with 
genes located in the 5’ region of the cluster being expressed posteriorly while 
genes in the 3’ region are expressed in the anterior regions (Graham et al. 1989, 
Pineault and Wellik 2014). Transcriptional and post-transcriptional mechanisms 
can also regulate Hox gene expression at multiple levels (Mallo and Alonso, 
2013).  
1.2.3.5.1 Craniofacial development 
The vertebrate craniofacial skeleton and the pharyngeal skeleton are derived 
from cranial neural crest cells (CNCCs) (Creuzet et al. 2005). Hox genes encode 
the major inhibitors of the craniofacial program carried by CNCCs, with their 
inhibition essential for proper jaw formation (Couly et al. 2002).  
Mice that are homozygous for a targeted mutation of Hoxa2 are born with cleft 
palates and display severe craniofacial abnormalities including a duplication of 
the ossification centres of the bones of the mid-ear and a mirror-image 
duplication of the lower jaw (Gendron-Maguire et al. 1993). Single mutants in 
Hox5 and Hox6 paralogous groups resulted in abnormal phenotypes at the 
cervicothoracic transition (McIntyre et al. 2007). 
1.2.3.5.2 Lumbar column and rib development 
Previously, it has been suggested that Hox paralogous groups play a dominant 
role in controlling the specification of characteristic morphologies of specific 
anatomical regions of the vertebral column. Compound mutants of the Hox10 
paralogous group first described Hox genes in their regional patterning along 
the AP axis (Wellik and Capecchi, 2003). Mice with combination deletions of the 
three Hox10 genes resulted in the development of extra ribs along the thoracic-
lumbar region suggesting Hox10 genes are involved in supressing rib 
development in normal skeletal development. In contrast, ectopic expression of 
Hoxa10 in the paraxial mesoderm of mice resulted in no rib formation 
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(Carapuço et al. 2005). Phenotypic defects have been noted in mutants for Hox 
genes from Hox5-9 with sternal versus floating rib production being controlled 
by Hox9 genes (McIntyre et al. 2007). Inactivation of Hox6 in mice resulted in 
smaller rib cages with an abnormal phenotype, including the loss of the first rib 
and distal fusions of ribs associated to thoracic vertebrae 2 to 4 (Figure 1.5) 
(McIntyre et al. 2007).  
 
 
 
Figure 1.5. Schematic diagram comparing phenotypes and affected regions of Hox 
paralogous deficient mice (red). Each Hox paralogous group mutant has a unique 
morphological characteristic in the vertebrae despite overlapping of affected 
regions between mutants. Adapted from (McIntyre et al., 2007). 
 
 
1.2.3.6 Hox genes in limb bud development 
The vertebrate limb is divided into three segments: 1) the proximal stylopod, 
which includes the humorous and femur, 2) the medial zeugopod that includes 
the radius/ulna in the forelimb and tibia/fibula in the hindlimb, and 3) the distal 
autopod including the paw bones and digits (Pineault and Wellik, 2014).  The 
HoxA and HoxD clusters have major roles during limb development and 
contribute to the specification of these regions in both the forelimb and 
hindlimb. During limb bud development from the lateral plate mesoderm, HoxD 
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genes are activated by remote enhancers that are located within two gene 
deserts flanking the cluster.  
The initiation of Hox gene expression occurs very early in limb bud 
development with the posterior Hox genes expressing in overlapping patterns. 
Hox paralogs, Hox9-13 pattern the limb skeleton along the proximal-distal axis. 
As limb bud development progresses Hox paralogous groups become restricted 
to their appropriate functional domains. In this instance Hox9 and Hox 10 are 
restricted to the stylopod, Hox11 in the zeugopod and Hox13 in the autopod 
(Figure 1.6) (Davis et al. 1995, Fromental-Ramain et al. 1996). 
 
 
 
Figure 1.6. Schematic representation of the limb bud development. Hox 
paralogous are progressively restricted to specific limb regions during 
development. Hox9-13 are expressed in an overlapping fashion early in the 
developing limb bud. Hox9/10 are restricted to the developing stylopod, Hox11 to 
the zeugopod and Hox13 in the autopod. (Adapted from Pineault and Wellik, 2014). 
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Skeletal development is disrupted in the absence of Hox genes (Newman and 
Wallis, 2003). E15 double mutants deficient for both HoxA and HoxD result in a 
severely truncated single cartilage model in the forelimbs with a lack of 
autopod development, while in mutant new-borns ossification resulted in a 
single bone rod with no zeugopod development (Kmita et al. 2005).  
1.3 Osteoarthritis 
Osteoarthritis is the most common and chronic form of degenerative joint 
disease and a major cause of severe pain and disability for those affected 
(Martel-Pelletier et al., 2016). Pathological changes that occur in osteoarthritic 
joints include the progressive destruction and loss of articular cartilage, a 
thickening of the subchondral bone, osteophyte formation, inflammation of the 
synovium, hypertrophy of the joint capsule and the degeneration of the 
ligaments and menisci of the knee (Chen et al., 2017; Rahmati et al., 2017). The 
main clinical symptoms for patients presenting with osteoarthritis include 
chronic pain, joint instability, stiffness and a radiographic joint space narrowing 
(Chen et al., 2017). There are several risks associated with the onset and 
progression of osteoarthritis including genetic predisposition, obesity, prior 
joint injury and, most commonly, aging (Yucesoy et al., 2015). 
Family based studies, linkage analysis and association studies have extensively 
investigated the genetic contribution to osteoarthritis, with an estimate of 
heritability of 40% being reported for the knee (Yucesoy et al., 2015). Over 80 
gene mutations or single-nucleotide polymorphisms (SNPs) have recently been 
confirmed as being associated with osteoarthritis pathogenesis via genome-
wide association studies performed on large number of osteoarthritis and 
control populations throughout the world (Chen et al., 2017). These include 
mutations or SNPs in genes important for structural factors including collagen 
type II and those involved in the TGF-β signalling pathway including Smad3 
(Chen et al., 2017). Genetic association studies have also helped identify the 
effects of specific gene variants on osteoarthritis pathogenesis, however they 
have also identified the need for more genetic linkage studies to be carried out 
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in order to identify the chromosomal regions involved in the disease process 
(Yucesoy et al., 2015). 
Obesity is currently a worldwide epidemic and it has long been recognised that 
there is an association between obesity and osteoarthritis (Felson et al., 1988). 
Patients with obesity develop osteoarthritis earlier and have more severe 
symptoms and a higher risk for infection. Additionally, obesity contributes to 
low-grade systemic inflammation through the secretion of adipokines as a 
result of an increase in biomechanical loading on the knee joint. For example, in 
high-fat diet-inducted mouse obesity models and in obese patients, levels a 
pro-inflammatory cytokines, including IL-1β, IL-6 and TNF-α were elevated 
(Chen et al., 2017). 
Knee injury increases the risk for osteoarthritis more than four times and is the 
major cause of knee osteoarthritis in young adults, with a reported 41-51% of 
patients with prior knee injury presenting with radiographic signs of knee 
osteoarthritis in later years (Roos, 2005). The most common injuries that may 
lead to osteoarthritis are cartilage tissue tear, joint dislocation and ligament 
strains, all of which can negatively affect joint stability (Blalock et al., 2015). In 
both mouse injury models and patients with traumatic knee osteoarthritis there 
are signs of inflammation of the joint, including an increase in cytokine and 
chemokine production, inflammatory cell infiltration, synovial tissue expansion 
and NF-κβ pathway activation (Lieberthal et al., 2015). 
Chronic low-grade inflammation contributes to the development and 
progression of osteoarthritis (Scanzello et al., 2017). During the progression of 
osteoarthritis, the entire synovium joint, including the cartilage, subchondral 
bone and the synovium, are involved in the inflammation process, with 
inflammatory factors such as IL-1β and TNF-α, as well as chemokines, 
contributing to the systemic inflammation that leads to the activation of the NF-
κB signalling pathway in both synovial cells and chondrocytes. Evidence that 
inflammation signals contribute to osteoarthritis pathogenesis comes from the 
recent Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathway analysis, 
which found that inflammation occurs through cytokine-induced mitogen-
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activation protein (MAP) kinases, NF-κB activation and oxidative 
phosphorylation (Li et al., 2014). 
Aging, however, is the most prominent risk factor associated with 
osteoarthritis. Half of all people aged over 65 years develop osteoarthritis, with 
incidence rates being substantially higher in females than males (Sulzbacher, 
2013, Kopec et al., 2010).  Patients usually present with an increase in the 
prevalence of pain, joint dysfunction and stiffness (Buckwalter et al., 2004). In 
addition to cartilage, aging affects other joint tissues, including synovium, 
subchondral bone and muscle, which is thought to contribute to changes in 
joint loading (Chen et al., 2017). Aging causes chondrocytes to increase 
production of inflammatory cytokines, alongside a reduction in repair response 
(Kuyinu et al., 2016). 
Osteoarthritis is now considered a disease of the whole joint as an organ and 
changes in gene expression and signalling pathways aid in the pathogenesis and 
progression of osteoarthritis (Loeser et al., 2012, Tew et al., 2014). Potential 
therapies for osteoarthritis may affect the different stages of disease differently 
and so it is important to determine these stages (Figure 1.7) (Poulet, 2017). 
 
 
 
Figure 1.7. The stages of osteoarthritis progression and potential therapy target 
points. Prevention therapy can be targeted to events that would usually increase 
stress on the joint over time. Targeted approaches to early stage of progression 
would be more successful than targeting late stage disease, were the only 
treatment maybe total joint replacement (TJR). (Adapted from Poulet, 2017). 
General Introduction 
 
Page | 25 
 
1.3.1 Osteoarthritis pathogenesis 
The initial stage of osteoarthritis is characterised by a repair response mediated 
by growth factors acting upon the chondrocytes. This stage marks the beginning 
of osteoarthritis but may not manifest clinically for many years (Sulzbacher, 
2013). One of the earliest pathological changes after the onset of osteoarthritis 
occurs under mechanical stress when chondrocytes become activated and start 
to synthesise IL-1α and IL-1β, TNF-α and prostaglandins, which promote 
catabolic activity and can lead to differences in the appearance of the articular 
cartilage of the joint (Loeser et al., 2012, Sulzbacher, 2013).  
The production of collagen type X by hypertrophic chondrocytes in the early 
stages of osteoarthritis, marks the terminal differentiation of chondrocytes that 
regulates the expression of proteolytic enzymes such as MMPs and ADATMTS’ 
which degrade the proteoglycan and collagen network (Akkriaju et al., 2015). 
The major drivers in the onset of osteoarthritis are therefore the degradation of 
both aggrecan and collagen by these proteases (Troeberg and Nagase, 2012) 
Abnormal remodelling and a thickening of the subchondral bone occurs at later 
stages of disease progression which subsequently leads to the formation of 
osteophytes that serve to correct instability in the joint caused by osteoarthritis 
(Figure 1.8) (Kuyinu et al., 2016). Other pathological changes include 
inflammation of the synovium and the degradation of ligaments and the 
menisci (Figure 1.8) (Loeser et al., 2012). Prolonged mechanical stress on the 
articular cartilage can also cause chondrocytes to release vascular endothelial 
growth factor (VEGF) which can lead to vascularisation of the synovium and 
vascular invasion of the calcified cartilage (Sulzbacher, 2013). 
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Figure 1.8. Healthy knee joint vs osteoarthritic knee joint. Characteristic features 
of osteoarthritis are shown including cartilage degradation, osteophyte formation 
and joint space narrowing. 
 
 
In healthy tissue chondrocytes remain in a quiescent state, with limited 
turnover of cartilage matrix. At the onset of disease, chondrocytes are activated 
and undergo cellular proliferation and increase their production of matrix 
proteins and matrix-degrading enzymes. Matrix-degrading enzymes are 
members of the matrix metalloproteinase (MMP) family and include 
aggrecanases, collagenases, serine and cysteine proteinases (Troeberg and 
Nagase, 2012).  
1.3.1.1 Aggrecanases  
Loss of aggrecan forms part of the initial changes in the cartilage extracellular 
matrix as osteoarthritis develops. Although this is a reversible process, loss of 
aggrecan leads to a reduction in tissue hydration and produces an environment 
were irreversible breakdown of the collagen network can occur (Verma and 
Dalal, 2011). The ADAMTS enzymes (A Disintegrin And Metalloproteinase with 
ThromboSpondin motifs) are a family of metalloproteinases that are involved in 
developmental and homeostatic processes (Kelwick et al. 2015). Several 
members of the ADAMTS family, including ADAMTS-1, ADAMTS-4, ADAMTS-5, 
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ADAMTS-8 and ADAMTS-9 have been shown to degrade aggrecan at a specific 
Glu-Ala site in the integlobular domain between the N-terminal G1 and G2 
globular regions (Fosang et al. 2008, Stanton et al. 2011), forming a sub family 
of enzymes known as aggrecanases.  
ADAMTS-5 has been established as the major aggrecanase in healthy and 
osteoarthritic mouse cartilage. ADAMTS-5 deficient mice are protected from 
aggrecan loss and cartilage erosion in both inflammatory and non-inflammatory 
models of arthritis (Glasson et al. 2005, Stanton et al. 2005). In normal cartilage, 
a tight regulation of ADAMTS-5 is crucial for maintaining a fine balance between 
aggrecan anabolism and catabolism. In this case, ADAMTS-5 is regulated by 
tissue inhibitor of matrix metalloproteinases (TIMPs) but during osteoarthritis 
the ADAMTS-5/TIMP balance is shifted in favour of catabolism (Malfait et al. 
2002).  
TIMPs are important regulators of ECM turnover, tissue remodelling and 
cellular behaviour due to their function as endogenous inhibitors of MMPs, and 
in some instances, of ADAM and ADAMTS (Brew et al., 2010). TIMPs are also 
involved in various biological processes, many of which are independent of 
MMP inhibition, including cell proliferation, anti-angiogenic, pro-and anti-
apoptotic and synaptic plasticity activities (Brew et al., 2010). There are four 
paralogous genes encoding TIMPs-1 to -4. While all four TIMPs inhibit MMPs, 
they each have varying affinities for different inhibitor-protease pairs (Murphy 
et al., 2011). TIMP-3 inhibits several members of the ADAM and ADAMTS 
families, giving it the broadest inhibition spectrum, and also differs from the 
others in being tightly bound to the ECM. In mice, global deletion of TIMP3 
causes lung emphysema-like alveolar damage and faster apoptosis of mammary 
epithelial cells after weaning, suggesting that TIMP3 is a major regulator of 
MMP activity in vivo (Leco et al., 2001). TIMP3 also regulates the processing of 
TNF-α by ADAM17, therefore playing a key role in innate immunity (Murphy et 
al., 2011). 
1.3.1.2 Matrix metalloproteinases  
MMPs participate in the onset of osteoarthritis via the degradation of collagen 
(Troeberg and Nagase 2012). MMPs are zinc-dependant enzymes that play a 
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critical role in the degradation of all types of ECM proteins including 
proteoglycans and collagen, a process central to the pathology of osteoarthritis 
(Troeberg and Nagase, 2012). In normal articular cartilage, chondrocytes 
maintain an equilibrium in which the rate of matrix synthesis equals the rate of 
degradation, which is maintained by TIMPs (Cawston and Young 2010). Among 
other matrix-degrading enzymes, including ADAMTSs, MMPs are synthesised at 
low levels as inactive proenzymes that require enzymatic cleavage to become 
activated, thus contributing to the maintenance of homeostasis (Cawston and 
Young, 2010). In osteoarthritis however, there is a change to this steady state 
which can cause inflammatory cytokines such as interleukin-1 beta (IL-1β) and 
tumor necrosis factor-alpha (TNF-α) to stimulate the activation and production 
of proteolytic enzymes and can disrupt the MMP (or ADAMTS)/TIMP balance 
and lead to breakdown of the cartilage matrix (Burrage et al., 2006).  
MMPs are classified into four major groups, based upon the ECM substrates 
that they cleave: collagenases, gelatinases, stromelysins and membrane type 
MMPs (MT-MMPs) (Cawston and Young, 2010). MMP-2 and MMP-9 are 
gelatinases whose protein levels are increased in the synovial fluid and tissues 
of patients suffering from rheumatoid arthritis (Yoshihara et al., 2000). MMP-3 
(or Stromelysin-1) is a stromelysin that is expressed in cartilage and upregulated 
during osteoarthritis (Chen et al. 2014).  Other stromelysins include MMP-7, -10 
and -11, which act upon proteoglycans, fibronectin and laminin (Knäuper et al., 
1993). MT-MMPs include MMP -14 to -17 and MMP-24 and contain a 
transmembrane and intracellular domain that anchors them to the cell surface 
(Verma and Hansch, 2007). The collagenases consist of MMP-1, -8 and -13 
which cleave native fibrillary collagens, but differ in their specificity for different 
collagens. MMP-1 and MMP-8 cleaves collagen type III and I respectively, while 
MMP-13 cleaves collagen type II (Poole et al., 2002, Burrage et al., 2006) 
1.3.1.2.1 MMP13 
MMP13 is thought to be the collagenase that plays the greatest role in the 
pathology of osteoarthritis with an increase in its expression in the cartilage of 
patients suffering from the disease (Wang et al. 2013). While MMP13 is highly 
efficient at degrading collagen type II, it also degrades proteoglycans, collagens 
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type IV and IX, osteonectin and perlecan (Wang et al., 2013, Goldring, 2012). 
Global knockout of MMP13 in mice demonstrated marked defects in the growth 
plate cartilage with an increase in the hypertrophic zone and delayed 
ossification (Takaishi et al., 2008). Transgenic mice that overexpress MMP13 
specifically in the cartilage develop a phenotype of cartilage degradation that 
strongly resembles that found in osteoarthritis, while cartilage degradation in 
MMP13 deficient mice is inhibited even in the presence of aggrecan depletion 
(Little et al., 2009, Neuhold et al., 2001). MMP-13 activity has therefore been 
implicated as the main collagenolytic activity in osteoarthritis progression.    
1.4 Animal models of osteoarthritis 
Large-scale gene expression studies have showed changes in gene expression in 
late stage osteoarthritis using human cartilage from end stage disease (Geyer et 
al., 2009; Loughlin, 2015). For example, the arcOGEN consortium has been the 
most powerful osteoarthritis genome-wide association study to date, with the 
analysis of over 7400 cases of osteoarthritis (arcOGEN, 2012). This study 
highlighted a number of biological pathways conferring genetic susceptibility to 
osteoarthritis. However, it remains very difficult to obtain human tissue from 
various stages of osteoarthritis and pair it with age-matched control tissue. 
Animal models therefore provide a powerful research tool to allow the study of 
osteoarthritis pathogenesis and progression under controlled conditions were 
the onset of disease and stages can be better defined and evaluated (Little and 
Zaki, 2012; Loeser et al., 2013).  
In vivo animal models are used to study the pathogenesis of osteoarthritis and 
the therapeutic potential of treatment modalities (Lampropoulou-Adamidou 
and Lelovas, 2014). Animal models provide genetically controlled tissue samples 
that are age-matched to study the pathogenesis of osteoarthritis. Osteoarthritis 
models have been developed in both small and large animals; however the 
most commonly utilised animal model remains the mouse for several reasons. 
These include the similarities to human osteoarthritis in the natural progression 
of the disease, the scope for genetic modification, as well as the short timescale 
over which mice develop osteoarthritis and/or age and the low cost compared 
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to larger animals (McCoy, 2015). Osteoarthritis is variable in both etiology and 
treatment and outcomes for patients (Blalock et al., 2015). There are a variety 
of routes to end stage osteoarthritis and they may represent a spectrum of 
diseases with the same endpoint. It is therefore important that osteoarthritis is 
classified into various clinical phenotypes and as such, classify the animal 
models of osteoarthritis into groups and sub-groups that share a relationship 
with the human osteoarthritis phenotypes (Figure 1.9) (Kuyinu et al., 2016). 
 
 
 
Figure 1.9. Animal models that replicate human primary osteoarthritis and 
secondary post-traumatic osteoarthritis in vivo. Typically, osteoarthritis is 
classified into primary and secondary osteoarthritis based on disease etiology. 
Primary osteoarthritis is naturally occurring while secondary post-traumatic 
osteoarthritis is usually associated with risk factors and causes leading to 
osteoarthritis, for example trauma. (OA: Osteoarthritis, PTOA: Post-traumatic 
osteoarthritis). Adapted from (Kuyinu et al., 2016). 
 
 
 
1.4.1 Spontaneous models of osteoarthritis 
The natural slow progression in human primary osteoarthritis is closely 
mimicked by the progression of osteoarthritis in certain animal models 
including the mouse, guinea pig and rabbit (Kuyinu et al., 2016). Osteoarthritis 
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is a degenerative disease and as such occurs predominantly in the elderly 
population, this aging is the major risk factor for spontaneous osteoarthritis; 
the most common form in humans (Chen et al., 2017). Several laboratory 
animals develop osteoarthritis spontaneously including the most common 
C57/BL6 strain, which develops osteoarthritic changes in the knee at 17 months 
of age with an incidence rate of 39-61% (Wilhelmi and Faust, 1976). These 
animal models are therefore valuable tools for studying natural OA 
pathogenesis (Chen et al., 2017). 
The STR/ort mouse is a well described model of spontaneous and naturally 
occurring osteoarthritis (Mason et al., 2001). In 1951, Strong isolated the 
STR/1N mouse strain during an extensive selective-breeding programme that 
was designed to identify traits for resistance to tumour induction at the site of 
injected carcinogens (Strong, 1944). Subsequent strains were treated with the 
carcinogen 20-methylcolanthrene for multiple generations creating the NHO 
strain. This was further treated with the carcinogen 4-methylcholantrene, 
which ended with the generation of the STR/1N strain, later renamed STR/ort, 
who exhibit obesity and spontaneous osteoarthritis at a young age (Staines et 
al., 2017). STR/ort mice develop osteoarthritis in knee, ankle, elbow and 
temporomandibular joints and show progressive molecular changes in 
osteoarthritis that are comparable to human disease, including loss of hyaline 
cartilage, osteophyte formation and subchondral bone sclerosis. The severity of 
articular cartilage lesions in STR/ort mice increases with age, with early 
osteoarthritis histologically visible at 18 weeks of age and late stage visible at 
40 weeks. Additionally, mild osteophytes had developed by 18 weeks compared 
to an increase in osteophyte maturation score by 40 weeks (Poulet et al., 2012). 
These mice, however, have a 50% greater body weight compared to other 
strains of mice, which may explain why osteoarthritis occurs at a much earlier 
stage (Mason et al., 2001). A correlation between osteoarthritis and 
chondrocyte metabolism was discovered utilising the STR/ort mouse model. 
This study found an upregulation of Wnt signalling, which renders adult 
articular chondrocytes susceptible to premature aging and cell death and 
contributes to osteoarthritis pathogenesis (Pasold et al., 2013) 
General Introduction 
 
Page | 32 
 
 Spontaneous models serve as a useful tool for osteoarthritis research as they 
simulate the slow progression of osteoarthritis in humans. However, there are 
major drawbacks to these models, such as the cost and length of time required 
for osteoarthritis to develop. These models do not manifest osteoarthritis until 
maturity and therefore short-term studies are difficult. The variability of disease 
incidence and progression between individual animals is also a major drawback 
(Kuyinu et al., 2016; Fang and Beier, 2014). 
1.4.2 Genetically modified models of osteoarthritis 
The ability to develop transgenic (or genetically modified) mice has become a 
powerful and extensively utilised tool in osteoarthritis research and has allowed 
researchers to understand specific genetic contributions to the pathogenesis of 
the disease (McCoy, 2015). For example, mice deficient in the glycoprotein 
ADAM15 develop osteoarthritis more rapidly compared to wild type mice 
(Böhm et al., 2005). MMP13-knockout mice that had undergone DMM surgery 
(destabilisation of the medial meniscus) are resistant to articular cartilage 
degeneration, indicating that MMP13 is required for the structural cartilage 
damage present in osteoarthritis (Little et al., 2009).  
1.4.2.1.1 Cre-LoxP recombination 
Global and conditional gene deletions often result in embryonic lethality (Mak 
et al., 2011; Ghosh et al., 2009). To overcome these problems the Cre/loxP 
system was developed. Cre recombinase is a 38 kDa protein from the 
bacteriophage P1 that catalyses the recombination between two loxP 
recognition sites (Hamilton and Abremski, 1984). Opposite orientation of the 
two loxP sites mediate the inversion of the intervening DNA by Cre 
recombinase, while loxP sites in the same orientation mediate the excision of 
the intervening DNA leaving only one loxP sequence at the post-recombination 
site (Figure 1.10) (Nagy, 2000). LoxP sites located on different chromosomes 
can mediate a chromosomal translocation (Bouabe et al., 2013). The first 
mouse in vivo experiments demonstrated that the Cre recombinase worked to 
recombine loxP sites in a mouse when expressed from a transgene (Lakso et al., 
1992). 
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Some conventional knockout mutations lead to embryonic lethality which 
hinders the ability to see effect of such a knockout later in development. In 
order to circumvent this problem, conditional deletion or overexpression of 
genes has been utilised using the Cre/loxP system to target the function of 
genes in an inducible manner that controls temporal and tissue-specific 
expression of the gene (Cascio et al., 2014). A requirement for temporal control 
of Cre-mediated recombination is that the inducible Cre recombinase be 
activated only by an exogenous ligand, not endogenous ligands. The inducible 
Cre recombinases are fusion proteins that are fused to specific mutated 
estrogen hormone ligand binding domains (Cre-ERT2), this allows the Cre 
recombinase to be kept in an inactive form in the cytoplasm. Upon binding to 
the exogenous estrogen ligand 4-hydroxytamoxifen, Cre recombinase 
translocates to the nucleus allowing for external temporal control of Cre 
activity, all without being activated by endogenous estrogen (Figure 1.10) (Feil 
et al., 1997; Indra., 1999; Jaisser, 2000). 
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Figure 1.10. Schematic diagram of CreERT2-mediated loxP-deletion system in 
mice. The excision site for the gene of interest (GOI) is flanked by two loxP sites 
(orange arrows). The CreERT2 transgene is introduced into mice by crossbreeding. 
(1) The Cre is fused to mutated hormone-binding domains of the estrogen receptor 
with a G400V/M543A/L544A triple mutation. The CreER recombinases are inactive 
via binding to Hsp90, but can be activated by the synthetic estrogen receptor ligand 
4-hydroxytamoxifen (OHT). (2) Upon treating the mice with tamoxifen, which is 
metabolised to OHT, the Cre recombinases become activated and move into the 
nucleus (3). This allows for the excision of floxed chromosomal DNA in both a 
spatially and temporally manner (4). 
 
 
The key to utilising this system to look into the effects of a particular gene in a 
tissue-specific manner is to identify a regulatory element that can direct the 
expression of the Cre recombinase in the tissue of interest. The excision of 
floxed chromosomal DNA can be controlled both spatially and temporally by 
combining tissue-specific expression of the CreERT2 genes with tamoxifen-
dependent activity in double transgenic mice and treating the mice with 
tamoxifen (Zhang et al., 2012). Cre recombinase has been placed under several 
gene promotors to target chondrocytes. Collagen type II is an early marker of 
chondrogenesis and is expressed from E9.5 in mouse cranial mesenchyme; 
however the expression of Col2a1 promoters do not become restricted to 
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cartilage until E12.5 (Davidson et al., 2014). Transgenic mice were generated 
were Cre recombinase was driven by the Col2a1 promoter, resulting in Col2a1-
driven Cre-ERT2 mice (Zhu et al., 2008). These mice demonstrated deletion of 
the target gene in a cartilage-specific and tamoxifen-inducible manner with high 
efficiency (Chen et al., 2007). The aggrecan promoter, A1, is expressed in 
embryonic and adult cartilage, being mainly restricted to differentiated 
chondrocytes (Han and Lefebvre, 2008). This enhancer was a direct target of 
the SOX trio, were Sox9 was unable to bind without L-Sox5/Sox6 (Han and 
Lefebvre, 2008). This enhancer has since been used to generate a murine line 
that expresses both luciferase and Cre-ERT2 recombinase specifically in 
chondrocytes, allowing the expression of the transgene to be monitored in real 
time using luciferase as a visual aid (Cascio et al., 2014). Prx1-Cre mice were 
also developed were the Cre recombinase expression was placed under the 
control of a 2.4kb regulatory element from the Prx1 promoter that was 
sufficient to drive expression in undifferentiated mesenchyme in the developing 
limb bud and in craniofacial structures during embryonic development from as 
early as E10.5 (Martin and Olson, 2000; Logan et al., 2002). A study utilising the 
Prx1 enhancer in Prx1CreER-GFP mice showed that transgene expression occurs 
in a subpopulation of periosteal cells and that these cells exhibit chondrogenic 
and osteogenic differentiation in culture, indicating that the transgene is 
expressed in osteochondro progenitor cells in the periosteum (Kawanami et al., 
2009). The development of mice harbouring a transgene under the influence of 
the Cre/loxP system allows researchers to carry out inducible gene knockout 
studies in cartilage tissues in a time-specific manner. 
While genetically modified animals serve as a useful tool for studying 
osteoarthritis more rapidly than spontaneous models, many risk factors for 
human osteoarthritis may occur later in life. Similarly, genetic variations 
contributing to the risk of human osteoarthritis generally occur via mechanisms 
more subtle than complete gene inactivation, for example single nucleotide 
polymorphisms and epigenetic changes (SNPs) (Fang and Beier, 2014). Despite 
these limitations, mouse models have already contributed extensively to the 
understanding of cartilage biology, including the biology of normal joints and 
the mechanisms underlying osteoarthritis pathogenesis. In parallel to 
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technological advantages, the continued use of mouse models will continue to 
contribute to the underlying mechanisms of osteoarthritis and perhaps aid in 
the development of therapeutic interventions in the future. 
1.4.2.2 Non-invasive model of post-traumatic osteoarthritis 
Non-invasive models of osteoarthritis can initiate post-traumatic osteoarthritis 
and negate the need of any chemical or surgical intervention, which can cause 
inflammatory changes as a result of infection and relies on the ability of the 
researcher to consistently reproduce the surgery on all animals (Kuyinu et al., 
2016). These models cause injury to the joint through mechanical loading in a 
precise and reproducible manner, but without breaking the skin or disrupting 
the joint capsule. Advantages to using non-invasive models are that early 
adaptive processes, which occur immediately after injury, can also be 
investigated using non-invasive models, and these models more accurately 
mimic the mechanically-induced mechanisms involved in human osteoarthritis 
caused by injury (Christiansen et al., 2015) 
Tibial compression involves subjecting mice to mechanical trauma via cyclic 
axial compressive loads that is applied to the lower leg through the ankle and 
knee joint, with loads transmitted through natural points of articulation and the 
contralateral joint remaining untreated as an internal control (de Souza et al., 
2005). Tibial compression has been used to demonstrate the induction of focal 
cartilage lesions and to determine differences in the short and long-term effects 
on the integrity of articular cartilage after single or multiple loading sessions 
(Poulet et al., 2011). Results showed that cartilage injury can be induced after 
only one loading episode and that multiple loading episodes induces an 
osteoarthritis phenotype which includes proteoglycan loss and the formation of 
osteophytes that increase in severity and are restricted to the lateral femur 
(Poulet et al., 2011).  
1.4.3 Induced models of post traumatic osteoarthritis 
1.4.3.1 Destabilisation of the medial meniscus (DMM) 
Tears to medial meniscus represent a major predisposing factor of joint 
instability and cartilage degradation in humans, and therefore the development 
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of osteoarthritis (Blalock et al., 2015). The murine surgical model of 
destabilisation of the medial meniscus (DMM) is the most widely used model of 
post-traumatic osteoarthritis as it mimics clinical meniscal injury and has 
become a gold standard for studying the onset and progression of the disease 
(Culley et al., 2015). DMM is performed by transection of the medial 
meniscotibial ligament (MMTL). Following the initial incision, the joint capsule 
on the medial side is incised using scissors to expose either the intercondylar 
region or the MMLT, which anchors the medial meniscus to the tibial plateau. 
The MMLT is cut, releasing the ligament from the tibial plateau thus 
destabilising the medial meniscus resulting in joint instability, resulting severity 
can vary between performing surgeons depending on the technique used 
(Culley et al., 2015). This instability leads to cartilage degradation, osteophyte 
formation and subchondral bone sclerosis (Glasson et al., 2004). Changes at the 
histological level can be seen from 6 hours post-surgery and include changes in 
the expression levels of cartilage matrix proteases. This rapid induction of 
osteoarthritis allows studies to be performed in a relatively short time frame 
(Burleigh et al., 2012). When used simultaneously with genetically modified or 
engineered mouse models, DMM surgery allows the study of a given gene in 
osteoarthritis initiation and/or progression. In mice, it has been reported that 
sex hormones play a critical role in the progression of osteoarthritis in the DMM 
surgical model, with males presenting with more severe osteoarthritis than 
females (Ma et al., 2007). 
Examination of the roles of AdamTS4 and AdamTS5 were performed using the 
murine DMM model. These studies identified AdamTS5 as the primary 
aggrecanase in mice after AdamTS5-deficient mice were protected from 
cartilage degradation following DMM surgery, but AdamTS4-deficient mice 
were not (Glasson et al., 2005; Glasson et al., 2004). Syndecan-4, a 
transmembrane heparin sulfate proteoglycan that regulates mesenchymal cell 
function during tissue repair, has also been shown to be functionally involved in 
cartilage remodelling. It was reported that Syndecan-4 knockout in transgenic 
mice prevented osteoarthritic damage to cartilage after DMM-induced 
osteoarthritis (Echtermeyer et al., 2009). 
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The mouse DMM model has also been used to examine gene expression 
profiles shortly after joint destabilisation, replicating what might happen after a 
medial meniscal tear in humans (Burleigh et al., 2012). Transcriptional analysis 
revealed changes in the regulation of extracellular matrix genes in late stage 
osteoarthritis (8 weeks post DMM surgery) induced by DMM (Gardiner et al., 
2015). It has also been shown that male mice who had undergone DMM 
surgery presented with more severe osteoarthritis than their female 
counterparts, revealing a role for hormones and sex in the progression of 
osteoarthritis (Ma et al., 2007). The DMM model is therefore ideal for studying 
osteoarthritis pathophysiology and its underlying mechanisms due to its 
reliability and reproducibility (Kuyinu et al., 2016). 
1.4.3.2 Chemically induced models of osteoarthritis 
Rapid osteoarthritis progression can also be induced using intra-articular 
injection of chemicals. Among the most commonly used approaches is the 
injection of monoiodoacetate (MIA), an inhibitor of glycolysis that causes 
chondrocyte death, neovascularisation, necrosis of the subchondral bone and 
inflammation (Guzman et al., 2003). The initiating event and pathological 
changes, however, are not typical of human osteoarthritis and differences in 
the transcriptome of cartilage from MIA-induced arthritis and human 
osteoarthritis have been reported (Barve et al. 2007). Other approaches include 
injection of carrageenan, collagenase and sodium urate; however the resulting 
pathology from these alternative approaches are also not generally accepted as 
being representative of human osteoarthritis (van Osch et al., 1993). While 
chemically induced models of osteoarthritis result in a rapid induction of 
disease, these models are less clinically relevant than other osteoarthritis 
models due to vast differences in the cartilage transcriptome when compared 
to human osteoarthritis (Barve et al., 2007).  
 
1.5 Post transcriptional regulation 
While it is known that osteoarthritis is a multi-factoral disease of the joint, 
genetic factors contribute to the development and progression of the disease 
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(Vincent and Watt, 2018; Chen et al., 2015). Recent evidence suggests that 
epigenetic and post-transcriptional regulation of critical genes in articular 
chondrocytes and in patients with osteoarthritis may contribute to the 
development and progression of disease (Fernández-Tajes et al., 2014). 
The post-transcriptional regulation of mRNA in articular chondrocytes is an 
efficient way to control the speed at which gene expression changes and 
appears to be important for sustaining cellular metabolism, coordinating 
chondrocyte maturation, stability and the degradation of RNAs, as well as 
maintaining the homeostasis of extracellular matrix synthesis (Bushati and 
Cohen, 2007; Tew and Clegg, 2010). To achieve correct spatial and temporal 
distribution of proteins, mRNAs are subjected to a complex array of regulatory 
controls during their transcription and translation. This can occur at a variety of 
levels including alternative splicing, transport, alternative polyadenylation and 
altered mRNA stability (Glisovic et al., 2008).  
In the vast majority of genes, UTRs are important regulatory elements that play 
major roles in the post-transcriptional regulation of gene expression 
(Matoulkova et al., 2012). In cooperation with various RNA-interacting factors, 
UTRs regulate mRNA stability, sub-cellular localisation, mRNA export to the 
cytoplasm and influence the total amount of synthesised protein during 
translation (García-Mauriño et al., 2017). Primary mRNA transcripts are 
endonucleolytically cleaved and most acquire a poly(A) tail in a nuclear process 
known as mRNA 3’ end formation, a crucial step that is essential for the 
development of mature mRNA  (Millevoi and Vagner, 2010). The 3’ end is 
cleaved at polyadenylation site (pA site) and the poly(A) tail is then attached to 
the primary transcript by poly(A) polymerase (PAP). Poly(A) binding protein 
(PABP) then recognises and binds to the poly(A) sequence, which requires a 
minimum of 27 adenines for stable 3’ end protection (Millevoi and Vagner, 
2010). Polyadenylation is an important process that protects the 3’ end from 
degrading exonucleases and for the export of mRNA to the cytoplasm (Millevoi 
and Vagner, 2010). 
UTRs possess a variety of cis-acting regulatory elements that are recognised by 
binding trans-acting elements. Their interplay is crucial for the post-
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transcriptional regulation of gene expression (Matoulkova et al., 2012). 
Adenylate uridylate (AU-rich) elements (AREs) are the most common regulation 
elements within the 3’ UTR and are the major elements responsible for 
translational repression and mRNA destabilisation (Barreau et al., 2005). Their 
presence is typical for short-lived mRNAs involved in early or transient 
regulatory responses (Matoulkova et al., 2012).  
While the rate of transcription and translation controls mRNA and protein 
levels, the stability and rate of decay is also involved in its expression levels in a 
highly controlled manner and can be perturbed during osteoarthritis (Tew et al., 
2014) 
Many aspects of mRNA stability and translatability are controlled by regulatory 
molecules that interact with the transcript itself. These most commonly include 
RNA binding proteins (RBPs) and small non-coding RNAs such as microRNAs 
(miRNAs). Interactions with RNA binding proteins or miRNAs leads to transcripts 
existing as ribonucleoprotein complexes within the cytoplasm (Gerstberger et 
al., 2014; Wahl et al., 2009).  RBPs and miRNAs interact specifically with the 
target transcript via nucleotide sequence and/or secondary structure. (Jiang 
and Coller, 2012). Both RBPs and miRNAs have been implicated in the 
pathogenesis of osteoarthritis in recent studies. A recent study by our group 
demonstrated for the first time how RNA binding proteins are able to post-
transcriptionally regulate gene expression in human chondrocytes (McDermott 
et al. 2016). Human articular chondrocytes were isolated from osteoarthritic 
knees and, alongside the SW1353 chondrosarcoma cell line, were treated with 
siRNA to mediate the knockdown of RNA binding proteins. siRNA are dsRNA 
with 2nt 3’ end overhangs that activate RNA interference (RNAi), leading to the 
degradation of mRNAs in a sequence-specific manner dependent upon 
complimentary binding of the target mRNA (Ambesajir et al., 2012). qRT-PCR 
analysis revealed significant increases in SOX9 mRNA, mRNA half-life and 
protein expression when the RNA binding protein tristetraprolin (TTP) was 
knocked down, indicating that TTP contributes to SOX9 mRNA instability. This 
also resulted in a stimulation of aggrecan mRNA expression. MMP13 expression 
was also significantly increased upon HuR knockdown and a number of known 
General Introduction 
 
Page | 41 
 
transcriptional repressors of MMP13 were found to be regulated by HuR. HuR 
therefore appears to act as an overall negative regulator of MMP13, particularly 
due to its influence on supressing the expression of RUNX2, SP1 and USF1, all 
transcriptional repressors of MMP13  (McDermott et al. 2016).  
Recent studies have also identified miRNAs that are involved in many 
pathological conditions, including osteoarthritis, and are also involved in the 
post-transcriptional regulation of catabolic and anabolic mRNAs. MMP13 was 
also identified as a direct target of miR-411 in chondrocytes and an 
overexpression of miR-411 led to an inhibition of MMP-13 expression (Wang et 
al. 2015).  
 
1.5.1 Micro RNAs 
Micro RNAs (miRNAs) are endogenous non-coding RNAs that have been 
implicated in the negative regulation of protein expression and RNA stability 
(Chen et al., 2015). miRNAs are first processed in the nucleus and RNA 
polymerase II (Pol II) is mainly responsible for the transcription of miRNA genes 
(Lee et al., 2004). Pol II-dependent miRNA gene expression enables temporal 
control, so that a specific set of miRNAs can be synthesised according to specific 
conditions and cell types. The product of Pol II-mediated expression is known as 
the pri-miRNA, which are usually several kilobases long and contain local 
hairpin structures. The pri-miRNA produced by Pol II is cleaved at the stem of 
the hairpin, which releases approximately 60-70 nucleotides called the 
precursor miRNA (pre-miRNA) (Zeng and Cullen, 2003). This processing step is 
performed by Drosha, which requires the DiGeorge syndrome critical region in 
gene 8 (DGCR8) in humans (Drosha-DGCR8 complex). Drosha, in conjunction 
with DGCR8, forms a large complex known as the microprocessor complex (Han 
et al., 2004). DGCR8 guides Drosha to slice pri-miRNA. Drosha cleaves RNA 
duplexes and thus processes the pri-miRNA to the pre-miRNA (Han et al., 2006). 
Pre-miRNAs are transported into the cytoplasm for further processing to 
become mature miRNAs. The nuclear cleavage process by Drosha defines one 
end of the mature miRNA. The pre-miRNA is released in the cytoplasm and is 
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subsequently processed by the endonuclease cytoplasmic Rnase III enzyme, 
Dicer, to create a mature miRNA (Hutvágner et al., 2001). Dicer is a highly 
specific enzyme that measures ~22nt from the pre-existing terminus of the pre-
miRNA and cleaves the miRNA strand (Figure 1.11). In order to degrade target 
mRNAs, miRNAs are bound by argonaute (AGO) subfamily proteins, forming a 
ribonucleoprotein complex called the RISC (RNA-induced silencing complex) 
(Nakanishi, 2016).  The miRNA-RISC complex induces gene silencing via 
translational repression or mRNA cleavage through sequence-specific 
interactions with the 3’ untranslated regions (UTRs) of specific target mRNAs 
(Figure 1.11) (Miyaki et al., 2009; Bushati and Cohen, 2007).  
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Figure 1.11. Schematic of how miRNAs are processed and their actions on mRNAs. 
miRNAs are processed in the nucleus and transcribed to pri-miRNA by polymerase 
II. Pri-miRNA is processed by DGCR8/Drosha complex to pre-miRNA, exported to 
the cytoplasm via exportin-5, where it is processed by Dicer to create mature 
miRNA. Argonaute binds mature miRNA, forming a complex called RISC, which 
induces gene silencing via mRNA cleavage or translational repression (Adapted 
from Lin and Gregory, 2015) 
 
The first miRNA to be specifically implicated in cartilage regulation was miR-
140, the expression of which was found to be restricted to the cartilage of the 
jaw, head and fins in a zebrafish model (Wienholds et al., 2005). Cartilage-
specific expression of miR-140 has also been reported in murine embryos, were 
histone deacetylase 4 (HDAC4) was also identified as a target of miR-140 
(Tuddenham et al., 2006). HDAC4-null mice display premature ossification due 
to early onset of chondrocyte hypertrophy, while mice overexpressing HDAC4 
results in an inhibition of chondrocyte hypertrophy and differentiation (Vega et 
al., 2004). These studies establish HDAC4 as a central regulator of chondrocyte 
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hypertrophy. Interestingly, expression levels of miR-140 are reduced in human 
osteoarthritis cartilage and is shown to correlate with MMP13 and IGFBP-5 
expression, both chondrocyte markers (Glasson et al., 2005). It has also been 
reported that miR-140 expression is suppressed by IL-1β, an inflammatory 
cytokine, which results in the chondrocyte-specific upregulation of the miR-140 
target ADAMTS5 (Glasson et al., 2005, Stanton et al., 2005). Combined, these 
findings indicate that miR-140 contributes a key role in cartilage development, 
matrix homeostasis and osteoarthritis (Miyaki et al., 2009).  
miRNAs and RBPs have generally been considered separate transcript 
degradation pathways, however it has recently been suggested that RBPs can 
be implicated in the regulation of miRNA activity through synergistic activity at 
the level of transcript decay, and by directly affecting the miRNAs (Jiang and 
Coller, 2012).  
1.5.2 RNA binding proteins 
RNA binding proteins are regulators of post-transcriptional gene regulation and 
are involved in the regulation of all steps of RNA biogenesis (Wurth, 2012). RNA 
binding proteins are classified based on their specific RNA binding domain and 
are able to regulate the fate of their target mRNA in a time- and space-
dependant manner (Gerstberger et al., 2014). There are 4 main classifications 
of RNA binding domain families: RNA recognition motifs (RRM), zinc-finger 
domains, K homology (KH) domains and double-stranded RNA binding motifs 
(dsRBMs) (Cléry, 2013). The RRM is the most abundant RNA-binding domain 
and subsequently the most studied (Maris et al., 2005). HuR is a ubiquitously 
expressed RNA binding protein that contains 3 RRMs that bind to AU rich 
elements of mRNAs and works by stabilising target mRNAs to post-
transcriptionally regulate many biological processes including cellular 
proliferation, growth and survival pathways (Dai et al., 2011). Zinc fingers are 
classical DNA-binding proteins that also bind RNA (Lunde et al., 2007). TTP is a 
well characterised member of a protein family that contain tandem CCCH zinc 
fingers and is crucial in preventing chronic inflammation as a feedback inhibitor 
by shutting down the pro-inflammatory response (Sanduja et al., 2012). The KH 
domain is found in proteins that have different functions including 
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transcriptional and translational regulation and splicing (Cléry, 2013). KH-type 
splicing regulatory protein (KSRP) binds to AU-rich element-containing mRNAs 
and is involved in the regulation of mRNA stability, with KH domains 3 and 4 of 
KSRP being required to promote ARE (adenosine and uridine-rich sequence 
element)-containing mRNA decay.  KSRP is also an integral part of the Dicer and 
Drosha complexes and regulates the biogenesis of a subset of mRNAs 
(Trabucchi et al., 2009). dsRBMs are essential for the preferential binding of 
dsRNA-binding proteins to double stranded RNA (dsRNA). dsRNA-binding 
proteins contain one or more dsRBMs and primarily interact with the A-form 
double helix, which has a shallow and broad minor groove and a narrow and 
deep major group in contrast to the typical dsDNA B-form helix, with no binding 
to ssRNA, ssDNA or dsDNA (Coolidge and Patton, 2000). Staufen1 (Stau1) is a 
dsRNA-binding protein involved in many post-transcriptional regulatory 
processes including its direct interaction with the ribosome to regulate 
translation, Staufen-mediated mRNA decay  and alternative splicing (Ricci et al., 
2014). While Stau1 is not essential for development, Stau1-deficient mice have 
defects in locomotor activity (Vessey et al., 2008). Together with miRNAs RNA 
binding proteins can also form micro ribonucleoprotein (miRNPs) and bind to 
complementary sequences in target mRNAs to regulate translation and RNA 
stability (Wurth, 2012).   
AREs are a major class of cis-elements located in the 3’ UTR that target mRNAs 
for degradation thereby regulating transcript stability and its translational 
efficiency and localisation (Fan and Steitz, 1998b; Wurth, 2012).  RNA binding 
proteins bind to specific sequences in the 3’ UTRs of target mRNAs via RNA 
binding domains thereby regulating mRNA decay (Wurth, 2012). RNA binding 
proteins have not yet been extensively studied in musculoskeletal diseases, but 
evidence exists that a number of them have key roles to play in ensuring 
homeostasis of these tissues. Recently, transgenic mouse models have been 
generated which target the proteins involved in the regulation and stability of 
ARE-containing mRNAs and examine the role of factors affecting mRNA decay 
rates. TTP is a signal-induced anti-inflammatory RNA-binding protein that binds 
ARE-elements to promote mRNA decay by guiding unstable mRNAs or pro-
inflammatory proteins for degradation and preventing translation in order to 
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shut-down the pro-inflammatory response and prevent chronic inflammation 
(Sanduja et al., 2012). Mice deficient in TTP develop a severe inflammatory 
phenotype 1-8 weeks after birth, including the development of erosive arthritis, 
alopecia, dermatitis, left-sided cardiac valvulitis, myeloid hyperplasia and 
autoimmunity (Taylor et al., 1996). The arthritis observed in TTP-null mice 
resembles inflammatory synovitis in humans, while cartilage and bone erosion 
coupled with synovial lining cell proliferation and altered patterns of joint 
involvement are similar to those seen in rheumatoid arthritis in humans (Taylor 
et al. 1996). These effects are caused largely, but not exclusively, by an increase 
in the stability of TNF mRNA leading to the overproduction of this cytokine in 
the myeloid compartment. Many of the observed phenotypes can be prevented 
with an injection of monoclonal antibodies that neutralise TNFα (Taylor et al., 
1996), or by creating dual knockouts of TTP and TNFα receptor (Carballo and 
Blackshear, 2001). TTP is also able to auto-regulate its own expression by 
binding to an ARE within its 3’UTR (Brooks et al. 2004). Interestingly, in human 
articular chondrocytes, previous work from our group has shown that TTP can 
regulate SOX9 mRNA stability and that TTP can bind to SOX9 mRNA 3’UTR 
elements (McDermott, 2016). 
 
1.5.2.1 HuR 
1.5.2.1.1 Structure and general function of HuR 
Human antigen R (HuR; also known as ELAVL1) is a member of the ELAV 
(embryonic lethal abnormal vision) RNA-binding protein family. HuR is a 
ubiquitously expressed RNA binding protein that contains two N-terminal RNA 
recognition motifs (RRMs) with high affinity to AU-rich elements, one C-
terminal RRM and the HuR nucleocytoplasmic shuttling domain between (HNS) 
RRM 2 and 3 (Güttinger et al., 2004; Uren et al., 2011) (Figure 1.12). HuR is 
predominantly nuclear were it is involved in the regulation of transcript splicing 
(Fan and Steitz, 1998). Alternative splicing of pre-mRNAs is a mechanism that 
produces multiple transcripts from a single gene, thereby contributing to 
transcriptome diversity.  This process is the deviation from the normal process 
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were introns are removed and exons are ligated in a sequential order, instead 
certain exons are skipped resulting in various forms of mature mRNA (Wang et 
al., 2015). HuR activity and function is associated with its subcellular 
distribution, translational and post-translational modifications and 
transcriptional regulation (Wang et al., 2013). RNA-binding proteins are key to 
the regulation of splicing and can interact with intronic and/or exonic 
sequences (Akaike et al., 2014). It has been reported that polypyrimidine tract-
binding protein 2 (PTBP2), itself an alternative splicing regulator expressed 
primarily in the brain, is alternatively spliced by HuR, were HuR knockdown 
increases the expression of exon 10 by 65% compared to  exon 9 and 11 
(Lebedeva et al., 2011). Exon 10 is flanked by HuR binding sites and the skipping 
of this exon leads to nonsense mediated decay (NMD) (Spellman et al., 2007).  
The nucleocytoplasmic shuttling domain allows HuR to shuttle to the cytoplasm 
were it binds to AU-rich elements (ARE) located in the 3’ untranslated region 
(UTR) of target mRNAs to modulate transcript stability and/or translation (Fan 
and Steitz, 1998c; Brennan and Steitz, 2001).  
 
 
 
Figure 1.12. Schematic diagram of the domain organisation of HuR. 
HuR contains 3 RNA recognition motifs (RRMs) and a hinge region 
(HNS) between RRM2 and RRM3. 
 
 
Previous work has led to the identification of the low-molecular-weight 
chemical inhibitor of HuR, MS-444 (Meisner et al., 2007). MS-444 is produced 
by a gram-positive bacteria Micromonospora and was originally characterised 
as a myosin light chain (MLC) kinase inhibitor (Blanco et al., 2016). As well as its 
role as a MLC kinase inhibitor, it was later found that MS-444 also inhibits HuR 
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homodimerisation and HuRs cytoplasmic translocation thereby preventing its 
function as a stabiliser of target mRNAs, and resulting in growth inhibition and 
loss of cytokine expression in inflammatory cell models (Meisner et al. 2007). 
This was the first time HuR had been identified as a drugable protein and also 
highlighted MS-444 as a potentially valuable tool for studying HuR function.  
Previously, it was identified that there was an enhanced expression of HuR 
during colon tumorigenesis, which correlated with poor clinical prognosis 
(Young et al., 2009). More recently, treatment with MS-444 was able to 
attenuate colorectal cancer tumour growth both in vitro and in vivo through 
enhanced apoptosis and decreased angiogenesis, supporting the notion that 
HuR may potentially be a valuable therapeutic target in a variety of cancers and 
that pharmacological inhibitors of HuR such as MS-444 may be useful tools in 
this process (Blanco et al., 2016). 
It has been suggested that HuR may bind to its target mRNAs in the nucleus and 
escort them to the cytoplasm while competing with mRNA decay inducing RBPs. 
This is due to HuR’s apparent reliance on stress signals when binding to target 
mRNAs that result in HuR becoming phosphorylated or methylated (Kim et al., 
2008; Li et al., 2002). For example, ultra-violet light stress has been associated 
with the mobilisation of prothymosin α (ProTα), an oncoprotein that promotes 
cell proliferation and prevents cell death, from the nucleus to the cytoplasm in 
a HuR-mediated fashion (Lal et al., 2005). 
Cross-linking immunoprecipitation analysis has identified over 4700 transcripts 
in the human genome that are known to associate with HuR (Uren et al., 2011; 
Lebedeva et al., 2011). In vitro studies have also shown that HuR is implicated in 
many pathophysiological processes, including tumorigenesis, cell-cycle control 
and inflammation, by targeting several mRNAs associated with development 
including growth factors, cyclins and cyclin inhibitors, proto-oncogenes and 
cytokines (Abdelmohsen et al., 2007; Brennan et al., 2001; Katsanou et al., 
2005). 
The HuR protein is extensively expressed in many cell types, including adipose, 
intestine, spleen and testis. As such, HuR has been implicated in a variety of 
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biological processes and has been linked to a number of diseases, particularly 
cancer and inflammation (Srikantan et al., 2012). A number of cancer-related 
transcripts containing ARE’s, including mRNAs for proto-oncogenes, cytokines, 
growth factors, and invasive factors, have been characterised as HuR targets. 
Increasing evidence supports HuR as the first RBP that is shown to play a critical 
role in carcinogenesis and caner progression by functioning as either an 
oncogene or a tumor suppressor regulating the expression of various target 
genes. Clinical data suggest that HuR overexpression is significantly related to 
specific clinical and pathological features, advanced stage, positive lymph nodes 
and poor survival in cancer patients (Wang et al., 2013). 
HuR has also been implicated in promoting inflammation and inflammatory 
diseases. The pro-inflammatory influence of HuR is linked to its interaction with 
mRNAs encoding pro-inflammatory proteins, most prominently TNF-a and IL-6, 
leading to their increased production in a variety of cell types, including 
fibroblasts and macrophages (Katsanou et al., 2005). Some anti-inflammatory 
cytokines also repress HuR function, for example IL-10 inhibits inflammation, in 
part by repressing the HuR-mediated stabilisation of mRNAs encoding pro-
inflammatory cytokines in monocytes and inflammatory cells in the 
myocardium (Krishnamurthy et al., 2009). The involvement of HuR in 
rheumatoid arthritis was suggested based on its promotion of TNF-a 
expression, while HuR-regulated COX-2 was associated with the development of 
rheumatoid and osteoarthritic cartilage (Srikantan et al., 2012). Interestingly, 
there is evidence for functional antagonism between HuR and TTP. In normal 
cells, COX-2 is regulated by AREs present in the mRNA, with HuR having been 
demonstrated in promoting the stability of COX-2 (Dixon et al., 2000; Dixon et 
al., 2001). In cancer cells however, a dysregulation in COX-2 mRNA stability 
promotes tumor growth and contributes the immune evasion and resistance to 
cancer immunotherapy (Liu et al., 2015). Previously, it has been demonstrated 
that during colon carcinogenesis increased HuR expression occurs alongside the 
reduction of TTP expression, correlated with an increase in COX-2 expression 
and substantially increasing its half-life (Young et al., 2009). This suggested that 
TTP antagonises HuR-mediated COX-2 mRNA stability and implied that TTP 
reduction and HuR gain of function are both required for COX-2 overexpression 
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(Young et al., 2009). In inflammation, it has been reported that HuR does not 
alter the levels of target cytokine mRNAs in the absence of TTPs destabilising 
functions, but synergises with a translational silencer called TIA-1 to reduced 
mRNA translation of the target cytokines (Katsanou et al., 2005). 
Many studies implicating HuR in additional diseases are rapidly emerging. In 
most of these, HuR elicits phenotypic trails previously described, including the 
promotion of inflammation, proliferation, angiogenesis and resistance to 
apoptosis. HuR has been implicated in cardiovascular disease, neurological 
pathologies, muscular disorders and lymphoproliferative disease (Srikantan et 
al., 2012). 
 
1.5.2.1.2 Regulation of HuR 
There are many molecules that regulate the transcriptional and post-
transcriptional regulation of HuR. For example, in gastric tumorigenesis the 
activation of AKT signalling increases the binding of the transcription factor 
p65/RelA (Rel-like domain-containing proteins) to a putative NF-ΚB (nuclear 
factor kappa-light-chain-enhancer of activated B cells) binding site in the HuR 
promoter (Kang et al., 2008). This study revealed HuR to be a direct 
transcription target of NF-ΚB (Kang et al., 2008). In addition, HuR is regulated by 
many miRNAs and RNA-binding proteins at the post-transcriptional level 
including TTP, RNPC1 (ribonucleoprotein C1), Mdm2 (murine double minute 2) 
and Hsf1 (heat shock transcription factor 1) (Figure 1.13) (Embade et al., 2012; 
Gabai et al., 2012; Al-Ahmadi et al., 2009). Interestingly, in normal cells, TTP 
binds and controls HuR mRNA through competition for the binding of HuR itself 
(auto-regulation) to its 3’UTR. An imbalance in HuR-TTP levels results in an 
increase in the invasiveness of cells during cancer progression (Astakhova et al., 
2009; Talwar et al., 2011).  
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Figure 1.13. Translational and post-translational regulators of HuR 
(Adapted from Govindaraju and Lee, 2013). 
 
 
As HuR is predominantly nuclear, the export of HuR to the cytoplasm is needed 
for HuR to function as an mRNA stabiliser. There are many stimuli that can alter 
HuR-dependant mRNA stability including cytokines, inflammatory mediators 
and oxidative stress and can result in alterations in HuR trafficking and changes 
in HuRs affinity for its target mRNAs (Abdelmohsen et al., 2008). This process is 
regulated by post translational modifications of HuR (Shen and Malter, 2015). 
Post-translational modifications give rise to acetylation, methylation and 
phosphorylation upon the chemical addition of different functional groups 
(acety-, methyl- and phosphor-, respectively). It has previously been reported 
that HuR is phosphorylated at many sites during nuclear export under various 
stress stimuli and this process results in an increase in the mRNA decay of 
target transcripts (Winzen et al., 1999; Doller et al., 2008). For example, 
oxidative stress, via cell-cycle checkpoint kinase 2 (Chk2) phosphorylation of 
HuR in human diploid fibroblasts, leads to an increase in SIRT1 mRNA due to 
dissociation of HuR-bound SIRT1 mRNA (Abdelmohsen et al., 2007). HuR is also 
subject to methylation. This was observed in cells overexpressing CARM1 and in 
macrophages stimulated with lipopolysaccharide, in both instances TNFα was 
stabilised (Li et al., 2002). Interestingly, this methylation also involves 
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competition of HuR with TTP for binding the ARE-containing TNFα mRNA (Dean 
et al., 2001; Carballo et al., 1998). 
Primary sequence specificity is often crucial for binding-site recognition by RNA 
binding proteins (Li et al., 2014). Experimental computational analysis have 
been utilised to identify consensus binding sequences for RNA binding proteins 
and has led to the identification of a 17-20 base long RNA general consensus 
sequence (NNUUNUUU) that is rich in uracil and was found in almost all mRNAs 
that have previously been reported as HuR targets (de Silanes et al., 2004; Li et 
al., 2014). 
SELEX (systematic evolution of ligands by exponential enrichment) is a low-
throughput method for detection of RNA binding protein sequence-binding 
preferences in vitro (Tuerk and Gold, 1990). This method involves the selection 
of high-affinity binding sequences from a randomised RNA oligonucleotide pool 
through purified protein, each then followed by PCR amplification. Resulting 
products are subsequently cloned and sequenced, which identifies a set of 
short sequences that are preferred by the particular protein (Li et al., 2014). 
Using the SELEX method, previous studies have reported that HuR has a ~10 
fold higher affinity to the U-rich sequence than for the AU-rich sequence, 
suggesting this may be the preferred binding sequence of HuR (Sokolowski et 
al., 1999). RIP-seq is a method used to investigate direct and indirect targets of 
a protein. Using a novel conditional knock-out model of HuR during CD4+ T 
activation, Techasintana et al performed RIP-seq then combined the data with 
data from RNA-seq to determine the direct and indirect target transcripts of 
HuR (Techasintana et al., 2014). This study showed that HuR may regulate 
genes in multiple canonical pathways involved in T cell activation as it identified 
known, and new, putative HuR-associated targets that are crucial for cytokine 
production, particularly the CD28 family signalling pathway (Techasintana et al., 
2014).  
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1.5.2.1.3 In vivo models of HuR 
A transgenic mouse model was used to overexpress HuR in the myeloid lineage 
which led to translational silencing of the ARE-containing transcripts, including 
TNF-α (tumor necrosis factor alpha) and Cox2 (cyclooxygenase 2), despite 
normal turnover (Katsanou et al., 2005). A role for HuR in germ cell function has 
also been suggested as a result of impaired gametogenesis in transgenic mice 
that overexpress HuR globally (Levadoux-Martin et al., 2003). Cre/loxP-
mediated postnatal global deletion of HuR in 8 week old mice resulted in 
cachexia and leathality within 10 days of tamoxifen administration, suggesting 
that HuR is essential for postnatal life. These HuR-null mice also presented with 
atrophy of organs involved in the immune and hematopoietic systems including 
bone marrow, thymus, spleen and lymph nodes (Ghosh et al., 2009). At the 
cellular level, HuR function was essential for cell survival as ablation of HuR led 
to a rapid induction of apoptosis in progenitor cells, whereas quiescent stem 
cells and differentiated cells were unaffected. As HuR levels declined, 
expression of the oncogene P53 that is critical for cell death was induced in 
progenitor cells. It was also reported that HuR binds and stabilises Mdm2 
mRNA, a critical regulator of p53, suggesting that HuR acts to regulate p53 
levels in progenitor cells and promote cell survival. This was the first time HuR 
had been reported as an essential post-transcriptional regulator in the survival 
of progenitor cell populations in hematopoietic and intestinal systems in vivo. 
This study, however, did not examine the functions of HuR in differentiated 
cells and quiescent stem cells, which do not require HuR for survival. 
Previous work generated a conditional allele of HuR by flanking its ATG-
containing second exon with two loxP sites, these mice were then crossed with 
transgenic mice that expressed Cre in the germ line in order to generate HuR 
null mice in the F2 progeny (Katsanou et al, 2009). Germline knockout of HuR in 
mice led to embryonic lethality after E14.5 (embryonic day 14.5) due to defects 
in labryrinth branching morphogenesis and syncytiotrophoblast differentiation 
during placental development (Katsanou et al., 2009). To overcome this 
embryonic lethality, HuR was knocked out using the Cre/loxP system where Cre 
was under the control of the Sox2 promotor. This allowed efficient loss of HuR 
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function in epiblasts that give rise to the embryo but not in the trophectoderm-
derived trophoblast cell types of the placenta. The epiblast-specific deletion of 
HuR in Sox2 Cre+ Elavl1-/- embryos led to smaller embryos past E14.5 that had 
lung dysmorphia and were devoid of spleens, and embryonic lethality between 
E17.5 and E19.5. Interestingly, HuR-null embryos displayed severe defects in 
skeletal development with a reduction in limb size with minimal ossification 
zones in scapulae, femurs and tibia, a fusion of the digits and a delay in 
endochondral ossification and osteogenic ossification of the craniofacial 
structures, with the exception of the mandibles (Figure 1.14). Another 
interesting observation was an incomplete fusion of the thoracic cage due to an 
open and bifid xyphiod process and a complete absence of ossified neural 
spines and zygapophyses in HuR null embryos. A less penetrant phenotype also 
occurred in less than 15% of embryos were HuR null embryos developed severe 
nasal clefting (Katsanou et al., 2009).  
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Figure 1.14. Comparison of alcian blue (cartilage) and alizarin red (bone) stained 
Sox2 Cre+ Elavl1+/- and Sox2 Cre+ Elavl1-/- E17.5 embryos. Craniofacial structures (D-
F), ribs (G-H) and long bones (I, K) all show deformities in the development of the 
skeleton with a lack of mineralisation in HuR-deficient embryos. There is also a 
fusion of the digits in the forepaw (J) and hind paw (L) (Taken from Katsanou et al., 
2009). 
 
 
Cytoplasmic HuR has the ability to interfere with the binding or activity of 
multiple other ARE binding proteins that function to promote mRNA turnover, 
and contribute to the stabilisation of different target mRNAs (Brennan and 
Steitz, 2001). It has therefore been suggested that HuR may regulate gene 
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expression by modulating the activity of miRNAs, which would result in the 
enhanced translation or stability of mRNA (Bhattacharyya et al., 2006). 
Recently, our laboratory has reported that siRNA-mediated knockdown of HuR 
mRNA in vitro resulted in a reproducible and significant increase in the 
expression levels of MMP13 in human articular chondrocytes (McDermott et 
al., 2016). In the same study, immunohistochemical analysis of developing 
mouse cartilage found that HuR protein is ubiquitously expressed throughout 
the developing embryo. Interestingly however, the condensing mesenchyme in 
the digits revealed a “checkerboard” pattern of HuR protein expression were 
cells that were strongly positive for HuR were positioned alongside cells with a 
weakened stain for HuR. HuR protein expression was also found to be reduced 
in hypertrophic chondrocytes of the costal cartilage, in the long bones of the 
fore and hind limb and in cells adjacent to the perichondrium in E16.5 embryos, 
these areas are implicated in the regulation of long bone growth and 
mineralisation (Vortkamp et al., 1996). In relation to MMP13, protein levels of 
HuR were reduced in hypertrophic chondrocytes and those in the earlier stages 
of differentiation were MMP13 expression levels were increased. Curiously, 
HuR levels do not affect the rate of MMP13 mRNA decay, which suggests that 
the regulation of MMP13 by HuR may occur in an indirect manner (McDermott 
et al., 2016). This data suggests a complex role of HuR in skeletal and embryonic 
development or that HuR indirectly regulates chondrocyte function through the 
post-transcriptional control of one or more regulatory genes. 
 
1.6 Research Aims and Hypothesis 
There is evidence from the literature that HuR influences skeletal development 
as well as the expression of markers of joint disease. Based upon this, the 
hypothesis of this thesis was that HuR regulates cartilage differentiation during 
development and degradation during disease progression. To test this 
hypothesis, the overall aims of this project were to:    
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1. Determine the role of HuR in embryonic development using murine 
cartilage-specific and skeletal-specific knockout models of HuR.  
 
2. Investigate the role of HuR in joint disease using skeletally mature, 
tamoxifen inducible, aggrecan-promoter driven Cre recombinase knockout 
mice and their response to osteoarthritis induced using the DMM model. 
 
3. Identify molecular mechanisms affected by HuR in vitro utilising both 
primary murine chondrocyte cultures and the ATDC5 chondrogenic cell 
line.  
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2 Materials and Methods 
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2.1 Animals 
2.1.1 Animal Husbandry 
Mixed background C57BL/6 X CBA B6BAF1 were used for all murine transgenic 
studies and all animal procedures were licensed by the UK Home Office under 
the Animal (Scientific Procedures) Act 1986; project licence numbers (PPL) 
70/7288 and 70/9047. Mice were housed at a specific pathogen free (SPF) 
mouse facility in the Biomedical Services Unit (BSU) at the University of 
Liverpool. Mice received 12 hours of light and dark and 45 ± 10% humidity at a 
temperature of 22 ± 2°c. Access to water and food was ad libitum. 
2.1.2 Transgenic Mice 
2.1.2.1 Generation of HuR floxed Acan -11kb Cre mice 
Cryopreserved HuRfl embryos were gifted from Dimitris Kontoyiannis at the 
Alexander Fleming Biomedical Sciences Research Center, Greece. Embryos were 
re-derived in the BSU facility at the University of Liverpool. Mixed background 
females were housed with vasectomised males and pseudopregnant females 
identified by the presence of a copulation plug. Embryos were transferred into 
pseudopregnant females. Resulting pups were genotyped for HuR and mated 
with Acan-A1-CreERT2luc mice to generate HuRfl/WTAcanA1-CreERT2luc+/- F1 
progeny mice. F1 mice were backcrossed to HuRfl/fl mice to produce F2 
HuRfl/flAcanA1-CreERT2luc +/- progeny. 
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Figure 2.1. Schematic diagram showing the crossing of HuRfl/fl and AcanA1-
CreERT2luc mouse lines. HuRfl/WTAcanA1-CreERT2luc+ mice were inter-crossed to 
yield a double transgenic line with the genotype HuRfl/fl AcanA1-CreERT2luc+. 
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Figure 2.2. Schematic of breeding programme to generate experimental mice and 
their control counterparts in HuRfl/flAcanA1-CreERT2luc mice. Experimental and 
control mice genotypes are shown. 
 
2.1.2.2 Generation of HuR floxed PRX1-Cre embryos  
6 week old, male PRX1-Cre mice were purchased from The Jackson Laboratory 
(005584). After acclimatisation the mice were bred with HuRfl/fl females to 
generate HuRfl/WTPRX1-Cre+/WT F1 mice. In order to induce HuR flox 
recombination, the HuRfl/WTPRX1-Cre+/WT F1 progeny were backcrossed to 
HuRfl/fl mice to produce a 25% occurrence of HuRfl/flPRX1-Cre+ F2 embryos that 
would have recombination at the HuR flox sites. 
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Figure 2.3. Schematic of breeding programme to generate experimental mice and 
their control counterparts in HuRfl/flPrx1-Cre mice. Experimental and control mice 
genotypes are shown. 
 
2.1.3 Genotyping of transgenic mice 
2.1.3.1 Reagents 
 
Table 2.1. Reagent list and volumes for genotyping lysis buffer 
Reagent Volume 
50mM Tris-HCL (pH8) 4.5mL 2M stock 
0.1M NaCl 5mL 3M stock 
1% SDS 10% 18mL 
20mM EDTA 7.2mL 500mM stock 
dH20 144.3mL 
Autoclaved and stored at room temperature 
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2.1.3.2 Proteinase K based extraction of genomic DNA 
Ear notches of adult mice and tail and rib samples from mice embryos were 
used for genotyping. Samples were digested in 100µl lysis buffer and 10mg/µl 
proteinase K solution (Thermo Fisher; AM2548) at 55°C overnight. Samples 
were cooled, vortexed and 100µl of 3M ammonium acetate pH5.2 was added to 
precipitate the proteins out of solution. Samples were vortexed briefly, 
incubated on ice for 5mins and centrifuged at 12,000g for 10mins at 4°C. 100µl 
chloroform was added and samples centrifuged at 12,000g for 10mins at 4°C. 
The upper aqueous phase was moved into a new Eppendorf containing 500µl of 
cold 100% molecular grade EtOH and 10µg GlycoBlue™ (Thermo Fisher; 
AM9516). Samples were inverted twice to mix and centrifuged at 12,000g for 
10mins at 4°c. EtOH was removed and 500µl of 70% EtOH was added to wash 
the pellet. Samples were briefly centrifuged at 12,000g for 1min. EtOH was 
removed and the pellet allowed to air dry for no longer than 10mins. The pellet 
was re-suspended in TE buffer (50µl for ear notches, 100µl for tail and ribs) and 
placed at -20°c for long term storage. 
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2.1.3.3 Genotyping of transgenic mice by PCR 
2.1.3.3.1 Primers 
 
Table 2.2. List of primer sequences and their respective product size used for 
genotyping of transgenic mice 
Primer 
Name 
Species 5’-3’ sequence Annealing Tm Target Product size 
HELp00_8 
Forward 
Mouse TGGACAGGACT
GGACCTCTGCT
TTCCTAGA 
68 Fabp2 
(internal) 
194bp 
HELp00_9 
Reverse 
Mouse TAGAGCTTTGC
CACATCACAGG
TCATTCAG 
68 Fabp2 
(internal) 
HELp01_0 
Forward 
Mouse GCATTACCGGT
CGATGCAACGA
GTGATGAG 
68 Cre 389bp 
HELp01_1 
Reverse 
Mouse GAGTGAACGA
ACCTGGTCGAA
ATCAGTGCG 
68 Cre 
HuR_geno 
Forward 
Mouse 
 
GTTCCATGGCT
CCCCATATC 
60 HuR 442bp WT 
549bp  
Recombinant 
HuR_geno 
Reverse 
Mouse 
 
AGCTTTGCAGA
TTCAACCTC  
60 HuR 
 
100ng of purified genomic DNA was gently mixed with 10µl REDExtract-N-
Amp™ PCR ReadyMix™ (Sigma-Aldrich; R4775), 100nM forward and reverse 
primer to a total volume of 20µl. An internal control primer set was used to 
observe the presence of DNA. 
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2.1.3.3.2 PCR cycling parameters 
Samples were run on a ThermoCycler 2720 (Applied Biosystems) using the 
following parameters: 
Cre/Internal 
Activation of polymerase  93°C  1min    
Denaturation    93°C  1min      
Annealing    68°C  2min    
Final step    72°C  5min 
Hold     4°C  - 
 
HuR 
Activation of polymerase  94°C  2min 
Denaturation    94°C  1min 
Annealing    60°C  1min  
Extension    72°C  1min 
Final step    72°C  10min 
Hold     4°C  - 
 
2.1.3.4 Analysis of genotype PCR reactions by gel electrophoresis 
1.5% (w/v) gels were made using agarose (Sigma; A9539) added to 1X Tris-
acetate-EDTA (TAE) buffer and microwaved for 1min 15sec per 100mL. 8µl of 
PeqGREEN (VWR; 732-2960) was added per 100mL of agarose/TAE buffer when 
temperature had lowered to 55°C, to enable visualisation of DNA bands under 
ultraviolet (UV) light. Gels were run at 10V/cm for 40mins and visualised using a 
UV transilluminator (BioRad ChemiDoc XRS) at 254nm. 
2.1.4 Timed matings 
Mice were paired for two nights and vaginal plug checks carried out daily. The 
first day of a vaginal plug equated to embryonic day 0.5 (E0.5). 
2.1.4.1 Tamoxifen and progesterone preparation and administration 
An aliquot of 50mg of tamoxifen (Sigma; T5648) was dissolved in 500µl of 
absolute ethanol and vortexed vigorously. The solution was then mixed with 
30 cycles 
30 cycles 
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4500µl corn oil (Sigma; C8267) and sonicated for 4x 30secs at lower pulse set to 
2, Amp 20% to a final concentration of 10mg/µl. An aliquot of 50mg 
progesterone (Sigma; P0130) was prepared in the same way.  
Tamoxifen was administered via intraperitoneal injection (IP) at a dose of 
1mg/10g body weight in mice aged 6 weeks. Pregnant mice were dosed with 
3mg tamoxifen and 1.5mg progesterone. Fresh batches of tamoxifen and 
progesterone were made prior to each injection. 
2.1.5 DMM surgery 
All mice received 3 separate doses of 1mg/10g body weight tamoxifen via IP 
injection at 6 weeks of age. Mice were anesthetised with isoflurane and micro-
surgical techniques were used to destabilise the medial meniscus of the right 
knee joints from 10 week old male HuRfl/flAgg-CreERT2luc- (control) and 
HuRflAgg-CreERT2luc+ mice, while left knees were not operated upon. An incision 
was made into SHAM control mice and the wound closed without 
destabilisation of the medial meniscus. All surgery was performed by veterinary 
surgeon Dr Peter Milner according to previous protocol (Glasson et al., 2007). 
2.2 Murine Tissue 
2.2.1 Collection 
Mice were culled via a raising concentration of CO2 followed by cervical 
dislocation and tissues were collected immediately. Embryos from pregnant 
females were collected, the yolk sac and placenta removed, and then 
immediately immersed into ice cold 95% ethanol to ensure embryo mortality.  
All surgical tools were autoclave sterilised. 
 
2.2.1.1 Embryo 
2.2.1.1.1 Whole mount alizarin red/alcian blue staining (McLeod, 1980) 
For embryos E15 and above 
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Embryos were fixed in 95% ethanol for 5 days or longer (up to 3 months). Skin, 
viscera and adipose tissue was removed and embryos placed in 100% acetone 
for 2 days to remove fat and keep embryo firm. Acetone was removed and 
embryos stained for 3 days at 37°C in at least 10mL of freshly prepared staining 
solution as follows: 
Table 2.3.  Reagent list and volumes for alizarin red and alcian blue staining solution 
Reagent Volume 
0.3% alcian blue 8GX (Sigma-Aldrich; A9186) in 70% 
EtOH 
1 volume 
0.1% alizarin red S (Sigma-Aldrich; A5533) in 95% EtOH 1 volume 
Glacial acetic acid 1 volume 
70% EtOH 17 volumes 
 
 
Embryos were washed with distilled water and cleared in a 1% aqueous solution 
of potassium hydroxide (KOH) for 12-48hours until skeleton was clearly visible 
through the surrounding tissue. Embryos were then cleared through 20%, 50% 
and 80% glycerol / 1% aqueous KOH solution for ~4 days each and stored in 
100% glycerol. 
2.2.1.2 Tissue processing 
2.2.1.2.1 For histological processing (Schmitz et al., 2010) 
Murine knee joints collected for histological analysis was fixed in 10% neutral 
buffered formalin (NBF) for 48hours followed by decalcification in 10% EDTA for 
3 weeks, changing for fresh solution frequently.  Samples were finally 
embedded in paraffin wax. 
2.2.1.2.2  For RNA processing 
Articular cartilage was isolated from the femoral head and tibial plateau using a 
curved micro rongeur surgical tool (Figure 2.4). Tissue taken for RNA analysis 
was frozen in liquid nitrogen (LN2) and ground to powder in a 35mm agate 
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mortar and pestle (Sigma-Aldrich; Z112496). 1mL TRIzol® reagent (Invitrogen; 
15596026) was added to each sample, incubated at room temperature for 30 
minutes and then these extracts were stored at -80°C until RNA purification was 
performed (as described in 1.7). 
 
 
 
 
 
Figure 2.4. Photograph of dissected murine femur and tibia depicting the site of 
articular cartilage removal. The micro rongeur allows the articular cartilage of the 
femur to be removed in a curved manner. 
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2.2.2 Recombination genotyping assay 
2.2.2.1 Primers 
 
Table 2.4. List of primer sequences used for recombination genotyping. 
Primer Name Species 5’-3’ sequence Tm Target Product size 
HuR_recomb 
Forward 
Mouse GATGCCAGCAAG
CTCTTTAC 
60 HuR 964bp Non-
recombined 
 
193bp 
Recombined 
HuR_recomb 
Reverse 
Mouse TAGCAGGTACCG
TCTCCACA 
60 HuR 
 
To assess recombination at the HuR flox sites, a PCR assay was designed with 
primers flanking the potentially recombined region (Table 2.4). Tissue from 
tamoxifen injected mice or embryos from tamoxifen injected females were 
digested using the proteinase K method previously described (section 1.1.3.2). 
100ng/µl of purified genomic DNA was again used for multiplex PCR using 10µl 
REDExtract-N-Amp™ PCR ReadyMix™ and the following primer pair. Previous 
positively recombined DNA was used as a control. 
2.2.2.2 Recombination assay PCR cycling parameters 
Samples were run on a ThermoCycler 2720 using the following parameters: 
 
Activation of polymerase  94°C  2min     
Denaturation    94°C  2min 
Annealing    60°C  2min       
Extension    72°C  2min 
Final step    72°C  10min 
Hold     4°C  - 
 
35 cycles 
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PCR products were run on a 1.5% (w/v) agarose gel at 10v/cm for 45mins and 
DNA bands visualised under UV light. 
2.3 Microcomputed Tomography (µCT) 
Knee joints were scanned in 75% EtOH in a SkyScan 1272 high resolution µCT 
scanner (Skyscan Aartselaar, Belgium) at 4.5µm voxel size. Scans were obtained 
at 50kV and 200µA with a 0.5mm aluminium filter and a rotation set of 0.3° 
(180° rotation) and reconstructed using NRecon (version 1.6.10.4; Skyscan). 
Embryos were also scanned at 20µm voxel size with a rotation set of 0.5°.  
2.3.1 Data viewer 
Dataviewer (SkyScan; Version 1.5.0) allows visualisation of the reconstructed 
datasets and was used to re-orientate scans so that the cross-section within the 
transverse plane was perpendicular to the long axis of the bone. Each dataset 
was resaved in the correct orientation for detailed analysis.  
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Figure 2.5. Orientation of knee joints in DataViewer. (A) Coronal, (B) 
transverse and (C) sagittal planes of mouse knee joints were orientated 
in all samples prior to volume of interest selection. 
 
 
2.3.2 CT-Analyser (CTan) 
CT-An (SkyScan; Version 1.15.4.0+) is an application used to measure the 
quantitative parameters and construct visual models from scanned 3D datasets 
obtained from the µCT SkyScan 1272. Re-orientated datasets were loaded and 
the region of interest (ROI) was free-hand selected from across the whole knee 
joint. ROIs included the tibial epiphysis, meniscus and the femoral lateral and 
medial condyles. Each selected ROI was saved as a new dataset and analysed 
using CT-An BATch MANager (BatMan) software (SkyScan) and morphometric 
parameters were recorded.  
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2.3.3 CTvox 
Embryo datasets were loaded in CTvox and transfer function parameters 
changed to enable visualisation of the embryonic skeleton. Lighting effects and 
shadows were added to increase the realism of the resulting image. Finally, the 
Flight Recorder option within CTvox was used to produce fly-through 
animations of the 3D datasets from scanned embryo datasets. 
2.4 Histology 
2.4.1 Tissue processing  
(Schmitz et al., 2010) 
For histological analysis, embryos and knee joints were processed in a tissue 
processor (Leica TP1020) as described in Table 2.5. 
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Table 2.5. Tissue processing protocols for whole mount stained embryos and 
decalcified bones 
Reagent 
Immersion period under vacuum (minutes) 
Whole mount stained 
embryos and embryos limbs 
E14.5 to E18.5 
Decalcified bone 
70% Ethanol 30 15 
95% Ethanol 30 60 
100% Ethanol 10 60 
100% Ethanol 10 60 
100% Ethanol 10 60 
100% Ethanol 10 60 
Xylene 30 60 
Xylene 30 60 
Wax 120 120 
Wax 120 120 
 
 
Knee joints were embedded in wax with the patella oriented downwards and 
6µm coronal sections were taken across the whole of the knee joint with every 
slide containing 4 sections. Embryos were oriented with the left side 
downwards and 5µm sagittal sections were taken across the limbs and whole 
embryo. Sections were cut using the Micron HM355S microtome with cool-cut 
and tissue transfer system (Thermo Scientific). 
2.4.2 Staining  
(Carson, 1996). 
Every 4th slide of adult limbs, representing approximately every 72µm across 
the whole joint, and every 3rd slide from embryo limbs were stained with 
toluidine blue (0.04% in 0.1M sodium acetate buffer [pH 4]) and counter-
stained with 0.2% fast green on an automatic slide stainer (Leica; ST5020) using 
the protocol in Table 2.6. 
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Table 2.6. Toluidine blue staining protocol 
Reagent Immersion period  
Xylene 10 minutes 
Xylene 10 minutes 
100% EtOH 2 minutes 
90% EtOH 2 minutes 
70% EtOH 2 minutes 
Buffer A* 1 minutes 
0.04% Toluidine Blue 15 minutes 
H20 10 seconds 
H20 10 seconds 
0.2% Fast Green 5 seconds 
H20 20 seconds 
Acetone 10 seconds 
Acetone 10 seconds 
Xylene 3 minutes 
Xylene 3 minutes 
(*Buffer A: 847ml acetic acid [2.85ml glacial acetic acid in 500ml dH20] and 153ml sodium 
acetate [6.8g sodium acetate in 500ml dH20]) 
 
Cleared embryo limbs that had previously been whole mount stained with 
alizarin red and alcian blue were dewaxed in 100% xylene twice for 20mins 
before being mounted. 
2.4.3 Digital slide scanning 
Sections were scanned on a TissueFaxs200 digital slide scanner (TissueGnostics) 
at x20 magnification in brightfield and visualised using Histoquest Software 
(Version 4.0.4.148, TissueGnostics). 
2.4.4 Scoring 
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One section from every slide of toluidine blue stained coronal mice knee joints 
were scored by two independent researchers using the OARSI histopathology 
initiative scoring system that was previously adapted (Glasson et al. 2010, 
Poulet et al. 2011) as described in Table 2.7. 
Table 2.7. Detailed list of murine knee joint osteoarthritis scoring system 
Grade Osteoarthritic damage 
0 Normal articular cartilage surface 
0.5 Loss of toluidine blue staining but no lesions 
1 Lesions in the superficial zone of articular cartilage 
2 Lesions down to the intermediate zone 
3 Lesions down to the tidemark with or without possible loss of 
articular cartilage up to 20% of the surface of the condyle 
4 Loss of articular cartilage tissue from 20-50% of the condyle 
surface 
5 Loss of articular cartilage tissue from 50-80% of the condyle 
surface 
6 
 
 
More than 80% loss of surface and/or exposed subchondral 
bone 
2.5 Western blot 
2.5.1 Reagents 
 
Table 2.8. 2X SDS sample buffer preparation 
Reagent Volume 
1M Tris-HCl, pH 6.8 625µL 
Glycerol 2.5mL 
10% SDS  2mL  
0.5% Bromophenol blue 200µL 
ddH20 Up to 9.5mL 
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Table 2.9. 10X TBS preparation 
Reagent Volume 
Tris base 24.2g 
NaCl 80g 
ddH20 up to 1l 
PH  7.4 
 
2.5.2 Protein extraction 
2.5.2.1 Guanidine protein extraction 
100mg wet weight pulverised cartilage and xiphoid from three 
HuRfl/flCreERT2luc+ and three HuRflCreERT2luc- mice were independently added to 
guanidine extraction buffer (4M guanidine hydrochloride, 65mM dithiothreitol, 
50mM sodium acetate and 1x complete mini protease inhibitor cocktail [Roche; 
04693124001]) at a concentration of 100mg/ml. Samples were agitated for 20 
hours at 4°C. 
2.5.2.2 Ethanol precipitation 
Samples were centrifuged at 12,000g for 10mins at 4°C. Supernatant was 
removed to a new vial. One volume of protein solution was added to nine 
volumes of ice cold 100% ethanol, mixed and then incubated overnight at -20°C. 
Samples were centrifuged at 12,000g for 15mins at 4°C, the supernatant was 
discarded and the pellet was washed by resuspension in 90% ethanol before 
centrifuging again at 12,000g for 5mins at 4°C. This wash step was repeated 
once more to remove traces of Guanidine. Samples were air dried until all 
ethanol had evaporated and pellets were re-suspended in 40µl 2x reducing 
sodium dodcyl sulfate (SDS) sample buffer (Table 2.8). 
2.5.3 Pierce™ Bicinchoninic acid protein assay (BCA) kit 
One Albumin standard was diluted in dH20 into several concentrations ranging 
from 0-2000µg/mL (0=blank). 25µl of each standard and 25µl of each sample 
were pipetted into a microplate well (655180; Greiner) in triplicate and 200µl of 
BCA Working Reagent (50:1, Reagent A:B) was added to each well. The plate 
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was mixed on a plate shaker for 30 secs and the plate covered and incubated 
for 30mins at 37°C. The plate was cooled to room temperature and the 
absorbance at 562nm measured using a BMG LABTECH SPECTROstar Nano 
microplate reader. 
2.5.4 Measurement of protein 
The average 562nm absorbance measurement of the blank standard replicates 
was subtracted from the 562nm measurements of all other individual standards 
and unknown sample replicates. A standard curve was produced by plotting the 
average Blank-corrected 562nm measurement for each BSA standard vs its 
concentration in µg/mL. The standard curve was used to determine the protein 
concentration of each unknown sample.   
2.5.5 Western Blot 
1µl of β-mercaptoethanol was added to 20mg of protein sample and boiled for 
10 minutes at 100°C. Samples were loaded onto a 4-12% NuPAGE gel 
(ThermoScientific; NP0322BOX) alongside a Novex pre-stained protein standard 
(Life Technologies; LC5800) and run in 1X NuPage SDS running buffer (Novex; 
NP002) at 100V for 15 minutes then 150V for 45 minutes. Separated proteins 
were transferred to a 0.2µm nitrocellulose transfer membrane (Perkin Elmer; 
NBA083G001EA) in 1x NuPage transfer buffer (Novex; NP00061-1) at 35V for 90 
minutes. Following transfer, membrane was shaken with 10ml of blocking 
buffer (5% skimmed milk powder in 1x Tris-buffered saline (TBS) (Table 2.9) for 
60 minutes at room temperature. The membrane was then incubated with 
primary antibodies raised against HuR (HuR 32A2 Monoclonal Antibody HRP; 
Insight Biotechnology; sd-5261) and GAPDH (Anti-GAPDH antibody produced in 
rabbit; Sigma Aldrich; G9545), diluted 1:1000 in 10ml blocking buffer, on a 
shaker at -20°C overnight. It was then washed in once in 1x TBS, twice in 1x 
TBS/0.1% Tween and once again in TBS for 5 minutes each. Fluorescently 
conjugated goat anti-Mouse (IRDye 800CW; Li-Cor; 925-32210) and Goat anti-
Rabbit (IRDye 680RD; Li-Cor; 925-68071) secondary antibodies were added to 
10ml blocking buffer and incubated with the membrane for 60 minutes at room 
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temperature. The membrane was then washed as before allowed to dry before 
imaging. 
2.5.6 Li-Cor analysis 
Using secondary antibodies labelled with IRDye near-infrared (NIR) fluorescent 
dyes, IRDye 800cw multiplexed with IRDye 680RD, on the same membrane 
allows for 2-colour detection when imaging fluorescence. Protein expression 
was measured on the Odyssey® CLx Imaging System (Li-Cor Biosciences) at both 
800nm and 680nm. Bands were quantified and normalised using Image Studio™ 
(Version 5.2). 
 
2.6 Cell culture 
2.6.1 Primary murine chondrocytes 
2.6.1.1 Isolation of murine cartilage 
Protocol adapted from (Gosset et al. 2008). 
One litter (8-11 animals) of 3-5 day old mice were culled via cervical dislocation. 
Mice were placed in a sterile flow hood in the back-down position and the skin 
cut from the navel to the sternum, then along the ribs. For costal cartilage, the 
diaphragm and soft tissue were removed from the rib cage. The isolated rib 
cages were placed in 1x PBS. Skin and soft tissue was removed using a scalpel 
and was cartilage removed from calcified bone. For articular cartilage, skin and 
soft tissue was also removed from the hind legs and the femoral condyles and 
tibial plateau from each mouse was isolated using scalpels and placed in 1x PBS. 
Ribs and articular cartilage were rinsed independently with 1x PBS.  
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2.6.1.2 Isolation of immature murine chondrocytes  
Culture medium: 
 
Table 2.10. List of reagents and volumes for the preparation of culture medium 
Reagent Volume 
DMEM (Life Technologies; 31885-049) 500mL 
Penicillin 100 U 
Streptomycin 100µg/mL 
 
 
Table 2.11. List of reagents and volumes for the preparation of 3mg/ml-1 digestion 
solution 
Reagent Volume 
Culture medium 25mL 
Collagenase D (Sigma Aldrich; 11088866001) 75mg 
 
 
2.6.1.2.1 Immature murine costal chondrocytes 
Cartilage pieces were incubated in 15ml digestion solution for 45min at 37°c, 
5% CO2. A 0.5mg ml-1 collagenase D solution was prepared by diluting 2.5ml 
digestion solution with 12.5ml culture medium. Tissue fragments were agitated 
using a 25ml pipette to detach soft tissue and cartilage pieces placed in a new 
Petri dish with 15ml collagenase D solution at 0.5mg ml-1 overnight at 37°c, 5% 
CO2. 
2.6.1.2.2 Immature murine articular chondrocytes (iMACs) 
Cartilage pieces were incubated in 10ml digestion solution for 45min at 37°c, 
5% CO2. Using a 25ml pipette, cartilage pieces were placed in a new Petri dish 
with 10ml fresh digestion solution for 45min at 37°c, 5% CO2. Cartilage pieces 
were agitated using a 25ml pipette to detach soft tissue and cartilage pieces 
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were placed in a new Petri dish with 10ml collagenase D solution at 0.5mg ml-1 
overnight at 37°c, 5% CO2. 
2.6.1.3 Primary chondrocyte seeding 
2.6.1.3.1 Immature murine costal chondrocytes 
The 15ml collagenase D solution with cartilage pieces was placed in a 50ml tube 
and successively passed through 25ml, 10ml and 5ml Pasteur pipettes to 
disperse cell aggregates and yield a suspension of cells. The cell suspension was 
filtered through a 50µM cell strainer over a 50ml tube and centrifuged at 400g 
for 10mins. The pellet was washed with 10ml 1x PBS and re-suspended with 
40ml culture medium plus 10% FBS (Sigma; F7524-500). Cells were seeded on a 
10cm culture dish at a density of 25 x 103 cells cm-2. 
2.6.1.3.2 Immature murine articular chondrocytes 
The 10ml collagenase D solution with cartilage pieces were placed in a 15ml 
tube and successively passed through 25ml, 10ml and 5ml Pasteur pipettes to 
disperse cell aggregates and yield a suspension of cells. The cell suspension was 
filters through a 50µM cell strainer over a 15ml tube and centrifuged at 400g 
for 10mins. The pellet was washed with 5ml 1x PBS and re-suspended with 
15ml culture medium plus 10% FBS (Sigma; F7524-500). Cells were seeded on a 
10cm culture dish at a density of 8 x 103 cells cm-2. 
2.6.1.4 Culture of immature murine chondrocytes 
Cultures were maintained under sterile conditions in a 37°c incubator with 5% 
CO2. Immature murine costal chondrocytes and iMACs reached confluence 6-7 
days after seeding. Culture media was changed 2 days after seeding. Once 
confluent, cells were trypsinised and transferred to T75 flasks and allowed to 
reach confluence before experiment. 
2.6.1.5 Optimisation of optimum MOI for iMACs 
In order to assess the multiplicity of infection (MOI) that would yield optimum 
uptake of Cre adenovirus, and therefore HuR flox site recombination, in 
immature murine chondrocytes without causing cell death, a green fluorescent 
protein (GFP) tagged adenovirus (Vector Biolabs; 1060) was used to transduce 
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cells. Immature murine chondrocytes were seeded at 260 x 103 per well in 6-
well plates and the following day treated with GFP adenovirus at MOIs between 
100 and 200 in 2mL of media per well. Cells were incubated for 24hours at 
37°C, 5% CO2. The virus-transduced media was removed and 2mL fresh media 
was added and cells incubated for a further 24 hours. The expression of GFP 
was viewed with an ultraviolet (UV) microscope (Nikon Eclipse Ti). Cells were re-
suspended in 200µl FACs reagent (1g BSA, 100mg NaN3, 100mL PBS) and 
detected with a FACScan flow cytometer (BD Biosciences, Accuri FloCytometer) 
with CellQuest software (BD Biosciences; Version 5.1). 
2.6.1.6 Adenoviral mediated excision of HuR 
Immature murine articular chondrocytes were seeded at 30 x 103 cells per well 
in a 12-well plate. After 24hours cells were transduced with a Cre recombinase 
adenovirus (Vector Biolabs; 1045) or the GFP adenovirus at MOI’s of 200. Cells 
were incubated for 24hours then media removed and 500µl TRIzol® reagent 
added and incubated for 10mins and stored at -80°C for RNA isolation. 
2.6.1.7 Tamoxifen induced excision of HuR 
2.6.1.7.1 Preparation of 4-OH Tamoxifen 
5mg 4-Hydroxytamoxifen (4-OH-T) (COMPANY) was dissolved in 1.25mL 100% 
EtOH to produce 10mM stock solution. 5µl of 10mM 4-OH-T was diluted in 
495µl of DMEM to make 100µM solution. 10µl of the 100µM solution was 
diluted in 990µl of DMEM to make a 1µM solution. 100µl of the 1µM solution 
was added to 900µl DMEM (supplemented with 10% FBS and P/S) and added to 
cells at a final concentration of 100nM per well in a 12 well dish. Fresh 4-OH-T 
was made per experiment. 
2.6.1.7.2 Treatment of iMAC’s with tamoxifen 
Immature murine articular chondrocytes were seeded at 30 x 103 cells per well 
in a 12-well plate. The following day, 1000µl of fresh culture medium containing 
100nM 4-OH-T was added to cells and incubated for 24hours at 37°C, 5% CO2. 
Media containing 4-OH-T was replaced with fresh culture media and RNA 
extracted from cells in 500µl TRIzol® reagent at 0, 24, 48 and 72 hours for qRT-
PCR analysis. 
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2.6.1.8 MS-444 mediated knockdown of HuR  
MS-444 was dissolved in DMSO to a final concentration of 10mM. Immature 
murine articular chondrocytes were seeded at 30 x 103 cells per well in a 12-
well plate. The following day cells were treated with 10mM MS-444 per 1mL 
media and cells incubated for 24hours at 37°C, 5% CO2. Media was then 
replaced with fresh culture media and RNA extracted from cells in 500µl TRIzol® 
reagent at 0, 24, 48 and 72 hours for qRT-PCR analysis. 
2.6.2 ATDC5 cells 
ATDC5 cells (RIKEN Cell Bank, Japan) were cultured in proliferation media 
consisting of DMEM/F-12, GlutaMAX, 5% FBS and 1% P/S at 37°c, 5% CO2. Cells 
were seeded at 6400 cells/cm2 unless otherwise stated. 
2.6.2.1 Foetal Bovine Serum Batch test 
ATDC5 cells are sensitive to changes in FBS batches. For this reason an FBS 
batch test was performed prior to carrying out experimental work on these 
cells. Cells were seeded in 6 well plates and DMEM/F-12, GlutaMAX (Life 
Technologies; 31331-093) supplemented with P/S and 5% FBS from various 
companies were independently added to cells. Media was changed every other 
day and RNA was extracted from cells on days 0, 2, 4, 6, 10 and 12 in 500µl 
TRIzol® reagent for qRT-PCR. 
2.6.2.2 Insulin-mediated differentiation 
To initiate ATDC5 differentiation in the chondrogenic lineage, differentiation 
media consisting of proliferation media supplemented with 10µg/ml human 
recombinant insulin (Sigma Aldrich; I2643), 10µg/mL human transferrin (Sigma 
Aldrich; 10652202001) and 30nM sodium selenite (Sigma Aldrich; S9133) was 
added to cells 24hours after seeding. Cells were cultured for 14 days and 
differentiation media was carefully changed every 2 days and then daily from 
day 10 onwards.  
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2.7 Real time reverse transcription polymerase chain 
reaction (qRT-PCR) 
2.7.1 TRIzol based RNA extraction 
Samples previously stored in TRIzol® reagent at -80°C were thawed on ice. 
100µl of chloroform was added for every 500µl TRIzol® reagent and shaken 
vigorously for 15secs and incubated for 2mins at room temperature. Samples 
were centrifuged at 12,000g for 15mins at 4°c. The RNA-rich upper aqueous 
phase was pipetted into a fresh 1.5mL centrifuge tube with 250µl isopropanol 
and 50µg/ml GlycoBlue™ (Invitrogen; AM9516) for precipitation. Samples were 
inverted to mix, incubated at -20°C for 10mins and centrifuged at 12,000g for 
10mins at 4°c. Supernatant was discarded and pellet washed in cold 75% EtOH 
was added to each tube before centrifuging at 12,000g for 5mins at 4°c. The 
supernatant was discarded and the pellet allowed to air dry for 10mins. The 
pellet was gently re-suspended in 25µl or RNase-free water. The concentration 
and quality of RNA was quantified using a Nanodrop spectrophotometer 
(Thermo Scientific; Nanodrop 2000). 
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2.7.2 cDNA synthesis 
1µl Random Primer (Promega; C1181) was added to 1µg RNA and incubated for 
5mins at 70°C. Samples were immediately placed on ice and the following was 
added to each sample: 
Table 2.12. cDNA synthesis reagents per sample 
Reagent Volume 
Reverse Transcriptase Buffer (Promega; M1701) 5µl 
dNTP mix, 10mM (Promega; C1145) 5µl 
RNAsin Plus (Promega; N2611) 0.6µl 
Molony-murine leukemia virus (M-MLV) Reverse 
Transcriptase (Promega; M1701) 
1µl 
Samples were incubated for 60mins at 37°C followed by 5mins at 95°C and 
stored at -20°C. 
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2.7.3 Quantitative Real-Time PCR (qRT-PCR)  
10ng of template cDNA was amplified in an AB 7300 Real Time PCR System 
(Applied Biosystems). The following reagents were prepared in a mastermix and 
added to the cDNA to a total volume of 20µl as described in Table 2.13. 
 
Table 2.13. qRT-PCR mastermix preparation per sample 
Reagent Volume 
Takyon Rox SYBR MasterMix dTTP Blue (Eurogentec; UF-
RSMT-B0701) 
10µl 
Forward Primer (100nM) 2µl 
Reverse Primer (100nM)  2µl 
dH20 to 20µl total 
 
 
 
2.7.3.1 qRT-PCR cycling parameters 
Samples were ran in three technical or biological replicates using the following 
PCR parameters: 
Activation of Takyon™   94°C  2min     
Denaturation    94°C  10sec      40 cycles 
Annealing/Extension   60°C  60sec    
Hold     4°C  - 
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2.7.3.2 Calculation of relative gene expression step using the comparative Ct 
Method 
Murine specific primers were used (Table 2.14). Average sample CT values were 
normalised to the housekeeping gene β-Actin and the ∆CT calculated for each 
gene using the following equation 
= 2-(average CT of gene of interest – average CT of housekeeping gene) (Livak and 
Schmittgen, 2001) 
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2.7.3.3 Primers 
Table 2.14. List of primer sequences for qRT-PCR analysis 
Primer 
Name 
5’-3’ Forward Primer Sequence 5’-3’ Reverse Primer Sequence 
HuR TGCAAAGCTTATTCGGGATAAAG GTGCTGATTGCTCTCTCTGCAT 
MMP13 CGATGAAGACCCCAACCCTAA  ACTGGTAATGGCATCAAGGGATA 
Sox9 AGTACCCGCACCTGCACAAC TACTTGTAGTCCGGGTGGTCTTTC 
Col2a1 TGGGTGTTCTATTTATTTATTGTCTTCC
T 
GCGTTGGACTCACACCAGTTAGT 
Col10a1 CATGCCTGATGGCTTCATAAA AAGCAGACACGGGCATACCT 
Acan CATGAGAGAGGCGAATGGAA TGATCTCGTAGCGATCTTTCTTCT 
RunX2 GACGAGGCAAGAGTTTCACC GGACCGTCCACTGTCACTTT 
Hoxa5 TCTCGTTGCCCTAATTCATCTTT CATTCAGGACAAAGAGATGAACAGAA 
Hoxb9 CAGGGAGGCTGTCCTGTCTAATC CTTCTCTAGCTCCAGCGTCTGG 
Hoxc6 CCTTCCTTATCCTGCCACCT GCTGGAACTGAACACGACAT 
Hoxc8 CGAAGGACAAGGCCACTTAAAT AGGTCTGATACCGGCTGTAAGTTT 
Hoxd4 TTCGGTGAACCCCAACTACAC AAATTCCTTTTCCAGTTCTAGGACTTG 
Hoxd13 GGTTTCCCGGTGGAGAAGTAC TGGACACCATGTCGATGTAGC 
Ihh CCCCAACTACAATCCCGACA TCATGAGGCGGTCGGC 
Pthrp AGTTAGAGGCGCTGATTCCTACA GGACACTCCACTGCTGAACCA 
β-Actin GACAGGATGCAGAAGGAGATTACTG CCACCGATCCACACAGAGTACTT 
 
Primers were designed using Primer-BLAST (NCBI) and the efficiency of primers was 
tested using the following equation: 
𝐸𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 = (10
1
𝑠𝑙𝑜𝑝𝑒
− 1) 𝑥 100 
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The best housekeeping gene was determined using the geNorm algorithm 
(Appendices Supplementary Figure 1) (Vandesompele et al., 2002). 
2.8  Statistics 
GraphPad Prism (Version 6) was used to perform statistical analysis. Individual 
statistics including normalisation is detailed for each experiment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HuR in embryonic skeletal development 
 
Page | 89 
 
 
 
 
 
 
 
 
 
 
 
 
3 HuR in embryonic skeletal 
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3.1 Introduction 
HuR-deficient embryos display severe skeletal defects in the ossification of the 
ribs, limbs and craniofacial structures (Katsanou et al. 2009). In our laboratory, 
we have previously shown that HuR expression levels are reduced in various 
areas of embryos, including hypertrophic chondrocytes and the perichondrium, 
regions that are known to regulate cartilage development, long bone growth 
and mineralisation (McDermott et al. 2016). Interestingly, siRNA-mediated 
knockdown of HuR in vitro increased levels of MMP13 significantly (McDermott 
et al. 2016). It was also shown that HuR protein levels are also reduced in areas 
were MMP13 levels are increased in developing mouse embryos. Taken 
together, these findings suggest a role for HuR in embryonic development 
(McDermott et al. 2016). 
Enhancers are able to drive the tissue specific expression of a target gene. A 
highly conserved non-exonic 359bp enhancer sequence, A1, has previously 
been identified 10kb upstream of the aggrecan transcription start site. 
Activated by its binding to the Sox trio, A1 was found to drive gene expression 
in differentiated articular and growth plate chondrocytes in both transgenic 
embryos and adult mice (Han and Lefebvre 2008). This aggrecan enhancer was 
subsequently used to create a murine line expressing both luciferase and the 
ligand-dependant chimeric Cre recombinase, Cre-ERT2 (Cascio et al. 2014). This 
allowed the expression of the transgene to be controlled in a temporal and 
cartilage-specific manner, while luciferase activity allowed expression to be 
monitored in real time. 
A proximally located 2.4kb Prx1 limb enhancer was also identified in the 5’ 
region of the Prx1 gene that is sufficient to drive the expression of a transgene 
in mesenchymal cells during limb bud development, in the lateral plate 
mesoderm and the cranial mesenchyme (Martin and Olson 2000). Cre activity 
was first observed at E9.5 in the limb buds and by E16.5 in the entire limb bud 
and inter-limb flank, and in the craniofacial mesenchyme. Cre-recombinase was 
later placed under the regulation of the Prx1 enhancer and lead to Cre 
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expression throughout the early limb bud mesenchyme and in a subset of 
craniofacial mesenchyme from E9.5 onwards (Logan et al. 2002) 
Previous studies have described the effect of general HuR knockout in 
developing embryos (Katsanou et al. 2009, Herjan et al. 2013). Importantly 
however, HuR ablation has not been more closely examined in a cartilage-
specific and skeletal-specific manner. We have therefore generated both a 
cartilage-specific, inducible knockout mouse model of HuR using the Cre/LoxP 
system were CreERT2luc is under the control of the aggrecan enhancer A1; and a 
non-inducible skeletal-specific knockout mouse model of HuR were Cre is under 
the control of a PRX1 enhancer element controlling limb bud and craniofacial 
development. By utilising Cre recombinases that enable the knockout of HuR in 
temporal and spatial manner, we are able to specifically examine the role of 
HuR during cartilage and bone development. 
3.2 Results 
3.2.1 Aggrecan-enhancer driven knockout of HuR results in reduced 
and altered cartilage mineralisation during embryonic 
development 
Previously, a 0.77kb genomic DNA fragment containing the second exon of the 
HuR gene was flanked with loxP sequences to generate HuRfl/fl mice (Figure 
3.1A) (Katsanou et al. 2009). To investigate the in vivo functions of HuR in a 
cartilage-specific and inducible manner, cryopreserved embryos containing the 
HuR floxed site were re-derived in surrogate mothers and at sexual maturity 
were subsequently crossed with transgenic mice expressing CreERT2 under the 
control of the aggrecan enhancer A1 (Figure 3.1B) (Han and Lefebvre 2008). The 
resulting HuRfl/WTAcanA1-CreERT2luc+ F1 progeny were subsequently 
backcrossed to yield an F2 progeny of HuRfl/flAcanA1-CreERT2luc+ mice. 
To knockout HuR during embryonic development, HuRfl/flAcanA1-CreERT2luc+/- 
mice were inter-crossed via timed matings and vaginal plugs checked for 
embryonic day E0.5. Pregnant females were dosed with 3mg tamoxifen and 
1.5mg progesterone via intraperitoneal injection at E9.5, the start of aggrecan 
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expression. Progesterone was given in order to counteract any potential for 
miscarriage due to the toxicity of tamoxifen. 4-hydroxy-tamoxifen is an 
estrogen ligand which allows Cre ERT2 to recombine the loxP sites that flank HuR 
and thereby excising HuR (Figure 3.2). Embryos were collected at E16.5. In 
order to test the efficiency of loxP recombination a DNA-based PCR assay 
needed to be developed. 
 
 
 
Figure 3.1. Schematic diagram of the complete Elavl1 locus on mouse 
chromosome 8. Magnifications of the region containing the second exon (red) 
in the floxed (HuRfl) and Cre-recombined locus (HuRfl/fl). LoxP genes are 
indicated as arrowheads). Forward primer remained the same (green) while 
the reverse primers are indicated in blue for genotyping and orange for the 
recombination assay. 
 
3.2.1.1 Genotyping and development of recombination assay 
Frequent genotyping of transgenic mice populations is required during 
conditional gene targeting and monitoring of tissue-specific Cre recombination 
efficiency. The first step in the identification of embryo genotypes was to 
perform a PCR for both HuR and Cre recombinase, as well as the internal 
control fatty acid-binding protein 2 (Fabp2). HuRfl/flAcanA1-CreERT2luc- mice 
were used as control for subsequent experiments. Gel electrophoresis revealed 
double transgenic embryos that contained both the floxed HuR alleles and Cre 
recombinase (Figure 3.2A).  
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We needed to confirm that Cre-mediated recombination of the loxP sites had 
occurred in the tamoxifen dosed double-mutant embryos. We first designed a 
recombination assay by designing primers that flanked the loxP sites and 
optimised PCR conditions on DNA extracted from the tails of both HuRfl/fl 
AcanA1-CreERT2luc+ and HuRfl/flAcanA1-CreERT2luc- embryos. AcanA1-Cre is 
expressed in the tail of mice (Cascio et al. 2014) and so recombination of loxP 
sites should have been detectable in this tissue. However, we did not see any 
detectable levels of recombination in the tail DNA. Previous Sox-9 mediated 
knockout of HuR resulted in changes in the ossification of the ribs; we therefore 
decided to check whether recombination had occurred at detectable levels in 
the DNA of the ribs of HuRfl/flAcanA1-CreERT2luc+ embryos. The recombination 
assay followed by gel electrophoresis revealed recombination in the ribs when 
compared to the ribs of HuRfl/flAcanA1-CreERT2luc- embryos. Fabp2 as an 
internal control ensured DNA was present in all samples (Figure 3.2B). 
 
 
Figure 3.2. Genotyping of transgenic HuRflAcanA1-CreERT2luc embryos. A) A 
representative sample of wild-type, heterozygous and homozygous floxed embryos 
were PCR genotyped and samples ran on a 1.5% agarose gel for DNA separation. (B) 
Recombination assay detailing successful knockout of the loxP flanked HuR 
fragment in the ribs of transgenic HuRfl/flAcanA1-CreERT2luc+ embryos as depicted 
by the 193bp fragment. HuRfl/flAcanA1-CreERT2luc+ and HuRfl/flAcanA1-CreERT2luc- 
mice were injected with tamoxifen and Cre negative mice used as controls for 
recombination assay. 
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3.2.1.2 Alizarin red and alcian blue whole-mount staining of Aggrecan A1-
driven HuR knockout E16.5 embryos 
After confirming the genotype, selected HuRfl/flAcanA1-CreERT2luc+ and 
HuRfl/flAcanA1-CreERT2luc- littermate embryos were stained with alizarin red and 
alcian blue to more closely examine any abnormalities in skeletal development. 
Embryos were stained with alcian blue for 1-4h followed by alizarin red for 3-4h 
using the whole mount stain protocol described by (Rigueur and Lyons 2014). In 
this protocol embryos are cleared into 1% KOH for 12h then transferred to 50% 
glycerol: 50% KOH. Staining showed a reduction in ossification particularly in 
the craniofacial regions and ribs of HuR deficient embryos (Figure 3.3D-F) when 
compared to Cre- littermates (Figure 3.3A-C). A lack of alcian blue staining was 
also observed in HuR deficient embryos in the areas surrounding the nasal 
cavity including the lateral, septal and in particular the alar cartilages (Figure 
3.3F). Interestingly, there were no immediate differences in the staining of the 
long bones of the forelimbs. Using this protocol however, embryos lacked a 
penetration of alcian blue and alizarin red stain in underlying tissues, while a 
higher concentration of glycerol : KOH during clearing meant embryos did not 
clear well. In order to get optimal alcian blue / alizarin red staining a new 
protocol was adopted.  
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Figure 3.3. Protocol one alizarin red and alcian blue whole mount staining of 
representative of HuRfl/flAcanA1-CreERT2luc+ and HuRfl/flAcanA1-CreERT2luc- 
embryos at E16.5. Initial whole mount staining using the Rigueur and Lyons (2014) 
protocol allowed visualisation of mineralised structures including the long bones of 
the fore- and hind-limbs and the ribs of Cre- (A) and HuR knockout (B) embryos. 
Altered ossification can be seen in the ribs and craniofacial structures of the HuR 
knockout embryos (B) and in the lack of alcian blue staining of the craniofacial 
structures when compared to Cre- (A). (HuRfl/flAcanA1-CreERT2luc+ n=4, 
HuRfl/flAcanA1-CreERT2luc- n=3). 
 
New litters of E16.5 HuRfl/flAcanA1-CreERT2luc+ and HuRfl/flAcanA1-CreERT2luc- 
embryos were whole mount stained with alizarin red and alcian blue using a 
protocol adapted from McLeod (1980). This protocol allowed for complete 
visualisation of the skeleton and a distinction between alizarin red stained bone 
and alcian blue stained cartilage. This staining approach demonstrated a similar 
altered ossification pattern in HuR knockout embryos to that observed in 
previous whole-mount stained embryos with the older method, however the 
new method improved visualisation of the skeletal structures (Figure 3.4A & B). 
Microscopic examination of HuRfl/flAcanA1-CreERT2luc+ embryos revealed severe 
defects in skeletal development. HuR knockout embryos exhibited deficient 
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mineralisation in the craniofacial structures of the frontal and dentary bones. 
Similar to the previous observations in Figure 3.3D-F, structures surrounding 
the nasal cavity in knockout embryos were less defined and remain mostly 
cartilaginous (Figure 3.4C).  Whole mount staining also revealed that skeletal 
structures including the ribs and intervertebral discs remained predominantly 
cartilaginous, highlighting a potential disruption to the endochondral 
ossification process in these tissues (Figure 3.4C). There was, however, no visual 
differences observed in the long-bones of HuR knockout embryos compared to 
their Cre- littermates. 
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Figure 3.4 . Representative skeletal staining of HuRfl/flAcanA1-CreERT2luc+ embryos 
vs HuRfl/flAcanA1-CreERT2luc- littermates injected with tamoxifen at E9.5 and 
harvested at E16.5. Alizarin red and alcian blue staining illustrates the altered 
ossification between HuR knockout (A & C HuRfl/flAcanA1-CreERT2luc+) and Cre- (B & 
D HuRfl/flAcanA1-CreERT2luc-) littermates, particularly in the ribs, spine and 
craniofacial regions. (HuRfl/flAcanA1-CreERT2luc+ n=2, HuRfl/flAcanA1-CreERT2luc- 
n=6). 
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3.2.1.3 Histological analysis of whole-mount stained embryo limbs reveals a 
shortening of the long bones in HuR knockout embryos 
 
Previously, Sox2 Cre+ HuR knockout embryos presented with shorter long 
bones, with minimal ossification zones in the scapulae, femurs and tibia 
(Katsanou et al. 2009), but no detailed examination of skeletal cell morphology 
has been carried out in HuR knockout embryos. We therefore decided to 
histologically section the fore- and hind-limbs of alizarin red/alcian blue stained 
HuR knockout and Cre- littermates (Figure 3.5). During tissue processing to 
prepare the samples for wax embedding, alcian blue staining was well retained 
in the tissue but alizarin red stain was lost. This loss of alizarin red appeared to 
be worse in the tissues from HuR knockout embryos (Figure 3.5 D-I). 
Nevertheless, the retained alcian blue staining allowed the cartilaginous and 
mineralised zones of the femur, tibia and fibula to be defined. The 
chondrocytes of the articular cartilage appear less organised in the HuR 
knockout embryos, with no distinction between hypertrophic, prehypertrophic 
and proliferative chondrocytes (Figure 3.5 F&I) when compared to the highly 
organised structure of the Cre- embryos (Figure 3.5C). Hypertrophic 
chondrocytes in mutant embryos also appear morphologically different with a 
reduction in size (Figure 3.5 F&I).  
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Figure 3.5. Representative histological sections of the hindlimbs from whole 
mount stained E16.5 HuR knockout and Cre- embryos. Chondrocytes of the 
articular cartilage appear to be less organised in the epiphysis of HuR knockout 
embryos, with no distinction between hypertrophic, prehypertrophic and 
proliferative chondrocytes (F+I). Morphological differences due to a size reduction 
in hypertrophic chondrocytes also appears in HuR knockout embryos. The tibia, 
fibula, femur, epiphysis and diaphysis are shown. Scale bars A,D,G = 500µm; B,E,H = 
100µm; C,F,I = 25µm. (HuRfl/flAcanA1-CreERT2luc+ n=2; HuRfl/flAcanA1-CreERT2luc- 
n=3). 
 
 
3.2.1.4 Micro CT analysis and bone volume 
Low-resolution µCT scans of E16.5 HuR knockout embryos confirmed a delay in 
endochondral ossification of the ribs, IVD and craniofacial structures (Figure 3.6 
B & C). Representative images of the scans depicts a lack of bone formation, 
particularly in the ribs (Figure 3.6 D) and altered ossification in the craniofacial 
structures (Figure 3.6 E), with the exception of the mandible which has mostly 
ossified in both knockout and Cre- embryos. µCT analysis revealed however, no 
HuR in embryonic skeletal development 
 
Page | 100 
 
statistically significant difference in bone volume between HuR knockout and 
Cre- embryos (p = ≤0.0152).  
HuR in embryonic skeletal development 
 
Page | 101 
 
 
HuR in embryonic skeletal development 
 
Page | 102 
 
Figure 3.6. Analysis of HuRfl/flAcanA1-CreERT2+ and HuRfl/flAcanA1-CreERT-+ 
embryos, injected with tamoxifen at E9.5 and harvested at E16.5. Micro CT 
analysis identified HuR knockout embryos exhibited impaired ossification (B&C) 
compared to Cre- littermates (A). In particular, the ribs, spine (D) and craniofacial 
structures (E) exhibit the most severe changes in mineralisation in HuR knockout 
embryos. (F= frontal, J= jugal, P = parietal, E = exoccipital, TV = throatic vertebrae, 
Cv = cervical vertebrae, S= sternum, D= dentary, H= humerus, R= radius, U= Ulna). 
All mice are HuRfl/fl, figures displayed as CreERT2luc + or -. 
 
 
 
3.2.2 PRX1-driven knockout of HuR results in altered long bone 
development 
The use of aggrecan CreERT2luc mice allowed knockout of HuR in cartilaginous 
tissues at specific time points during development. We also wanted to 
understand whether HuR was necessary for control of skeletal development 
before cartilage differentiation had taken place. We therefore crossed HuRfl/fl 
mice with non-inducible, transgenic Prx1-Cre mice were Cre recombinase is 
reported to be expressed in the early limb bud mesenchyme and developing 
craniofacial structures from E9.5 (Logan et al. 2002). Resulting progeny with the 
genotype HuRfl/WTPrx1-Cre+/- were subsequently backcrossed to HuRfl/fl mice to 
produce litters were one in four embryos are of the phenotype HuRfl/flPrx1-
Cre+/- (Figure 3.7A)  
3.2.2.1 Genotyping and recombination assay 
F2 progeny from HuRfl/WTPrx1-Cre+/- and HuRfl/fl crosses were collected at E13.5 
and E16.5. Embryos were genotyped via PCR for HuR status and for the 
presence of the Prx1 Cre recombinase gene. Gel electrophoresis revealed 
double transgenic embryos that contained both the floxed HuR alleles and Cre 
recombinase (Figure 3.7B).  
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Figure 3.7. Schematic diagram showing the crossing of HuRfl/fl and Prx1-Cre mouse 
lines and resulting genotypes. (A) HuRfl/fl mice were crossed with Prx1-Cre+/- mice 
to yield a non-inducible transgenic line containing HuRfl/fl Prx1-Cre+/- that would 
result in HuR conditional knockout embryos. (B) Genotyping revealed HuRfl/fl Prx1-
Cre+/- embryos.  
 
3.2.2.2 Prx1-driven HuR knockout at gestation E13.5 
3.2.2.2.1 Phenotype of Prx1-Cre driven HuR knockout embryos 
During HuR Prx1-Cre embryo collection we noticed some were phenotypically 
different compared to their control littermates. Genotyping confirmed these 
phenotypically different embryos to be HuRfl/flPrx1-Cre+ embryos. Prx1-Cre 
mediated knockdown of HuR appeared to result in a severe shortening of both 
the hind- and fore- limbs in varying degrees of severity (Figure 3.8 B & C) when 
compared to Cre- littermates (Figure 3.8A) at E13.5. The patterning of the digits 
was also affected with some HuRfl/fl Prx1-Cre+ embryos lacking any digit 
formation (Figure 3.8C). Craniofacial structures also appear to be affected by 
the tamoxifen recombination of HuR flox sites, with one embryo lacking a fully 
formed eye socket (Figure 3.8C). Another embryo also displayed a cleft palate 
(Figure 3.8D). All mutant embryos were also smaller in size than control 
littermates. 
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Figure 3.8. Representative photographs of HuRfl/flPrx1-Cre+ and HuRfl/flPrx1-Cre- 
embryos at E13.5. Prx1-Cre mediated HuR knockdown leads to smaller embryos 
with stunted limb growth (red arrows), inadequate patterning of the digits and a 
flattened facial structure (B and C) when compared to Cre- littermates (A). One 
embryo also displayed a cleft palate (blue arrow) (D), while another presented with 
a deformed eye socket (green arrow) (C). (HuRfl/flPrx1-Cre+ n= 10 HuRfl/flPrx1-Cre- 
n=15) 
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3.2.2.2.2 Alizarin red and alcian blue whole-mount staining of HuRfl/flPrx1-Cre 
E13.5 embryos 
E13.5 HuRfl/flAcanA1-CreERT2+ and control HuRfl/flAcanA1-CreERT2-  embryos 
were whole mount stained with alizarin red and alcian blue, again adapted from 
a previously described protocol (McLeod, 1980). As these embryos were 
younger than previously whole-mount stained embryos, they may have been 
damaged if placed directly into 1% KOH so they were instead cleared through 
the series of 20%, 50% and 80% glycerol: 1% KOH solutions straight after 
alizarin red and alcian blue staining. Examination of HuRfl/flPrx1-Cre+ embryos 
revealed a severe phenotype affecting cartilage development in the limbs as 
well craniofacial development (Figure 3.9 B-D). HuRfl/fl Prx1-Cre+ embryos 
present with severely stunted limb development and inappropriate patterning 
of the tibia/fibula, radius/ulna and paws indicating severely dysregulated 
chondrogenesis during limb bud development. Whole mount staining of Prx1-
driven HuRfl/flPrx1-Cre+ embryos at E13.5 reveals that long bone cartilage 
formation has begun in embryo B, particularly in the hindlimb were tibia 
cartilage is present, however there is a distinct lack of autopod development. 
Embryo C also lacks autopod development but is also lacking in tibia 
development, while embryo D completely lacks development of bones that 
should be present after joint development, including the tibia/fibula and the 
radius/ulna. It appears that cartilage development of the ribs and spine is also 
altered in HuRfl/flPrx1-Cre+ embryos when compared to the complete structures 
of the Cre- embryo. There is also some less severe differences in the cartilage 
formation of the craniofacial regions, most noticeably around the nose and eye 
socket and a shortened dentary in embryos C and D. 
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Figure 3.9. Representative whole mount skeletal staining of HuRfl/flPrx1-Cre+ 
embryos vs HuRfl/flPrx1-Cre- littermate at E13.5. Embryos were stained with alcian 
blue and alizarin red to highlight cartilage and bone respectively, and cleared with 
KOH/glycerol as previously described. Endochondral bone formation has not yet 
begun in E13.5 embryos so alizarin red staining is absent from these embryos. 
Alcian blue staining shows a severe lack of cartilage development in varying 
degrees of severity in HuRfl/flPrx1-Cre+ embryos (B, C, D) compared to Cre- (A). 
(HuRfl/fl Prx1-Cre+  n= 10, HuRfl/flPrx1-Cre- n=15) 
 
 
3.2.2.2.3 Histological analysis of E13.5 embryo limbs 
To examine the phenotype of the cartilage in the affected long bones in more 
depth we histologically sectioned the entire fore- and hind- limbs of Prx1-Cre 
driven HuR knockout embryos and their Cre- control counterparts. Limbs were 
sectioned at 5µM thickness and stained with toluidine blue and counterstained 
with fast green. Microscope analysis of stained sections confirmed disruption to 
the development of skeletal structures. In Prx1-mediated HuR knockout 
embryos there appeared to be no cartilage formation and a lack of definition of 
the developing forelimb (C) and hindlimb (L) autopods of embryo 3 when 
compared to patterning and cartilage development of the autopods in the 
forelimb (A) and hindlimb (J) of Cre- embryo 1  (Figure 3.10). There was 
however, variability in the lack of cartilage development in HuRfl/flPrx1-Cre+ 
embryos as there is cartilage formation in both the forelimb (B) and hindlimb 
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(K) of embryo 2. HuR knockout driven by Prx1-Cre recombination also severely 
affected the forelimbs, were cartilage development of the long bones appears 
to be disrupted during chondrogenesis. The morphology of chondrocytes is also 
altered from rounded hypertrophic chondrocytes in the Cre- embryos to a 
flattened and more compact state in HuR knockout embryo limbs (Figure 3.10 H 
& I). 
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Figure 3.10. Representative histological sections of HuRfl/flPrx1-Cre+ and 
HuRfl/flPrx1-Cre- E13.5 littermate embryo forelimbs and hindlimbs. Histological 
analysis confirmed a delay in the development of the long bones of the ulna and 
radius in HuRfl/flPrx1-Cre+ embryos 2 (B) and 3 (C) and in the hindlimb of embryo 3 
(L), particularly during endochondral ossification. Chondrocyte morphology also 
appears to be altered in HuRfl/flPrx1-Cre+ embryos compared to HuRfl/flPrx1-Cre-. 
Scale bars A,B,C,J,K,L = 500µm; D,E,F,M,N,O = 100µm; G,H,I,P,Q,R = 25µm. 
(HuRfl/flPrx1-Cre+ n= 6 HuRfl/flPrx1-Cre- n=6) 
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3.2.2.3 Prx1-driven HuR knockout at gestation E16.5 
3.2.2.3.1 Phenotype of Prx1-Cre driven HuR knockout embryos 
In order to examine the role of HuR knockout during various time points of 
embryonic development, we next examined Prx1-Cre HuR knockout embryos at 
E16.5, after which point the skeleton is fully formed in wild type mice. Upon 
embryo collection, we again noticed differences between littermates, however 
differences were less severe than in E13.5 embryos. Genotyping confirmed 
these embryos to be of the genotype HuRfl/flPrx1-Cre+. Prx1-mediated knockout 
of HuR resulted in substantially smaller embryos compared to Cre- littermates 
(Figure 3.11), however, while limbs were overall smaller in size, they appeared 
to be normal in E16.5 embryos suggesting the severe effects observed in limb 
development at E13.5 had been rescued by E16.5. 
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Figure 3.11. Representative photographs of HuRfl/flPrx1-Cre+ and HuRfl/flPrx1-Cre-
embryos at E16.5. Prx1-Cre mediated HuR knockdown leads to smaller embryos 
(Embryo 3) compared to Cre- littermates (Embryo 1), however in varying degrees of 
severity (Embryo 2). It appears that Embryo 3 exhibits small delays in the 
development of the autopod of both the fore- and hind-limbs (L&O respectively) 
compared to Cre- (J&M respectively). (FL = forelimb, HL = hindlimb). (HuRfl/flPrx1-
Cre+ n= 4, HuRfl/flPrx1-Cre- n=5) 
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3.2.2.3.2 Alizarin red and alcian blue whole-mount staining of HuRfl/flPrx1-Cre 
E16.5 embryos 
In order to visualise the skeleton in E16.5 embryos, whole mount staining was again 
performed with alizarin red and alcian blue as previously described in Methods 
section 2.2.1.1.1. Examination of E16.5 embryos revealed differences in bone 
mineralisation of HuRfl/flPrx1-Cre+ embryos compared to their HuRfl/flPrx1-Cre- 
counterparts (Figure 3.12). HuRfl/flPrx1-Cre+ embryos lacked any alizarin red 
staining and therefore any bone development (Figure 3.12 B & C). There was 
variation in the severity of HuR knockout embryos, with some more severely 
affected than others, with embryo C being smaller than embryo B. Differences 
were observed in the development of cartilage in knockout embryos, 
particularly in the craniofacial structure. While other structures, including the 
limbs that are severely affected at E13.5, did not seem to differ from their Cre- 
littermates except for the overall size. 
 
 
Figure 3.12. Representative whole mount skeletal staining of HuRfl/flPrx1-Cre+ 
embryos vs HuRfl/fl Prx1-Cre- littermate at E16.5. To visualise bone and cartilage 
formation, embryos were stained with alizarin red and alcian blue, respectively and 
cleared with KOH/glycerol as previously described. HuRfl/flPrx1-Cre+ embryos are 
smaller (B&C) than their Cre- littermates (A), to varying degrees. There is also a lack 
of alizarin red staining in HuRfl/flPrx1-Cre+ embryos suggesting bone mineralisation 
has not occurred (B&C). (HuRfl/flPrx1-Cre+ n= 4, HuRfl/flPrx1-Cre- n=5) 
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3.2.2.3.3 Histological analysis of E16.5 embryo limbs 
In order to further examine the rescued phenotype of the limb buds from Prx1-
Cre driven E13.5 to E16.5 embryos, fore- and hind- limbs from E16.5 
HuRfl/flPrx1-Cre+ embryos and their HuRfl/flPrx1-Cre- littermates were 
histologically sectioned at 5µM thickness, stained with toluidine blue and 
counterstained with fast green. Analysis of the stained sections appeared to 
show a lack of mineralisation in the primary ossification center of the long 
bones including the ulna/radius and the tibia in embryo 3 (Figure 3.13 C, F, I & 
L) compared to Cre- embryo 1 (A, D, G & J). The phenotype of embryo 2 seems 
to match that of the Cre- phenotype (B, E, H & K). Cartilage formation of the 
digits of the forelimb in embryo 3 also appears delayed, which is similar to the 
delay in the development of the autopod in E13.5 embryos.  
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Figure 3.13. Representative histological sections of HuRfl/flPrx1-Cre+ and HuRfl/fl 
Prx1-Cre- E16.5 littermate embryo forelimbs and hindlimbs. It would appear that 
HuR knockout in embryo 3 has resulted in a lack of bone formation in the center 
ossification region of the radius, ulna (F) and tibia (L) when compared to the 
rescued phenotype of embryo 2 (E&J) and the Cre- embryo 1 (D&K). (U=ulna, 
R=radius, T=tibia). (Scales bars = 100µm) (HuRfl/flPrx1-Cre+ n= 4, HuRfl/flPrx1-Cre- 
n=5). 
 
 
3.2.2.3.4 Micro CT imaging of HuRfl/fl Prx1-Cre embryos at E16.5 
E13.5 embryos have little to no bone formation yet and so µCT scanning at this 
stage was not an option for these embryos. We therefore µCT scanned HuR 
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floxed Prx1-Cre embryos at E16.5 in order to analysis the developing skeleton. 
In low-resolution µCT scans of E16.5 HuRfl/flPrx1-Cre+ embryos there appears to 
be a delay in the ossification of skeletal bone (Figure 3.14 B), including the ribs 
and intervertebral discs (IVD) (Figure 3.14 C) and craniofacial structures (Figure 
3.14 D). In embryo 3 the fibula does not appear to have developed (Figure 3.13 
I&L) and there is a shortening of the forelimbs (Figure 3.14 E), suggesting a lack 
of mineralisation of the long bones.  
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Figure 3.14.  Analysis of HuRfl/flPrx1-Cre+ and HuRfl/flPrx1-Cre- embryos at E16.5. 
Micro CT analysis identified Prx1-driven HuR knockout embryos that exhibited 
impaired ossification (B) compared to Cre- littermates (A). In particular, differences 
in bone mineralisation can be seen in the ribs, spine (C), craniofacial structures (D) 
and the long bones of the limbs (E and F). (F= frontal, J= jugal, P = parietal, E = 
exoccipital, TV = throatic vertebrae, Cv = cervical vertebrae, S= sternum, D= 
dentary, H= humerus, R= radius, U= Ulna). (HuRfl/flPrx1-Cre+ n= 4, HuRfl/flPrx1-Cre- 
n=5) 
  
3.3 Discussion 
In this chapter, two murine lines were generated in order to knockout HuR in 
vivo in both a cartilage specific manner using CreERT2 under the control of the 
Aggrecan A1 enhancer, and a skeletal-specific manner were Cre recombinase 
was under the control of a Prx1 regulatory element. Taken together, the data in 
this chapter suggests a role for HuR during skeletal development and 
demonstrates that HuR may be involved in the cellular processes affecting 
chondrogenesis and endochondral ossification. 
 
Previously, skeletal defects were observed in embryos with a Sox2-Cre driven 
knockout of HuR that is induced early in embryonic development, phenotypes 
in particular included a shortening of the long bones and a delay in osteogenic 
ossification of the limbs, ribs and craniofacial structures of these mutants. 
Therefore the objectives of this chapter was to use AcanA1-CreERT2luc and Prx1-
Cre transgenic mice to drive the knockout of HuR in a chondrocyte-specific and 
limb bud mesenchyme-specific manner, targeting chondrocytes and the 
developing limb buds and craniofacial structures, respectively. In our Prx1-Cre+ 
HuRfl/fl E13.5 embryos we observed a similar but more severe skeletal 
phenotype resulting in the alteration of chondrogenesis and the mineralisation 
of the long bones which appears to have been delayed or stopped during 
development. One mutant embryo also had a cleft palate, which has previously 
been shown to affect Prx1fl/flPrx2fl/fl double mutants (ten Berge et al. 1998). 
 
Vertebrate long bones form during the process of endochondral ossification in 
which chondrocytes proliferate, differentiate into hypertrophic chondrocytes 
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and are gradually replaced by bone matrix (Wuelling and Vortkamp 2010). The 
growth of a skeletal element depends on precise regulation of chondrocyte 
proliferation and hypertrophy, in particular proliferation of columnar 
chondrocytes and the expansion of the hypertrophic region (Karp et al. 2000). 
This process is coordinated and tightly regulated by secreted growth factors, 
which activate transcription factors specific to chondrocytes including Sox9 and 
Runx2, to ensure the continuous elongation of the epiphyseal growth plates 
(Wuelling and Vortkamp 2010). 
The molecular mechanisms by which HuR affect chondrogenesis are still not 
clear. Interestingly, parathyroid hormone-related protein (PTHrP) is known to 
promote chondrogenesis and supress hypertrophy (Kim et al. 2008), while Hox 
genes are major regulators involved in the patterning of the vertebrate rib cage 
(McIntyre et al. 2007); both processes that are affected by cartilage- and 
skeletal- specific HuR knockout. Based on our current understanding of cartilage 
development and of HuR mRNA interactions, candidate processes of how HuR 
may affect chondrogenesis are described here.  
3.3.1 Indian hedgehog and Parathyroid Hormone-related protein 
are key regulators of endochondral ossification 
Indian hedgehog (Ihh), a member of the hedgehog family of secreted signalling 
molecules, is widely recognised as a critical regulator of long bone development 
and growth and regulates a number of processes. Ihh null mice exhibit long-
bone defects and joint fusions, with severely abnormal long bone development 
as a result of reduced chondrocyte proliferation and delayed then abnormal 
chondrocyte maturation. These mice also completely lack any mature 
osteoblasts specifically in the endochondral skeleton, indicating that Ihh 
signalling plays multiple regulatory roles in endochondral bone formation (St-
Jacques et al. 1999).   
During embryonic cartilage development, Ihh is first detected at E11.5 in 
chondrocytes of the early cartilaginous condensation. Upon the initiation of 
hypertrophic differentiation production becomes restricted to prehypertrophic 
and hypertrophic chondrocytes that are adjacent to the proliferation zone. Ihh 
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participates in a negative feedback look were Ihh stimulates PTHrP production 
in the periarticular regions of the developing cartilage elements. PTHrP diffuses 
into the growth plate region and signals to the PTH/PTHrP receptor (Ppr1) to 
regulate chondrocyte differentiation by maintaining the cells in a proliferative 
state and prevents hypertrophic differentiation (Chau et al. 2011). As the 
epiphyseal growth plate continues to elongate, cells that become distant from 
the source of PTHrP differentiate into prehypertrophic and early hypertrophic 
chondrocytes which further express Ihh (Vortkamp et al. 1996, Chau et al. 
2011). This negative feedback loop controls the distance between the 
hypertrophic zone and the articular surface of the joint (Salva and Merrill 2017). 
In the absence of Ihh, PTHrP expression is reduced which leads to accelerated 
hypertrophy of chondrocytes (Vortkamp et al. 1996), while targeted disruption 
of PTHrP or Ppr1 in mice results in a dwarfism phenotype as a result of a 
reduction in the proliferating zone of cells and an advanced onset of 
hypertrophic differentiation (Amizuka et al. 1994). 
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Figure 3.15. Schematic of the Ihh/PTHrP negative feedback loop during 
chondrogenesis. (A) PTHrP diffuses into the growth plate region maintains the cells 
in a proliferative state to prevent hypertrophic differentiation. Cells that become 
distant from the source of PTHrP differentiate into prehypertrophic and early 
hypertrophic chondrocytes which further express Ihh. In this normal model, HuR 
might directly stabilise PTHrP keeping chondrocytes in a proliferative state. (B) 
Working hypothesis of how HuR ablation might affect the Ihh/PTHrP negative 
feedback loop. HuR deletion potentially results in a lack of stability of PTHrP which 
may result in an inhibition of chondrocyte proliferation and early hypertrophy. 
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PTHrP is a peptide hormone whose mRNA is alternatively spliced to yield three 
isoforms (139, 141 and 173), which undergo extensive posttranslational 
processing to give rise to a family of mature secretary forms of the peptide. As 
previously described, PTHrP regulates cell growth and differentiation 
throughout embryonic development and in adult life. It is however, also a 
tumour survival factor for multiple cancers, including human renal cell 
carcinoma, and in this capacity its expression is regulated by mRNA stability. It 
has previously been found that PTHrP mRNA contains an AU-rich 3’UTR and is a 
target for HuR binding leading to upregulation of PTHrP by HuR through the 
increase of PTHrP mRNA stability (Danilin et al. 2009). HuR knockdown led to a 
decrease in PTHrP mRNA expression and a 70% reduction in the half-life of the 
main PTHrP mRNA isoform, 141, with papers reporting that HuR regulates 
PTHrP expression in human lung adenocarcinoma cells (Danilin et al. 2009, 
Lauriola et al. 2013).  
Here, we describe how the ablation of HuR in both a chondrocyte- and skeletal- 
specific manner results in severely abnormal chondrogenesis and endochondral 
ossification, a process that is highly regulated by the Ihh-PTHrP negative 
feedback loop. PTHrP 34 is an isoform of PTHrP that has been shown to most 
significantly enhance chondrogenesis and suppress hypertrophy in MSCs (Lee 
and Im 2012). It is therefore possible that during normal chondrogenesis HuR 
binds to stabilise PTHrP mRNA, while in this study a lack of HuR has decreased 
PTHrP stability, which has disrupted the Ihh-PTHrP negative feedback process 
resulting in an inhibition of chondrocyte proliferation which may have an effect 
on skeletal development (Figure 3.15). 
3.3.2 Hox genes 
Previously, the identification of HuR target mRNAs revealed that the aberrant 
expression of genes that controlled axis specification and the patterning of 
skeletal segments, including Hox paralogous, correlated with embryonic defects 
in Sox2-mediated HuR knockout mice including poor outgrowth of the limb 
buds and fusions among the long and short limb elements (Katsanou et al. 
2009). Interestingly, mRNA levels of Hoxd13, a regulator of limb patterning, is 
downregulated during ablation of HuR and is absent from E12.5 mouse 
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forelimbs in vivo, while Hoxb9, involved in the control of thoracic skeletal 
element specification, is upregulated (Katsanou et al. 2009) 
It is also interesting to note that previously, HuR has been identified as a key 
regulator of RNA processing, expression and function of the Hox gene Ubx 
during neural development in Drosophila, through direct interaction (Rogulja-
Ortmann et al. 2014). A previously described AU-rich element is present within 
the 3’ UTR of Ubx (Rogulja-Ortmann et al. 2014) and, while Ubx is a Hox gene 
specific to insect species, it is possible that Hox genes involved in mouse 
skeletal patterning and limb outgrowth also contain AU-rich elements that may 
potentially interact directly or indirectly with HuR. Hoxb6 has also been 
reported to contain AU-rich elements but has been shown to not interact with 
HuR (Katsanou et al. 2009). 
3.3.3 Sox9 in limb bud development 
Sox9 is expressed in mesenchymal cells before condensation in the developing 
skeleton and is continually expressed during chondrocyte differentiation (Jo et 
al. 2014). Sox9 null mice results in failed chondrogenesis as a result of a 
disruption to the PTHrP-Ihh regulatory loop due to its essential role in the 
expression of Ihh and PTHrP (Akiyama et al. 2002, Dy et al. 2012). Previously, 
our group has shown that SOX9 is controlled post-transcriptionally by mRNA 
turnover in response to cellular stress and that its half-life negatively correlates 
with the total SOX9 mRNA expression levels in both human articular 
chondrocytes (HAC) and bone marrow derived stem cells (BMSC) (Tew and 
Clegg 2011). SOX9 half-life has since been shown to not be significantly affected 
by siRNA-mediated knockdown of HuR in SW1353 cells (McDermott et al. 
2016). 
Previously, conditional Sox9 knockout utilising the same Prx1-Cre resulted in 
newborns with severely stunted limb growth (Akiyama et al. 2002). Skeletal 
staining with alizarin red and alcian blue indicated a complete absence of 
cartilage and bone with no discernible chondrogenic mesenchymal 
condensations that form the autopod digits. Little or no expression of Runx2, 
which is essential for osteoblast differentiation, was also detected in the limb 
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buds of the Sox9 knockout mice. There were no osteoblasts present in the 
mutants, suggesting Sox9 is crucial for the expression of Runx2 and the 
differentiation of osteoblasts. High levels of apoptosis was also observed in the 
mesenchymal cells of E13.5 Sox9 knockout embryos in areas were chondrogenic 
mesenchymal condensations differentiate to form cartilage. This also suggested 
that mesenchymal cells do not survive in the distal part of limb buds when Sox9 
is not present. 
Sox9 is critical in the processes of the chondrocyte differentiation pathway 
during endochondral bone formation and has been shown to associate with 
RNA-binding proteins (Girardot et al. 2018). As the phenotypes of HuRfl/fl Cre+ 
embryos observed in this chapter are similar to that observed in Prx1-Cre 
mediated Sox9 deficient embryos, there is possible that HuR may down-
regulate Sox9 through an intermediate factor. This would disrupt 
chondrogenesis and perhaps play a role in the defects in endochondral 
ossification of the limbs and ribs we observe in Prx1- and Aggrecan–Cre HuRfl/fl 
embryos, respectively.  
3.3.4 Regulation of bone cell differentiation 
Skeletogenesis is formed by two developmental processes; 1) endochondral 
ossification which accounts for most skeletal elements including the long bones 
and 2) intramembranous ossification which is responsible for the formation of 
most of the craniofacial skeleton (Lefebvre and Bhattaram 2010). In 
intramembranous ossification, mesenchymal cells directly differentiation into 
osteoblasts to form bone (Shahi et al. 2017). During endochondral ossification 
however, aggregated mesenchymal cells are differentiated into chondrocytes, 
which are then progressively substituted by bone. The replacement of 
chondrocytes by bone cells is dependent on the mineralisation of the 
extracellular matrix in a highly regulated manner (Ortega et al. 2004). 
BMPs and Runx2 are both able to stimulate osteoblast differentiation and bone 
formation (Phimphilai et al. 2006). BMPs activate signal transduction pathways, 
including SMAD proteins, in order to express target genes including Runx2. 
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Contrastingly, Runx2 directly binds to enhancer regions of target genes to 
induce osteoblast-specific gene expression (Phimphilai et al. 2006).  
Bone morphogenetic proteins (BMPs), members of the TGF-β superfamily, 
regulate the maturation of mesenchymal osteochondroprogenitor cells to 
osteoblasts (Karamboulas et al. 2010). The BMP signalling pathway is essential 
for endochondral bone formation and disruption to this process can cause a 
vast range of skeletal anomalies (Beederman et al. 2013). For example, 
chondrocyte-specific knockout of Bmp2 resulted in chondrodysplasia with a 
severe disorganisation of chondrocytes in the growth plate that results in 
defects in chondrocyte proliferation, differentiation and apoptosis, ultimately 
leading to skeletal growth impairment (Shu et al. 2011).  
Runx2 is essential for the commitment and differentiation of mineralising cell 
types during both endochondral ossification and intramembranous ossification. 
Global knockout of Runx2 results in a complete lack of ossification, owing to the 
mutational arrest of osteoblasts (Komori et al. 1997). Chondrocyte specific 
knockout of Runx2 resulted in lethality and failed endochondral ossification as a 
result of an absence of mature chondrocytes, vasculature and marrow in the 
limbs and the near absence of the proliferative zone in the growth plates 
(Haiyan Chen et al. 2014). Runx2 and BMPs cooperatively interact to stimulate 
osteoblast gene expression (Phimphilai et al. 2006). HuR may play a role in the 
post-transcriptional regulation and stabilisation of BMP and/or Runx2 in vivo 
and a by knocking out HuR in a chondrocyte- or skeletal- specific manner may 
alter their expression levels during endochondral ossification and have the 
potential to cause the severe skeletal defects we observed in this chapter.   
These studies combined with our own suggest that HuR might post-
transcriptionally regulate gene networks involved in limb patterning, outgrowth 
and axial and craniofacial skeletal development in a spatiotemporal manner 
through transcriptional and post transcriptional regulation. The mechanisms 
surrounding the severe skeletal phenotypes observed in this study, however, 
still remain unknown and currently unexplored. Previous work suggested HuR 
might interact indirectly with MMP13 (McDermott et al. 2016). As discussed, 
Hox genes, Sox9, BMPs and Runx2 are all involved in the regulation of skeletal 
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patterning, particularly in the regions that affect our Aggrecan- and Prx1- driven 
HuRfl/fl embryos. Therefore, in a similar pattern, one possibility here is that HuR 
may interact with a regulatory element that may promote activation or 
inactivate one or more of these genes and/or by a direct or indirect interaction 
with the Ihh/PTHrP negative feedback loop. More work is necessary to 
elucidate the mechanisms by which HuR acts on markers of chonrogenesis at 
the mRNA and protein level. 
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4.1  Introduction 
To determine the importance of HuR in skeletally mature animals, 
HuRfl/flAcanA1-CreERT2+ mice were administered tamoxifen for flox site 
recombination in adult mouse cartilage and its effect on osteoarthritis 
progression was determined. 
The biology of many post transcriptionally controlled genes has been 
investigated in relation to osteoarthritis and other degenerative joint diseases 
because of their roles in the regulation of ECM production and degradation in 
chondrocytes (Tew and Clegg 2011). The importance of post-transcriptional 
gene regulation in the development and progression of such diseases has been 
increasingly reported. To date, a number of studies have demonstrated that a 
wide variety of parameters including biomechanical stress, differentiation and 
cytokine signalling can regulate post transcriptional control in chondrocytes 
(Tew and Clegg 2011). These changing environments have been implicated in 
osteoarthritis by altering the control of cartilage homeostasis, which can 
contribute to altered rates of mRNA turnover. 
Previously, it has been reported that a number of genes involved in the 
pathogenesis of osteoarthritis are differentially regulated at the post-
transcriptional level (Tew et al. 2014). This study also reported that there is an 
increase in the number of rapidly turned over mRNAs in osteoarthritis 
chondrocytes, which suggests that osteoarthritis may affect the post-
transcriptional regulatory mechanisms that control the expression of these 
genes. As RNA binding proteins are critical regulators of mRNA decay our lab 
has worked to investigate the influence of RNA binding proteins in articular 
cartilage. Previous work from our laboratory has identified RNA binding 
proteins as regulators of gene expression in chondrocytes (McDermott et al. 
2016). In particular, TTP was demonstrated to be a modulator of Sox9 mRNA 
decay by acting as a suppressor of Sox9 expression leading to its instability. In 
parallel, a decrease in TTP levels also led to a stabilisation of Sox9 mRNA. 
Interestingly in the same study, it was also reported that siRNA-mediated 
knockdown of HuR significantly increased MMP13 expression in chondrogenic 
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cultures and also regulated the expression of a number of known 
transcriptional repressors of MMP13, including RUNX2 and SPI1 (McDermott et 
al. 2016). HuR is known to be ubiquitously expressed within mouse embryos 
(Ma et al. 1996), however, it was also found that protein levels of HuR were 
down-regulated in developing skeletal structures were levels of MMP13 are 
increased, particularly in hypertrophic chondrocytes (McDermott et al. 2016). 
MMP13 is expressed in hypertrophic chondrocytes during endochondral 
ossification and clinical investigation revealed patients with osteoarthritis have 
high MMP13 expression; its regulation by HuR is therefore particularly 
interesting and could point to a role for HuR in osteoarthritis development 
(Wang et al. 2013). Studies have shown that MMP13-overexpressing transgenic 
mice develop a spontaneous OA-like articular cartilage destruction phenotype 
(Neuhold et al. 2001). While mice deficient in MMP13 are resistant to 
osteoarthritic cartilage erosion, they are not resistant to chondrocyte 
hypertrophy or osteophyte development (Little et al. 2009).  
The aims of this chapter were to analyse the role of HuR in mouse articular 
cartilage, examining both short term deletion as well as its role in the 
development and progression of osteoarthritis. 
 
4.2  Results 
4.2.1 Confirmation of loxP recombination and flox site 
recombination 
HuRfl/fl AcanA1-CreERT2luc mice were genotyped as previously described in 
Methods Section 1.1.3 to identify Cre-positive and Cre-negative individuals who 
were homozygous for the HuR floxed alleles (Figure 4.1A). Cre expressing cells 
will also be expressing luciferase in these mice so, in order to confirm 
genotyping results, selected mice were injected with luciferin and then scanned 
using an IVIS machine to assess luciferase expression. A strong luminescent 
signal was observed in HuRfl/flAcanA1-CreERT2luc+ mice but not HuRfl/fl 
CreERT2luc- mice (Figure 4.1B). 
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Figure 4.1. Genotyping and luciferase expression in HuRfl/flAcanA1-CreERT2luc+ and 
HuRfl/fl AcanA1-CreERT2lu-T mice. (A) PCR and gel electrophoresis confirmed the 
genotypes of Aggrecan-driven Cre recombinase in mice that were hetero- or 
homozygous for HuR flox. (B) In these mice, luciferase is expressed bicistronically 
with the Cre. Cre expression in aggrecan-expressing tissues could therefore be 
confirmed using bioluminescence imaging of luciferase activity. 
 
 
Next, to assess the efficiency of HuR knockout in the articular cartilage and 
other cartilaginous tissues of adult HuRfl/flAcanA1-CreERT2+ mice, we 
administered three evenly spaced doses over 1 week of 1mg/10g body weight 
tamoxifen to 6-week old HuRfl/fl AcanA1-CreERT2luc+ mice and their Cre- 
littermates. We then sacrificed the mice after 2 weeks and collected tissue for 
recombination and western blot analysis. The DNA recombination assay was 
performed as described in in Methods Section 1.2.2 using DNA isolated from the 
articular cartilage, tail, xiphoid and lumbar spine. PCR analysis and gel 
electrophoresis showed that the loxP sites flanking HuR had recombined and 
excised the HuR fragment in all tissues of HuR AcanA1-CreERT2luc knockout 
mice compared to no recombination in Cre- control mice (Figure 4.2A). To 
further confirm HuR knockdown at the protein level, western blot analysis was 
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conducted. Initially protein was extracted from the articular cartilage of both 
legs from one mouse but this did not yield enough protein to carry out a 
western blot. To overcome this, protein was extracted from the articular 
cartilage of both knees from three HuRfl/flAcanA1-CreERT2+ mice and pooled. The 
same process was conducted using three HuRfl/flAcanA1-CreERT2- littermates.  
Consistent with the DNA recombination result, western blot analysis of these 
pooled samples demonstrated that HuR protein levels had decreased in the 
articular cartilage of HuRfl/fl AcanA1-CreERT2luc+ mice compared to Cre- 
littermates two weeks after tamoxifen treatment (Figure 4.2B).  
 
 
Figure 4.2. Recombination assay and western blot analysis suggesting protein 
reduction in HuRfl/flAcanA1-CreERT2luc+ mice. (A) Recombination assay was 
performed on the isolated DNA from several cartilaginous tissues in both HuRfl/fl 
AcanA1CreERT2luc+ and HuRfl/fl AcanA1CreERT2luc- mice. PCR followed by gel 
electrophoresis shows the higher molecular weight band which is the floxed allele, 
and the lower band is the same allele, which has been subject to Cre-mediate 
recombination (B) Western blot analysis was independently performed on the 
protein from the articular cartilage from three HuRfl/flAcanA1-CreERT2luc+ and three 
HuRfl/flAcanA1-Cre- mice. Protein analysis revealed HuR protein levels are reduced 
in Cre-positive mice compared to Cre-negative littermates. (AC: articular cartilage, 
T: tail, X: xiphoid, LS: lumbar spine). 
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4.2.2 Tamoxifen delivery does not alter cartilage pathology in 
HuRfl/flAcanA1-CreERT2+ mice after 5 weeks 
Global HuR knockout results in embryonic lethality and knockout of HuR early in 
embryonic development results in severe skeletal defects (Katsanou et al., 
2009). In order to assess the initial severity of HuR recombination in the 
articular cartilage of young adult mice, HuRfl/fl AcanA1-CreERT2luc+ and their Cre- 
counterparts were dosed three times in 1 week with 1mg/10g body weight in 
order to induce HuR knockout. Mice were sacrificed 5 weeks after the final 
injection and tissue collected. Mouse joints were fixed in 10% NBF for 48 hours 
followed by decalcification in 10% EDTA for 3 weeks. Joints were then 
processed for standard paraffin embedding for histological analysis. 
4.2.2.1 Histological examination of HuRfl/flAcan-CreERT2luc+ and HuRfl/flAcan-
CreERT2luc- knee joints 
To examine the articular cartilage, mice knee joints were sectioned coronally at 
6µm across the entire joint. Sections were dewaxed, rehydrated and stained 
with toluidine blue and counter-stained with fast green. Histological analysis 
revealed no apparent phenotypic differences between HuRfl/flAcanA1CreERT2+ 
and HuRfl/flAcanA1CreERT2- mice indicating that there is no acute change in the 
pathology of the articular cartilage or surrounding tissue in tamoxifen treated 
HuRfl/flAcanA1-Cre+ mice (Figure 4.3A) compared to control counterparts (Figure 
4.3B) in either the medial and lateral compartments (Figure 4.3 C&D and E&F, 
respectively). A histopathology scoring system was used to quantify and assess 
articular cartilage lesion severity (Glasson et al. 2010).  
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Figure 4.3. Representative histological images of toluidine blue stained 
HuRfl/flAcan-CreERT2luc+ and HuRfl/flAcan-CreERT2luc- 6µm coronal sections. There is 
no apparent difference in the surface of the articular cartilage between Cre- (A) and 
HuRfl/fl (B) sections. Medial (C&D) and lateral (E&F) compartments also do not 
contain any observable differences in the articular surface of Cre- and HuRfl/fl mice. 
(HuRfl/flAcanA1-CreERT2luc- n=4; HuRfl/flAcanA1-CreERT2luc+ n=4) 
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Lesion severity of the articular cartilage of these mice was scored using a 
modified form of the OARSI histopathology grading system for mouse 
osteoarthritis (Glasson et al. 2010), as described in Methods section 1.4.4. Four 
compartments (medial and lateral tibia and medial and lateral femur) from 
sections throughout the entire joint allowed for the most severe lesion to be 
determined as the maximum lesion score per joint and per compartment. 
Lesion severity was also graded in each compartment at 120µm intervals across 
the joint. This also allowed a mean grade per joint and per compartment to be 
obtained in order to measure any changes to the joint after tamoxifen induced 
recombination.  
The lesion severity score of both HuRfl/flAcanA1-CreERT2+ and control mice did 
not exceed grade 1 suggesting any damage to articular cartilage surface was 
minimal in the given time frame of 5 weeks following tamoxifen administration. 
Overall, there seems to be a slight increase in both the maximum and mean 
scores in HuRfl/flAcanA1-CreERT2+ mice compared to control mice (Figure 4.4A), 
however there was no significant difference. There are also no significant 
differences in the maximum lesion severity score for each of the 4 
compartments; however there appears to be an increase in the maximum 
severity of the lateral femur in HuRfl/flAcanA1-CreERT2+ mice (Figure 4.4B). In 
keeping with this data, there are no significant differences in the mean lesion 
severity score of any compartment (Figure 4.4C).  
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Figure 4.4. Lesion severity scores of 
HuRfl/flAcanA1-CreERT2+ knee joints 
5 weeks after tamoxifen, compared 
to Cre- counterparts. (A) The 
maximum and mean lesion severity 
scores were calculated across the 
whole joint for HuRfl/fl (red) and Cre- 
mice. While there is a slight increase 
in the mean lesion severity score in 
HuRfl/fl mice, there is no significant 
difference (B) The maximum lesion 
severity score in the individual 
compartments of the joint. There is 
a small increase in the maximum 
score in both the medial femur and 
lateral tibia of HuRfl/fl mice 
compared to Cre- mice but again 
there is no significance in the 
differences. (C) There is no 
statistically significant differences in 
the mean lesion severity score of 
the individual compartments. Data 
is presented as individual data 
points for each animal as well as the 
mean (horizontal line) and the 
standard deviation/error (error 
bars) for each group. 
(HuRfl/flAcanA1-CreERT2luc- n=4, 
HuRfl/flAcanA1-CreERT2luc+ n=4) 
 
 
4.2.2.2 Micro CT 
Micro-CT (µCT) imaging is a valuable tool that can be used to investigate the 
morphometric changes in joints in animal models of osteoarthritis. µCT has 
successfully been used to study the changes in the subchondral bone 
architecture in the knee joints of collagenase-induced OA mice (Botter et al. 
2008) and in surgical destabilisation models (Moodie et al. 2011). µCT has low 
sensitivity for soft tissue and therefore is a major challenge for imaging 
osteoarthritis models as the visualisation of the degenerative changes in 
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cartilage are compromised (Tremoleda et al. 2011). For analysis, the tibial 
epiphysis was therefore manually selected as representative of subchondral 
bone and osteoarthritis severity. 
Prior to histological analysis, mice knee joints were scanned on a µCT scanner at 
4.5µm voxel size with a rotation set of 0.3° (180° rotation) to assess bone 
density and volume. Projection images were acquired and computerised 
reconstruction of the 3D stack of images was performed using NRecon. Analysis 
was performed on the reconstructed 3D image stack which was rotated along 
all three major axes to align and position all samples the exact same way. The 
epiphysis of the tibia was manually selected with the volume of interest (VOI) 
tool using the easily identifiable growth plate as a reference point. The tibial 
epiphysis was further analysed for differences in bone volume, trabecular 
thickness and trabecular separation between HuRfl/flAcanA1-CreERT2+ and 
HuRfl/flAcanA1-CreERT2- mice, which showed no significant differences in all 
parameters measured (Figure 4.5A, B&C, respectively). 
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Figure 4.5. Micro-CT analysis of the tibial epiphysis in HuRfl/flAcanA1-CreERT2luc+ 
mice and HuRfl/flAcanA1-CreERT2luc- counterparts 5 weeks after tamoxifen 
treatment. The tibial epiphysis was analysed for differences in bone volume (A), 
trabecular thickness (B) and trabecular separation (C) between HuRfl/flAcanA1-
CreERT2+ mice and their Cre- counterparts. No significant differences were observed. 
Data is presented as individual data points for each animal as well as the mean 
(horizontal line) and the standard deviation/error (error bars) for each group. (Bone 
volume p=<0.9212; Trabecular thickness p=<0.9072; Trabecular separation 
p=<0.3758). (HuRfl/flAcanA1-CreERT2luc- n=5; HuRfl/flAcanA1-CreERT2luc+ n=5) 
 
 
4.2.3 HuR knockout during the progression of DMM-induced 
osteoarthritis 
4.2.3.1 DMM surgery  
DMM is the most widely used model of post-traumatic osteoarthritis in mice 
due to its high reproducibility and its rapid onset and progression of disease. In 
order to preliminarily assess whether HuR knockout affects articular cartilage 
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during the progression of osteoarthritis, male HuRfl/flAcanA1-CreERT2luc+ and 
control Cre- mice were dosed three times with 1mg/10g body weight tamoxifen 
at 6 weeks of age and DMM or SHAM surgery was performed at 10 weeks of 
age on the left leg, while the contralateral leg remained unoperated. The mice 
were sacrificed 5 weeks post-surgery and tissue collected and processed for 
µCT and histological examination.  
4.2.3.2 Analysis and scoring of histological sections 
The entire knee joint of both HuRfl/flAcanA1-CreERT2+ and HuRfl/flAcanA1-
CreERT2- mice that had either DMM or SHAM surgery were sectioned coronally 
and stained with toluidine blue and fast green. Histological analysis revealed 
that DMM surgery led to severe lesions in the articular cartilage of the DMM 
mice (Figure 4.6 A&B), while control SHAM surgery caused no damage (Figure 
4.6 C&D).  
The lesion severity scoring system was again applied to these mice in the same 
way as previously described by scoring the compartments of the medial and 
lateral tibia and femur and determining the maximal and mean lesion severity 
scores of the articular cartilage for each joint. First, the overall summed 
maximum score and the overall summed mean score was determined in 
HuRfl/flAcanA1-CreERT2+ DMM and SHAM mice and Cre- DMM and SHAM mice 
(Figure 4.6 E&F, respectively). As expected there was a significant increase in 
the maximum and mean scores of DMM treated mice compared to SHAM mice, 
confirming DMM surgery was successful in inducing osteoarthritis. There was a 
small increase in the overall maximum (Figure 4.6E) and mean (Figure 4.6F) 
scores of HuRfl/flAcanA1-CreERT2+  mice compared to HuRfl/flAcanA1-CreERT2- in 
both DMM and SHAM treated mice, however these observations were not 
statistically significant. 
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Figure 4.6. DMM surgery induces osteoarthritis progression in both HuRfl/fl and 
Cre- mice. Toluidine blue stained sections of DMM performed on Cre- (A) and HuRfl/fl 
(B) and control SHAM surgery performed on Cre- (C) and HuRfl/fl (D). Maximum (E) 
and mean (F) grades of lesion in the entire knee joint are both slightly increased in 
DMM treated mice in response to tamoxifen. This difference however is minimal 
and is not significantly different. There is no difference in the lesion severity grade 
between HuRfl/flAcanA1-CreERT2+ and Cre- mice upon SHAM surgery. Significant 
differences were observed between SHAM and DMM treated mice in both 
HuRfl/flAcanA1-CreERT2+ and Cre- mice (p=<0.001). Red ring shows areas of high 
cartilage degradation. Data is presented as individual data points for each animal as 
well as the mean (horizontal line) and the standard deviation/error (error bars) for 
each group. (HuRfl/flAcanA1-CreERT2luc- SHAM n=3, DMM n=3; HuRfl/flAcanA1-
CreERT2luc+ SHAM n=3, DMM n=4) 
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Next, the lesion severity scores from the 4 compartments of the joint, the 
medial and lateral tibia and femur, were analysed. Images of toluidine blue 
stained sections of the medial compartments showed severe osteoarthritis 
lesions in the tibia and femur of DMM treated mice (Figure 4.7 A&B) compared 
to control SHAM animals (Figure 4.7 C&D). Lesion severity scores shows there is 
an increase in both the maximum and mean score of the DMM treated medial 
tibia compartment of HuRfl/flAcanA1-CreERT2+ mice compared to their 
HuRfl/flAcanA1-CreERT2- counterparts (Figure 4.7 E&F). These differences, 
however, are not statistically significant. There was no difference in the severity 
score in the medial femur (Figure 4.7 G&H) and no differences in either the 
tibial and femoral surfaces of the lateral compartment (Figure 4.8). 
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Figure 4.7. Histological and histopathology scoring analysis of the medial 
compartments of HuRfl/flAcanA1-CreERT2+ and HuRfl/flAcanA1-CreERT2- knee 
joints treated with DMM and SHAM surgery. Histological analysis revealed 
similarities in articular structure in the medial compartments of Cre- (A) and 
HuRfl/flAcanA1-CreERT2+ (B) mice that had undergone DMM surgery. This was 
confirmed via histopathology scoring were no significant difference was observed 
in either the tibial (E) or femoral (G) medial compartments when HuR was knocked 
out. Red ring shows areas of high cartilage degradation. Data is presented as 
individual data points for each animal as well as the mean (horizontal line) and the 
standard deviation/error (error bars) for each group. (Medial tibia DMM 
p=<0.09175, SHAM p= 0.21132; Medial femur DMM p=<0.1596, SHAM p=<0.5). 
(HuRfl/flAcanA1-CreERT2luc- SHAM n=3, DMM n=3; HuRfl/flAcanA1-CreERT2luc+ SHAM 
n=3, DMM n=4) 
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Figure 4.8. Histological and scoring analysis of the lateral compartments of HuRfl/fl 
and Cre- knee joints treated with DMM and SHAM surgery. Histological analysis 
revealed no differences between the lateral compartments of Cre- (A) and 
HuRfl/flAcanA1-CreERT2+ (B) mice that had undergone DMM surgery. This was also 
confirmed via histopathology scoring were no significant differences were observed 
in either the tibial (E) or femoral (G) medial compartments when HuR was knocked 
out. Data is presented as individual data points for each animal as well as the mean 
(horizontal line) and the standard deviation/error (error bars) for each group. 
(Lateral tibia DMM p=<0.18442, SHAM p=<0.21132; Lateral femur DMM 
p=<0.3709, SHAM 0.10394). (HuRfl/flAcanA1-CreERT2luc- SHAM n=3, DMM n=3; 
HuRfl/flAcanA1-CreERT2luc+ SHAM n=3, DMM n=4) 
 
4.2.3.3 Micro CT analysis 
Knee joints from both DMM and SHAM HuRfl/flAcanA1-CreETRT2+ and 
HuRfl/flAcanA1-CreETRT2- mice were scanned on a µCT scanner at 4.5µm voxel 
size with a rotation set of 0.3° (180° rotation) as previously described. Images 
were reconstructed and the 3D stack projection was orientated along all three 
major axes to position samples exactly the same for further analysis (Figure 4.9 
C-F). The epiphysis of the tibia was manually selected with the VOI tool using 
the easily identifiable growth plate as a reference point (Figure 4.9 A&B).  The 
medial meniscus has been destabilised in the DMM model compared SHAM 
mice (Figure 4.9 B&A, respectively). The BATman software was used for 
quantification of the selected tibial epiphysis. Bone volume, trabecular 
thickness and trabecular separation were analysed. No significant differences 
were observed between DMM and SHAM HuRfl/flAcanA1-CreERT2+ mice for any 
of these parameters (Figure 4.10 A-C), indicating that the progression of 
osteoarthritis in our DMM mice at 5 weeks did not significantly affect the 
subchondral bone and also that there was no influence of HuR knockdown at 
this time point. 
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Figure 4.9. Micro CT analysis of SHAM and DMM HuRfl/flAcanA1-CreERT2+ mice 
knee joints. Knee joints were scanned and reconstructed using NRecon along the 
coronal plane (C&D) and the sagittal plane (E&F). The tibial epiphysis was manually 
selected as a representative of subchondral bone (A&B). The medial meniscus is 
destabilised in DMM surgery and a subchondral bone sclerosis is highlighted by the 
red arrow (D). 
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Figure 4.10. Micro-CT analysis of the tibial epiphysis in HuRfl/flAcanA1-CreERT2luc+ 
mice that had undergone either DMM or SHAM surgery. There are no significant 
differences concerning the bone volume (A), trabecular thickness (B) or trabecular 
separation (C) in HuRfl/flAcanA1-CreERT2+ mice that had undergone DMM surgery 
compared to control SHAM mice. Data is presented as individual data points for 
each animal as well as the mean (horizontal line) and the standard deviation/error 
(error bars) for each group. (DMM bone volume p=<0.637; trabecular thickness 
p=<0.905; trabecular separation p=<0.606. SHAM bone volume p=<0.653; 
trabecular thickness p=<0.986; trabecular separation p=<0.429). (HuRfl/flAcanA1-
CreERT2luc- SHAM n=3, DMM n=3; HuRfl/flAcanA1-CreERT2luc+ SHAM n=3, DMM n=3) 
 
4.3 Discussion 
The regulation of articular cartilage mRNAs by post-transcriptional miRNAs and 
RNA binding proteins has emerged as a further tier of regulation in joint 
diseases such as osteoarthritis (Tew and Clegg, 2010). Recently, our group has 
found that HuR knockdown in vitro leads to an increase in the expression levels 
of the cartilage degrading enzyme MMP13 (McDermott et al., 2016). This was 
the first time RNA binding proteins have been shown to post-transcriptionally 
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regulate genes in chondrocytes and implies a role for post-transcriptional 
regulation by HuR during chondrogenesis, and perhaps in osteoarthritis were 
MMP13 expression levels are elevated. The role of HuR has not previously been 
examined in vivo with respect to articular cartilage and osteoarthritis 
progression. 
To date the RNA binding protein transgenic model that demonstrates the 
strongest phenotypic links toward a chondrogenic differentiation role has been 
the Sox2-Cre-driven model of HuR deficiency, which results in the severe 
skeletal phenotype described in Chapter 1 section 1.5.2.1.3 (Katsanou et al., 
2009). In this chapter HuR was knocked down in a chondrocyte-specific manner 
in young adult HuRfl/flAcanA1-CreERT2luc+ mice after tamoxifen-mediated 
recombination of the loxP sites, determined by Cre-luciferase expression and 
western blot analysis. We had first evaluated the effect of HuR ablation on the 
pathology of the knee joint after 5weeks utilising histological and µCT analysis 
to determine whether any acute effects of HuR deficiency were visible. There 
was no significant difference in the pathology of the knee joint after this time, 
meaning for subsequent DMM experiments the response to joint instability is 
not clouded with an acute response to HuR loss. Adult systemic deletion of HuR 
results in total lethality of all mice within 10 days (Ghosh et al. 2009), we can 
therefore be confident that expression of the cre-recombinase in 
HuRfl/flAcanA1-CreERT2luc+ is restricted to cartilage, as induced HuR loss in this 
case does not lead to death or acute illness. In order to decipher whether HuR 
knockout affects articular cartilage a longitudinal study would need to be 
performed with a larger sample size.  For example, a study examining the effect 
of interleukin-6 (IL-6) knockout in mice found that the gene knockout led to 
spontaneous osteoarthritis development only after 18 months of age whilst 
younger, 3-month old mice required collagenase injection into the joint to 
induce disease (de Hooge et al. 2005). Due to this potentially long time frame, 
we therefore decided to induce osteoarthritis in our cartilage-specific 
HuRfl/flAcanA1-CreERT2+ mice using the surgical DMM model. 
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4.3.1 Post-transcriptional regulation in osteoarthritis 
Post-transcriptional regulation of genes has an important role in many 
biological processes and the disruption of this tier of regulation is often 
implicated in disease (Faour et al. 2003). The use of mouse models of 
osteoarthritis, including DMM surgery, have identified many of the cellular and 
molecular changes that occur in osteoarthritis (Shen et al. 2017), however post-
transcriptional gene control in chondrocytes remains poorly understood. There 
is also evidence suggesting that genes important during chondrogenesis can be 
post-transcriptionally regulated in chondrocyte in vitro cultures. For instance, 
hyperosmotic stress has previously been shown to result in an increase in the 
mRNA levels of the essential cartilage transcription factor Sox9, associated with 
the regulation of SOX9 mRNA decay in human osteoarthritic chondrocytes via 
the p38 MAPK pathway (Tew et al., 2009). Furthermore, bone morphogenetic 
protein -2 (BMP-2), which is crucial to the development of the embryonic and 
post-natal skeleton can be regulated by TNFα in chondrocytes through 
alteration in its mRNA stability (Pizette and Niswander, 2000, Fukui et al., 2006). 
BMP-2 is particularly crucial in developing limb buds promoting the 
differentiation of prechondrogenic mesenchymal condensations into 
chondrocytes. 
Here, we conducted a preliminary study examining the role of HuR knockdown 
5 weeks after the induction of osteoarthritis via DMM surgery. As measured by 
osteoarthritis histopathology scoring, induction of specific HuR knockdown in 
articular cartilage did not significantly affect the severity of osteoarthritis 
disease progression. However, there was an increased variability in the HuR 
knockdown data with higher summed and maximal scores in the medial tibial 
compartment, which suggests that a larger, higher powered study is necessary. 
For non-preliminary studies a power analysis should be performed for all 
studies were groups are compared (Sexton et al., 2008). The basic principle of a 
power calculation is to determine the number of individuals needed to detect a 
significant difference in treatment, as such in order to calculate sample size a 
general idea of the expected results in required (Noordzij et al., 2010). As this is 
a preliminary study and we have very few sample subjects in each group of our 
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study, the results cannot be generalised to the wider population. It would 
therefore be necessary to complete this study with a larger sample size having 
completed a power calculation; this is performed and discussed in greater detail 
in the concluding chapter of this thesis. 
 
4.3.2 HuR during osteoarthritis 
While there is no significant difference in the articular cartilage of 
HuRfl/flAcanA1-CreERT2+ mice compared to controls after DMM-induced joint 
instability, HuR may still play a role in the development of osteoarthritis. Genes 
known to influence osteoarthritis might be direct or indirect targets of HuR 
regulation, and there is evidence that this can occur. Runx2 is a crucial 
transcription factor involved in the regulation of chondrocyte hypertrophy, as 
well as an inducer of osteoblast differentiation, whose expression levels have 
been shown to be increased in human osteoarthritic cartilage (Zhong et al. 
2016). An overexpression of Runx2 in transgenic mice results in an activation of 
MMP13 and ADAMTS5, both matrix degrading enzymes, in chondrocytes (Wang 
et al. 2012). Runx2 increases the transcription of MMP13 by binding to 
osteoblast-specific gene osteocalcin (OSE2), located in the proximal promotor 
of MMP13 (Hess et al, 2001). During chondrocyte differentiation, Runx2 also 
interacts with Osterix to cooperatively induce MMP13 expression (Nishimura et 
al. 2012). Runx2 undergoes multiple levels of regulation and miRNAs have been 
implicated in its post-transcriptional control during MSC lineage determination 
and in osteoarthritis (Huang et al. 2010, Martinez-Sanchez et al. 2012). A recent 
report identified Runx2 as a novel target of miR-105 and demonstrated that 
miR-105 expression is downregulated in osteoarthritis (Ji et al. 2016). 
Recently, a study reported that, while control mice developed severe 
osteoarthritis-like defects including the degradation of articular cartilage and 
subchondral bone after DMM surgery, Aggrecan-CreERT2luc driven knockout of 
Runx2 significantly ameliorated these defects. It was also shown that MMP13 
levels were significantly reduced in Runx2 knockout mice. Taken together these 
findings suggest that osteoarthritis-like defects can be partially rescued after 
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Runx2 inhibition (Liao et al. 2017). Based on this and previous studies that 
demonstrate how Runx2 regulates MMP13 expression, and that it can be post-
transcriptionally regulated by miRNAs, it is possible that RNA-binding proteins 
may also regulate Runx2 expression in chondrocytes and during osteoarthritis 
progression. Our group has previously reported that upon siRNA-mediated 
knockdown of HuR in chondrosarcoma cells and human articular chondrocytes 
the overall mRNA expression of Runx2 was decreased suggesting HuR may play 
a role in its regulation, however there was no change in Runx2 mRNA decay 
(McDermott et al. 2016). Because HuR works by increasing the stability of its 
target mRNAs, there would be the potential for a knockout of HuR to cause a 
downregulation of Runx2 expression through an intermediate factor and thus 
partially decelerate the rate of osteoarthritis progression. Further work, 
however, is required to confirm HuRs role in regulating genes involved in 
chondrogenesis and to conclude whether HuR plays an active role in the 
development of osteoarthritis. For example, a relatively simple initial 
experiment could be to use the wax embedded sections from the mice used in 
this DMM pilot study for immunohistochemical analysis. This would allow 
examination of the protein localisation of HuR, also confirming protein levels 
had been reduced in vivo, and the localisation and abundance of other genes of 
interest and potential targets of HuR. By examining the distribution and 
abundance of HuR and other markers of chondrogenesis we can identify genes 
differentially regulated by the knockdown of HuR during disease development 
in vivo. 
In summary, this chapter reports that articular cartilage is not acutely affected 
by the loss of HuR in adult mice after 5 weeks. However, variability in the 
medial tibial compartment is interesting and would benefit from a higher 
powered study. It is possible that the effects of HuR deficiency in adults do not 
manifest until much later in adult life, however while we fully intended to 
explore this avenue Home Office project licence issues meant we had to halt 
this part of the project. This would, however, be a potential next step for the 
continuation of this work. It has previously been reported that inducing 
chondrocyte death by transgenic expression of toxins leads to a reduction in the 
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cell population but not does lead to cartilage damage (Zhang et al. 2016). This 
study also reported that after surgical induction of osteoarthritis in mice, 
cartilage damage was actually increased in mice with intact chondrocytes 
compared to animals were chondrocytes had been killed (Zhang et al. 2016). 
These findings suggest that chondrocyte death does not drive cartilage damage. 
Another study reported that HuR-deficiency in pancreatic ductal 
adenocarcinoma cells resulted in significantly elevated levels of cell death 
compared to control cells (Lal et al. 2017). While this study was performed on 
different cell types, it is possible that in our HuR transgenic mice, HuR 
knockdown might lead to chondrocyte cell death which may not alter the 
integrity of the articular surface. In vitro studies utilising chondrogenic cell lines 
and primary chondrocytes from HuR floxed mice would help to identify 
molecular changes that occur during HuR loss and provide a better insight into 
the post transcriptional functions of HuR in cartilage. 
Although conditional inactivation or overexpression of genes via the Cre/loxP 
system is a common method to investigate the function of genes in vivo, one 
must keep in mind that this method has limitations. To achieve efficient gene 
recombination Cre/loxP relies on the potency of each transgenic promoter to 
drive the expression of the Cre recombinase, with transgene copy number 
usually proportional to expression strength (Elefteriou and Yang, 2012). 
Chromosomal position effect can cause this variability and can often relate to 
the insertion site of the transgene, which can insert into a transcriptionally 
more or less active chromosomal region. Tools are available to understand the 
relative intensity of Cre activity in different cells or tissues. The ROSA26-lacZ 
line has one copy of the bacterial gene lacZ inserted into chromosome 6 
(Kisseberth et al., 1999). The associated mouse promoter drives β-galactosidase 
expression in all adult tissues and, when generating a double transgenic line 
with inducible Cre recombinase, is a useful tool for visualising Cre recombinase 
expression after recombination (Guarente et al., 1981). AcanA1-CreERT2luc mice 
were used in this study to generate HuR knockout mice specifically in aggrecan 
expressing cells. AcanA1-CreERT2luc mice were initially generated by Cascio in 
2013 and were subsequently mated with the ROSA26-lacZ mice in order to 
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establish the areas of Cre recombinase expression in vivo (Cascio et al., 2013). 
This study reported that Cre recombinase under the aggrecan A1 reporter was 
activated by tamoxifen and was specifically expressed in cartilaginous 
structures and developing skeletal structures in embryos and cartilage tissues in 
adults. As this validation was confirmed prior to breeding with HuRfl/fl mice we 
can therefore be confident that Cre recombinase expression is restricted to 
chondrocytes in our double transgenic mice. However, while CreERT2 is ~10 
times more sensitive to 4OH-tamoxifen in vivo than the original CreERT, one 
major limitation of the CreERT2 system is that it may be somewhat leaky, 
resulting in weak constitutive activation (Elefteriou and Yang, 2012). 
One highly important parameter to consider when generating conditional 
knockout mice is the efficiency of flox recombination (Elefteriou and Yang, 
2012). As discussed, Cre transgenic lines have varying levels of Cre recombinase 
expression, while floxed genes have differing chromosomal accessibility to be 
clipped by the Cre recombination, which combined leads to variable 
recombination efficiency (Elefteriou and Yang, 2012). It is therefore necessary 
to validate and confirm knockdown both at the mRNA and protein levels. This 
however proved a technically challenging aspect of the work presented in this 
chapter. For mRNA, we initially attempted to extract the RNA from the articular 
cartilage from individual mice, however the abundance of isolated RNA was 
very low and subsequent qRT-PCR was therefore unsuccessful. We next decided 
to pool the articular cartilage of several mice from the same genotype when 
extracting the RNA, this again resulted in low abundance RNA and qRT-PCR was 
unsuccessful. Extracting high-quality RNA in sufficient amounts from articular 
cartilage has previously been reported as challenging due to low cellularity and 
high proteoglycan content in the ECM (Bleu et al., 2017; Ruettger et al., 2010). 
After many attempts at optimising techniques for mRNA isolation and analysis 
proved unsuccessful we decided to examine the protein expression levels. 
However, isolating the protein from individual mice also resulted in low protein 
abundance that was undetected by western blot. We therefore also pooled the 
articular cartilage from 3 mice per experimental and control groups, the results 
of which are reported in figure 4.2B, this figure however is not great and the 
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amount of time already spent on this validation meant this was the best we 
could do. Further optimisation would enable more definitive levels of protein 
expression to be analysed. We are currently optimising immunohistochemical 
analysis for HuR on the histological sections taken from mice in this study in 
order to confirm HuR protein knockdown in vivo. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analysis of HuR knockdown in chondrocytes in vitro 
 
Page | 152 
 
 
 
 
 
 
 
 
 
 
 
5 Analysis of HuR knockdown in 
chondrocytes in vitro  
 
 
 
 
 
 
 
 
Analysis of HuR knockdown in chondrocytes in vitro 
 
Page | 153 
 
5.1 Introduction 
As discussed in Chapter 3, HuR knockdown has a detrimental effect on the 
developing skeleton during embryonic development. Based on the results of 
Chapter 4, it would appear that HuR knockdown does not have an effect in the 
adult joint or during the progression of osteoarthritis. While phenotypic 
differences in the ribs, limbs and craniofacial structures of the developing 
embryo can be observed after HuR knockout, the molecular mechanisms 
affecting chondrocyte function remain unknown. This chapter will focus on the 
use of in vitro systems in order to determine the molecular mechanisms 
involved in the regulation of chondrocyte function by HuR. 
5.1.1 Primary chondrocytes 
Isolation and culture of primary chondrocytes is a commonly used method for 
studying the molecular mechanisms involved in the regulation of progression of 
chondrogenesis. Several culture models, including primary cultures of mouse, 
rabbit and rat chondrocytes, have proved useful tools for studying 
chondrogenesis. Especially since normal animal chondrocytes and 
chondrocytes/mesenchymal cells from developing or young tissue are more 
readily available than human chondrocytes, were generally only chondrocytes 
from old and/or osteoarthritic tissue can be obtained. Chondrocytes are 
generally isolated using enzymatic digestion of the tissue, typically with an 
initial digestion with trypsin or hyaluronidase to remove proteoglycan from the 
matrix, followed by collagenase to break down the collagen structure of the 
tissue. Collagenase D contains collagenase and other proteases that is ideal for 
gentle tissue dissociation of murine chondrocytes (Thirion and Berenbaum 
2004). An important consideration when working with primary chondrocytes is 
that they quickly dedifferentiate in monolayer culture. This process is 
characterised by a loss of the cells’ rounded morphology as they switch to a 
proliferative, fibroblastic phenotype. This change in phenotype is accompanied 
by reduced expression of chondrocyte marker genes such as Col2a1, aggrecan 
and Sox9, alongside a general reduction in ECM synthesis and an increase in 
expression fibroblastic genes such as Col1a1 (Hardingham et al. 2002).  
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5.1.2 Immortalised cell lines for studying chondrogenesis 
When studying the molecular mechanisms of chondrogenesis in vitro, 
chondrogenic cell lines are frequently used as an alternative to primary 
chondrocytes (Phull et al., 2016). There are several chondrogenic cell lines 
available, which range from transformed cells isolated from cartilage tumours 
to primary cells that have been immortalised in the laboratory (Phull et al., 
2016). Advantages of cell lines include their stable phenotype, relative ease of 
culture and their ability to generate large numbers of cells for large scale 
experiments (Maqsood et al., 2013). However, their stable phenotype also 
represents a significant drawback to their use as it generally differs significantly 
from primary chondrocytes meaning that care has to be taken when 
interpreting results (Lorsch et al., 2014). Nevertheless, although immortalised 
cell lines cannot be substituted entirely for primary cultures, experiments using 
primary chondrocytes are limited by the number of cells that can be derived 
from tissue samples, the donor variability and the phenotypic instability of the 
cells when they are allowed to divide in adherent monolayer culture (Otero et 
al., 2014). Overall, the ease of use and reproducibility of chondrocyte cells lines 
has led many scientists to use them for detailed molecular studies and for 
preliminary hypothesis generation studies, prior to validation of experimental 
conclusions in primary chondrocyte cultures (Otero et al., 2014).  
There are a number of cell lines that have been used for the study of 
chondrogenesis and osteogenesis including C3H10T1/2 (Lin et al. 2009), RCJ3 
(Spagnoli et al. 2001) and CFK2 cells (Filion and Labelle 2004). When compared 
to all the chondrogenic cell lines, however, ATDC5 cells have been reported to 
exhibit a higher frequency of chondrogenic differentiation and are some of the 
most chondrocytic in their actions (Atsumi et al. 1990). 
ATDC5 is a murine chondrogenic progenitor cell line derived from mouse 
embryo teratocarcinoma (AT805) cells that undergo cellular condensation and a 
sequential process of chondrocyte differentiation and eventually hypertrophy 
when insulin, transferrin and sodium selenite are added to the culture medium. 
Insulin is necessary as a growth factor, transferrin as an iron transporter and 
sodium selenite is a potent antioxidant (Atsumi et al. 1990). ATDC5 cells are 
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maintained in an undifferentiated state during their rapid proliferation, which 
allows large numbers of cells to be generated for use in in vitro culture systems 
to mimic cellular condensation during chondrogenesis. This cell line is therefore 
a useful in vitro model for exploring molecular mechanisms during 
chondrogenesis (Yao and Wang 2013).  
Previous work examining the effect of RNA binding protein knockdown in 
primary human chondrocytes and in the human chondrosarcoma-derived cells 
SW1353 led to the observation that expression of HuR negatively regulates 
MMP13, as its knockdown via siRNA leads to significant and reproducible 
elevated levels of MMP13 expression with no notable difference in its rate of 
decay (McDermott et al. 2016). The distribution of HuR in mouse E13.5 and 
E16.5 embryos also led to regional differences in the expression of HuR being 
identified, with lower expression levels in hypertrophic chondrocytes and in 
those adjacent to regions involved in the regulation of mineralisation and long 
bone growth, including the perichondrium were MMP13 expression is elevated 
(McDermott et al. 2016). This finding is interesting because, as previously 
mentioned in section 1.3.1.2.1, MMP13 is considered a marker of terminal 
chondrocyte differentiation during endochondral ossification. In order to build 
upon these findings, experiments were performed to elucidate mechanistic 
details of HuR’s role in chondrogenesis and osteoarthritis progression in the in 
vitro chondrocyte models: the ATDC5 cell line, and primary articular 
chondrocytes isolated from HuRfl/fl mice. 
A high-throughput biochemical screen previously identified the low molecular 
weight compound, MS-444, as an inhibitor of HuR that was originally isolated 
from the culture broth of Micromonospora (Nakanishi et al. 1995). HuR 
homodimerises before binding to RNA, a process that is mediated by RRMs 1 
and 2 (Kasashima et al. 2002, Meisner et al. 2007). MS-444 acts to interfere 
with the formation of HuR dimers and inhibits HuR’s ability to bind to its target 
ARE-containing mRNAs and influences HuR’s cytoplasmic location (Meisner et 
al. 2007).  Primary chondrocytes from transgenic mice containing floxed sites 
and which conditionally express Cre recombinase are an ideal tool for studying 
the ablation of a specific gene in vitro. 4-hydroxytamoxifen has previously been 
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utilised to induce nuclear localisation of Cre recombinase in in vitro culture 
systems were cells contain both the floxed alleles and estrogen receptor-bound 
Cre recombinase under the control of a specific promoter (Yang et al. 2014). An 
alternative approach for the delivery of Cre recombinase is the use of viral 
vectors. Adenovirus vectors are a popular tool for foreign gene delivery to 
mammalian cells, in part due to their ability to infect many different cells types 
and tissues and because they don’t require cell division for infection unlike 
retroviruses. Adenoviral vectors that express Cre recombinase have been 
utilised to mediate loxP recombination in in vitro systems (Badorf et al. 2002). 
As previously discussed in Chapter 3, deletion of HuR in cartilage- and skeletal- 
specific manners during embryonic development leads to abnormalities in 
chondrogenesis and endochondral ossification. Exactly how loss of HuR causes a 
severely abnormal skeletal phenotype remains unknown. In this chapter, in 
vitro assays using both ATDC5 cells and murine primary chondrocytes are 
utilised to try to determine HuR’s molecular impact during chondrocyte 
differentiation. 
5.2 Results 
5.2.1 Determining the optimum concentration of MS-444 
The well-established chondrocytic cell line ATDC5 was used as a reproducible 
model of chondrogenic differentiation. (Kartsogiannis and Ng 2004). To 
determine optimum concentration for observing functional effects of HuR 
inhibition using MS-444, undifferentiated ATDC5 cells were plated at 6400 
cells/cm2 and treated with varying concentrations of MS-444 for 24 hours. RNA 
was extracted with TRIzol® and cDNA prepared for qRT-PCR quantification. 
Results were analysed using the comparative Ct method (2-∆Ct) such that each 
genes mRNA was quantified relative to β-Actin. Were MS-444 was added to a 
treatment group, the same volume of DMSO was added to control groups. 
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Figure 5.1. qRT-PCR analysis of mRNA expression levels of marker genes in ATDC5 
cells treated with varying concentrations of the HuR inhibitor MS-444. ATDC5 cells 
were seeded at 6400 cells/cm2 and treated with either 10µM, 50µM or 100µM of 
MS-444 for 24 hours. Red data points indicate statistically significant differences in 
the expression levels compared to that of control conditions without MS-444 (p < 
0.005, one way ANOVA with Dunnett’s post hoc testing). Horizontal lines represent 
the mean value of each data set. Each data point represents the result of an 
independent experimental replicate. (n=3) 
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Undifferentiated ATDC5 cells were treated with 10µM, 50µM and 100µM of 
MS-444. Analysis by qRT-PCR showed that gene expression levels of HuR were 
significantly increased when treated with 50µM of MS-444 for 24 hours (Figure 
5.1A). MMP13 levels were significantly increased at both 10µM and 50µM 
(Figure 5.1B) but not at 100µM, suggesting saturation of MS-444 does not 
increase effectiveness of HuR inhibition. Col2a1 mRNA was detected at very low 
levels in the undifferentiated ATDC5 cells and was significantly reduced further 
by treatment with MS-444. (Figure 5.1C). Sox9 levels increased significantly at 
both 10 and 50µM (Figure 5.1D). Markers of terminal differentiation Col10a1 
and Runx2 both observed an increase in gene expression (Figure 5.1E+F), with a 
significant increase of Col10a1 when treated with 50µM MS-444. Based on this 
data, we therefore decided to continue the rest of the experiments using 50µM 
MS-444. 
 
5.2.2 HuR knockdown during chondrogenic differentiation 
Differentiation of ATDC5 cells follows a well-defined and established 
endochondral program were the cells differentiate from chondroprogenitors to 
hypertrophic chondrocytes over 2 to 3 weeks following stimulation of confluent 
monolayers with insulin (Atsumi et al. 1990). Previously, the mRNA expression 
of Col2a1, Col10a1, Sox9 and RunX2 during chondrogenic differentiation of 
ATDC5 cells were analysed using qRT-PCR (Caron et al. 2016). It was shown that 
during differentiation of ATDC5 cells Col2a1 and Sox9 were increasingly 
expressed from day 7 onwards, which established chondrogenic differentiation 
and Col10a1 and Runx2 were also increased from day 7 and 10 marking 
chondrocyte hypertrophy (Caron et al. 2016). Interestingly Sox9 expression is 
also transiently increased in the first few hours of differentiation. 
In order to measure the baseline mRNA levels of HuR and markers of 
chondrogenesis in ATDC5 cells during chondrogenic differentiation, cells were 
treated with differentiation media containing insulin for 21 days and RNA 
extracted at days 0, 4, 14 and 21. MMP13 was increasingly expressed from day 
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14 onwards to significantly different levels than that of days 0 and 4 (Figure 
5.2B). To determine that chondrogenic differentiation had occurred, expression 
of the chondrocyte markers Col2a1 and Sox9 was measured alongside that of 
the markers of terminal differentiation Col10a1 and Runx2. Col2a1 and Col10a1 
(Figure 5.2 C &E, respectively) had both increased expression by day 14 
onwards, with a statistically significant increase of Col2a1 by day 21. Runx2 
expression also increased over the course of chondrogenic differentiation, 
though not significantly, and plateaued by day 21 (Figure 5.2F). Sox9 expression 
significantly increased after day 4 to a steady state (Figure 5.2D). However, in 
this experiment any transient increase of Sox9 during the early stages of 
differentiation could not be detected.  
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Figure 5.2. qRT-PCR analysis of mRNA expression levels of marker genes in ATDC5 
cells that have undergone chondrogenic differentiation. ATDC5 cells were seeded 
at 6400 cells/cm2. After 24 hours cells were differentiated in the chondrogenic 
lineage for 21 days with insulin treatment. Red data points indicate conditions were 
expression was significantly different to that of Day 0 conditions (p < 0.05, one-way 
ANOVA with Tukey’s post hoc testing). Horizontal lines represent the mean value of 
each data set. Each data point represents the mean of an independent 
experimental replicate.  (n=3) 
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To examine the effects of MS-444-mediated inhibition of HuR function during 
chondrocyte differentiation, ATDC5 cells were differentiated with insulin with 
or without the addition of 50µM MS-444 for the first 48 hours. RNA was 
extracted for qRT-PCR at 0, 1, 2, 4, 8, 24 and 48 hours and 4, 7, 10 and 14 days 
in order to ensure adequate representation of the mRNA levels over the course 
of the 14 days. Compared to cells without MS-444 treatment, HuR mRNA levels 
were only slightly decreased with the addition of MS-444 for the first 48 hours 
(Figure 5.3A). This is potentially because MS-444 was only added for the first 48 
hours of chondrocyte differentiation and may have needed continuous 
treatment throughout the course of the experiment to observe significant 
changes compared to control conditions. MMP13 expression levels, however, 
were higher during the first hours of differentiation, when the MS-444 was 
present, but then appeared to be inhibited in the later stages of the process 
(Figure 5.3B). Col2a1, Aggrecan and Col10a1 mRNA levels steadily increased 
over the course of the experiment with no differences observed between the 
control and MS-444 treated cells (Figure 5.3 C, E + F respectively). Sox9 mRNA 
expression also increased over the course of the experiment with no difference 
between MS-444 treated cells and non-treated cells (Figure 5.3D). A reduction 
in Runx2 expression can be seen between 24 and 48hours in MS-444 treated 
cells compared to non-treated and a significant reduction in Runx2 expression is 
observed at day 14 (Figure 5.3G).  
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Figure 5.3. qRT-PCR analysis of mRNA expression levels of marker genes in ATDC5 
cells undergoing chondrogenic differentiation for 14 days with or without 50µM 
MS-444 present during the first 48 hours of culturing. ATDC5 cells were seeded at 
6400 cells/cm2 and treated with 50µM MS-444 for the first 48 hours of 
chondrogenic differentiation with the addition of insulin in differentiation media 
and time points taken at various intervals for 14 days. Note the X-axis is a 
categorical and not linear time scale. Each data point represents the mean of an 
independent experimental replicate.  (**** = p < 0.0001) (n=3) 
 
 
5.2.3 MS-444 treatment differentially regulates the mRNA levels of 
genes involved in chondrogenesis  
Limited availability of MS-444 meant that continuous application over a 21-day 
time course was not possible. We instead decided to assess over a shorter time 
period of 7-days. ATDC5 cells were treated with 50µM MS-444 continuously for 
7 days, a point at which many marker genes’ expression is altered under 
chondrogenic conditions. Cells either remained undifferentiated or were 
differentiated with the addition of insulin in the culture medium. Here, 
induction of differentiation by insulin does not seem to alter HuR mRNA levels 
after 7 days (Figure 5.4A). However, after continuous treatment with MS-444 
HuR levels in both differentiating and undifferentiated cells are significantly 
reduced, suggesting MS-444 does act to inhibit HuR but is not affected by the 
morphological state of the chondrocyte. MMP13 levels are significantly 
increased after MS-444 treatment compared to control and Day 0 (Figure 5.4B). 
MMP13 levels are increased in untreated differentiating ATDC5 cells (insulin 
treatment), however expression levels do not seem to increase again in 
differentiating cells with MS-444 treatment (M+I treatment). Col2a1 mRNA 
levels are decreased in all conditions when compared to day 0, however levels 
are increased when compared to control conditions after the 7 day time course 
(Figure 5.4C). Sox9 is significantly increased in differentiating cells due to an 
induction by insulin. Both undifferentiated and differentiating cells result in a 
significant repression of Sox9 expression after 7 days of continuous treatment 
with MS-444 (Figure 5.4D). As a marker for chondrocyte differentiation, it was 
no surprise that Col10a1 expression levels were increased during chondrocyte 
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differentiation in untreated cells due to insulin addition in cells without MS-444 
(Figure 5.4E). However, mRNA levels of Col10a1 were inhibited to Day 0 levels 
by MS-444 treatment after 7 days of differentiation (M+I). Runx2 mRNA levels 
remained at similar levels to the control condition after 7 days of differentiation 
with insulin. MS-444 treatment however, significantly repressed the mRNA 
levels of Runx2 in both differentiating and undifferentiated cells (Figure 5.4F).  
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Figure 5.4. qRT-PCR analysis of mRNA expression levels of marker genes in ATDC5 
cells treated with and without constant exposure to 50µM of the HuR inhibitor 
MS-444, in chondrogenically differentiated (insulin) and undifferentiated cells. 
ATDC5 cells were seeded at 6400 cells/cm2. After 24 hours cells were switched to 
chondrogenic differentiation media for 7 days supplemented with 50µM MS-444 or 
equivalent volume of DMSO carrier as control.  Data was analysed by two-way 
ANOVA with Tukey post hoc testing. p values for statistically significant differences 
between conditions are shown. Horizontal lines represent the mean value of each 
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data set. Each data point represents the mean of an independent experimental 
replicate. (M + I = 50µM MS-444 and Insulin) (n=3) 
 
5.2.4 Knockdown of HuR in primary murine chondrocytes via 
tamoxifen  
While chondrogenic cell lines are useful tools in the study of the molecular 
mechanisms involved in chondrogenesis, primary chondrocyte cultures remain 
one of the most powerful tools for the investigation of molecular events that 
are associated with chondrocyte differentiation. A process of dedifferentiation 
occurs to primary chondrocytes grown in monolayer, marked by a loss of 
collagen type II and aggrecan, and an induction of collagen type I expression 
(Kartsogiannis and Ng 2004). Dedifferentiation can be influenced by seeding 
density and is accelerated by growth in medium supplemented with serum and 
by passage number. We therefore only used primary chondrocytes up to and 
including passage three in experiments. The primary culture of immature 
murine articular chondrocytes (iMACs) and primary costal chondrocytes have 
previously been described (Lefebvre et al. 1994). 
In order to observe the effect of HuR knockdown in murine primary 
chondrocytes, HuRfl/flAcanA1-CreERT2luc+ mice were crossed and resulting 
progeny used for chondrocyte isolation. Per biological replicate, one litter of 
neonates between 5 and 6 days old were sacrificed and both articular and 
costal chondrocytes were isolated via collagenase digestion as previously 
described in Methods section 2.6. Articular chondrocytes were seeded at a 
density of 8 x 103 cells/cm2, while costal chondrocytes were seeded at 25 x 103 
cells/cm2 and allowed to proliferate for 7 days or until confluent prior to 
experiment. Both articular and costal chondrocytes exhibit a typical 
chondrocyte morphology, with a polygonal shape (Figure 5.5 A&B, 
respectively). There were, however, difficulties in the isolation of pure murine 
costal chondrocytes, in that removal of the muscle and other tissue from the rib 
cartilage was difficult and subsequently resulted in other cell populations being 
present in small amounts in culture (Figure 5.5B).  The isolation of pure articular 
chondrocytes proved less difficult and resulted in cleaner populations of 
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chondrocytes. As a result iMACs were selected for future primary chondrocyte 
experiments. 
 
 
 
Figure 5.5. Primary articular chondrocytes 7 days after isolation from HuRfl/fl 
AcanA1-CreERT2luc+ pups. Articular chondrocytes (A) and costal chondrocytes (B) 
were isolated from 5-6 day old HuRfl/fl AcanA1-CreERT2luc+ pups and proliferated for 
7 days prior to experiment. Images were taken on a Nikon microscope 7 days after 
seeding onto 10cm cell culture dishes. (Scale bar = 100µm) 
 
 
 
After murine articular chondrocyte isolation cells were left to reach confluence 
for 7 days, at which time cells were seeded into 6 well plates. 2 days after 
seeding, cells were treated for the first 24 hours with 100nM of 4-
Hydroxytamoxifen, the active metabolite of tamoxifen which binds to the 
estrogen receptor of the CreERT2luc complex to enable recombination of HuR 
flox sites. RNA was extracted from cells at 0, 24, 48 and 72 hours. 
Compared to control conditions, 4-Hydroxytamoxifen treatment significantly 
reduces HuR mRNA expression levels by 48 hours suggesting recombination of 
the HuR floxed alleles has occurred, however the trend of HuR expression in 
tamoxifen treated cells still seems to increase over time in parallel to control 
cells (Figure 5.6A). Upon tamoxifen-mediated HuR knockdown in primary 
articular chondrocytes MMP13 expression levels reduce over the time course to 
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a significant difference by 72 hours (Figure 5.6B). This is opposite to what we 
see in MS-444-mediated HuR knock-down in ATDC5 cells were MMP13 levels 
increase upon tamoxifen treatment, but this may be due to mechanistic 
differences between cell lines and primary cells. There is no significant 
differences in the expression levels of both Col2a1 and Sox9 upon HuR knock-
down (Figure 5.6 C&D, respectively). Expression levels of Acan are reduced by 
48 hours though not significantly and return to control levels by 72 hours 
(Figure 5.6E), while Col10a1 expression is significantly increased 72hours after 
tamoxifen treatment (Figure 5.6F). Runx2 mRNA levels seem to be the most 
affected by tamoxifen-mediated HuR knock-down, with a significant reduction 
at 48 and 72 hours after tamoxifen treatment (Figure 5.6G). This is in keeping 
with a previous increase in Runx2 expression upon MS-444-mediated HuR 
knock-down in ATDC5 cells.  
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Figure 5.6.  qRT-PCR analysis of mRNA expression levels of marker genes in HuRfl/fl 
AcanA1-CreERT2luc+ primary articular chondrocytes treated with tamoxifen for the 
first 24 hours. After isolation of primary articular chondrocytes, cells were plated at 
25 x 103 cells/cm2 and treated with 100nM tamoxifen for the first 24 hours. RNA 
extraction was performed at 24, 28 and 72 hours following treatment. Absolute 
values are normalised to 0 hour. Data was analysed by two-way ANOVA with Tukey 
post hoc testing and p values for statistical significance between conditions are 
provided. Horizontal lines represent the mean value of each data set. Each data 
point represents the mean of an independent experimental replicate.  (n=3) 
 
5.2.5 Determining the optimum MOI for adenoviral infection 
We next decided to utilise adenoviral infection of Cre adenovirus into isolated 
HuRfl/fl AcanA1-CreERT2luc- articular chondrocytes for HuR knock-down. In order 
to minimise the amount of adenovirus used to reduce cell stress whilst still 
getting optimum infectivity, it is necessary to determine the optimum 
multiplicity of infection (MOI) in each cell type. MOI is the ratio between the 
number of virus particles in an infection and the number of host cells. In order 
to determine the optimum MOI in murine primary articular chondrocytes we 
used an adenovirus that expresses enhanced green fluorescent protein (eGFP) 
under the control of the ubiquitous cytomegalovirus (CMV) promoter. Since 
GFP is easily visualised under florescence microscopy, the eGFP adenovirus can 
be used to determine the transduction efficiency and to optimise the MOI in a 
specific cell type. After seeding onto 12-well culture plates, articular 
chondrocytes were treated for 24 hours with eGFP adenovirus at MOIs of 100, 
125, 150, 175 and 200. After a further 24 hours cells were visualised under a 
microscope. eGFP expressed well in the cells under luminescent microscopy at 
MOI 200 (Figure 5.7B).  
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Figure 5.7. GFP fluorescence in HuRfl/fl AcanA1-CreERT2luc- primary articular 
chondrocytes at MOI of 200. Primary articular chondrocytes were seeded at 25 x 
103 cells/cm2 and treated with eGFP-adenovirus at MOI 200 after 24 hours. After a 
further 24 hours fluorescence was visualised using a Nikon Microscope. Scale bar = 
100µm. 
 
 
In order to quantify the number of cells infected, adenoviral-treated cultures 
were fixed in FACs medium and processed on a FACScan flow cytometer. 
Percentage uptake of eGFP into cells were as follows: MOI 100 - 73.7% (Figure 
5.8B), MOI 125 - 79.9% (Figure 5.8C), MOI 150 - 82.4% (Figure 5.8D), MOI 175 - 
77.5% (Figure 5.8E) and MOI 200 - 85% (Figure 5.8F). An optimum MOI of 200 
was determined to gain 85% adenoviral uptake and was therefore used for 
subsequent Cre adenoviral transduction. 
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Figure 5.8. FACS analysis of eGFP expressing primary articular chondrocytes. 
Primary articular chondrocytes isolated from 4-day old HuRfl/fl AcanA1-CreERT2luc- 
mice were incubated with eGFP adenovirus over a range of MOIs (100, 125, 150, 
175 and 200) for 24 hours. After cell fixation cells were analysed on a FACScan flow 
cytometer machine and GFP expression quantified compared to control conditions. 
An optimum MOI of 200 was selected.  
 
 
5.2.6 Knockdown of HuR in primary murine chondrocytes via Cre 
adenovirus 
Having identified that high infection rates could be achieved in primary 
chondrocytes using the eGFP adenovirus we next used the same system to 
knockdown HuR in these cells. Cre recombinase was delivered to HuRfl/fl 
AcanA1-CreERT2luc- murine articular chondrocytes via infection with a Cre-
expressing adenovirus. Cells were seeded at a density of 25 x 103 cells/cm2 and 
treated with a 200 MOI of Cre adenovirus for 24 hours, after which time 
adenovirus media was changed for normal proliferation media for a further 48 
hours. RNA was collected at time points 0, 24, 48 and 72 hours (were 0 hours 
was immediately before adenoviral infection) in TRIzol® and qRT-PCR was used 
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to determine changes in gene expression for makers of chondrogenesis. 
Following adenoviral treatment of HuRfl/fl AcanA1-CreERT2luc- primary 
chondrocytes, HuR expression levels were reduced over the 72-hour time 
course when compared to a control eGFP treatment of cells (Figure 5.9A). This 
was encouraging and suggested the knockdown of HuR via adenoviral 
transduction was successful. Other markers of chondrogenesis were not as 
clearly affected by Cre adenoviral treatment when compared to control 
conditions (Figure 5.9 B-F). There was, however, only one biological replicate 
performed for this experiment and to confirm the results and gain a better 
understanding of how HuR knockdown affects the molecular mechanisms 
associated with chondrogenesis in primary chondrocytes, more repetitions are 
necessary. For this data to be robust, a minimum of three biological repeats per 
experimental time point are needed. The use of biological replicates will 
diminish the amount of false positives that arise from the sampling process. As 
with the data presented here, technical replicates are also needed. 
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Figure 5.9. qRT-PCR analysis of marker genes in Cre and eGFP adenoviral treated 
primary murine articular chondrocytes. Articular chondrocytes were transfected 
with Cre adenovirus at an MOI of 200 for 24 hours followed by 48 hours in 
proliferation media. RNA was extracted at 0, 24, 48 and 72 hours after adenoviral 
infection for qRT-PCR analysis. Adenovirus eGFP was used as a control. (n=1. 
Technical replicates are shown). 
Analysis of HuR knockdown in chondrocytes in vitro 
 
Page | 175 
 
5.3 Discussion 
The objectives of this chapter were to use various methods of HuR knockdown 
in both the ATDC5 cell line and in primary murine articular chondrocytes to 
examine the effect of HuR knockdown during chondrogenesis and 
endochondral ossification. Few studies have highlighted the roles of HuR in 
regulating markers of chondrogenesis. Katsanou et al performed a microarray 
study on HuR knockout and WT mouse embryonic fibroblasts (MEFs) to 
determine HuR target mRNAs that are involved in embryonic development 
(Katsanou et al. 2009). While many genes involved in various biological 
processes were identified to be up (240) or down (155) regulated in HuR 
knockout MEFs, the aggrecanase ADAMTS5 was also found to be significantly 
upregulated in these cells. Other markers of chondrogenesis were not 
identified, however differences in cell types mean they may not be detected in 
any other cell types except those that they are specific to, for example aggrecan 
is a cartilage-specific protein and would not be present in MEF’s. 
Another study by Techasintana et al utilised RNA immunoprecipitation 
sequencing (RIP-Seq) and RNA-sequencing (RNA-Seq) to investigate the direct 
and indirect targets of HuR in HuR knockout CD4+ T immune cells during 
activation and Th2 differentiation (Techasintana et al. 2015). Analysis revealed 
new HuR-associated targets that are crucial during T cell activation and immune 
mechanisms. To date, no study has investigated in detail target mRNAs of HuR 
during chondrogenesis and endochondral ossification.  
We therefore decided to examine the molecular effects of HuR inhibition or 
knockdown in chondrogenic cultures to try to uncover potential mechanisms of 
action. ATDC5 cells are a well-established, in vitro model of chondrogenesis, so 
were used to explore HuRs role during chondrogenic differentiation. Critical 
genes involved in the regulation of mesenchymal progenitor cells to 
hypertrophic chondrocytes includes Sox9, Collagen type II and Aggrecan during 
chondrogenesis and Collagen type X, MMP13 and Runx2 during endochondral 
ossification (Li and Dong 2016). Based on this knowledge, this chapter examined 
Analysis of HuR knockdown in chondrocytes in vitro 
 
Page | 176 
 
changes in the mRNA expression levels of various markers of chondrocyte 
differentiation when HuR is knocked down in vitro. 
5.3.1 ATDC5 cells 
qRT-PCR analysis of ATDC5 cells treated for 24 hours with various 
concentrations of the HuR inhibitor MS-444 did not provide any significant 
inhibition of HuR at any of the examined concentrations. However, while HuR 
levels did not detectably decrease in this experiment, MMP13 levels 
significantly increased. There was also a significant increase in Col10a1, another 
marker of chondrocyte differentiation, at 50µM MS-444 treatment. This is 
consistent with the proposed mechanism of action of MS-444, where MS-444 is 
reported to inhibit HuR homodimerisation and HuRs cytoplasmic translocation 
thereby preventing its function as a stabiliser of target mRNAs (Meisner et al., 
2007). This could suggest that HuR might play a role in maintaining 
chondrocytes in a proliferative state, while down-regulation of HuR allows 
chondrogenic differentiation. This theory parallels the previous working 
hypothesis in Chapter 3, that HuR might act upon the Ihh/PTHrP negative 
feedback loop and its deletion may lead to early chondrocyte hypertrophy and 
altered endochondral ossification, this is however speculative and more work 
will need to be complete to validate this theory. Due to the significant gene 
expression changes of all but Runx2 when treated with 50µM MS-444 
treatment of ATDC5 cells, we decided to continue with this concentration for 
further treatment experiments.  
ATDC5 cells were treated with MS-444 for the first 48 hours and subsequently 
differentiated down the chondrogenic lineage (Figure 5.3). Unexpectedly, Sox9 
expression increased well into chondrocyte hypertrophy (day 10+) (Figure 
5.3D). Runx2 expression was also significantly reduced by 14 days after MS-444 
treatment compared to control conditions. After coming to the conclusion that 
continuous treatment of MS-444 was necessary for inhibition of HuR mRNA in 
ATDC5 cells, a 7-day time course of continuous treatment with MS-444 was 
performed and showed that MS-444 significantly down regulates HuR mRNA 
levels in both differentiated and proliferating ATDC5 cells. Interestingly, while 
MMP13 mRNA levels were significantly elevated after MS-444 treatment in 
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undifferentiated cells, upon induction of chondrogenesis MMP13 levels did not 
significantly change from control conditions. MS-444 treatment also resulted in 
a significant decrease in the mRNA expression levels of both Col10a1 and Runx2 
during differentiation when compared with non-treated cells (Figure 5.4 E+F). 
This is contradictory to the mechanism by which MS-444 has been reported to 
inhibit HuRs ability to stabilise its target mRNAs, a inhibition of HuR should 
therefore result in an increase in its target mRNA levels. However, previous 
work has suggested that HuR may act through an indirect intermediate factor as 
HuR acts as a negative regulator of MMP13 but does not affect its rate of decay 
(McDermott et al., 2016). These observations are interesting as Runx2 is a 
marker of chondrocyte hypertrophy and has previously been shown to regulate 
MMP13 expression (Wang et al. 2004). Its ectopic expression has also been 
shown to result in the expression of hypertrophic markers including Col10a1 
and MMP13 (Hess et al. 2001). Interestingly, in Chapter 4 of this thesis there 
was no significant difference observed between chondrocyte-specific HuR 
knockout mice that had undergone DMM surgery and the control group that 
had undergone SHAM surgery. Runx2 expression levels are increased in human 
OA cartilage and the deletion of Runx2 in articular chondrocytes has been 
shown to decelerate the progression of DMM-induced osteoarthritis in adult 
mice (Wang et al. 2004, Liao et al. 2017). If MS-444 treatment does inhibit HuR 
that results in a direct or indirect reduction in Runx2 mRNA levels in vitro, it 
may be possible that a similar situation occurs in vivo in which HuR knockout in 
chondrocytes may result in a decrease in the progression of OA caused by or 
resulting in a direct or indirect reduction of the mRNA levels of Runx2. It is 
important to note, however, that these are not direct comparisons. The work in 
this chapter focuses on immortalised cell lines and primary chondrocytes 
isolated from neonates, which will still have a more developmental phenotype 
than those in the mice used for DMM who were 10-weeks old at the point of 
surgery. This theory also conflicts with findings of an increase in MMP13 mRNA 
levels upon knockdown of HuR in previous reports (McDermott et al. 2016), as 
increased MMP13 levels have been shown to have a direct impact on the 
progressive worsening of OA (Wang et al. 2013). Again, this comparison is 
between an immortalised cell line and primary chondrocytes undergoing 
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osteoarthritis chondrocyte responses and so could explain inconsistencies 
between the two sets of data. It has been reported that Sox9 can repress 
chondrocyte hypertrophy by blocking the activation of Runx2 (Zhou et al. 2006). 
Sox9 is a pivotal regulatory factor in chondrogenesis and is one of the earliest 
markers of chondrocyte differentiation in condensing mesenchyme (Lefebvre 
and Dvir-Ginzberg 2017). While the upregulation of Sox9 can promote 
chondrogenic differentiation in bone marrow-derived mesenchymal stem cells, 
it can also slow the process of chondrocyte hypertrophy; resulting in a 
reduction of Sox9 expression in hypertrophic chondrocytes (Akiyama et al. 
2004, Yang et al. 2011). 
These possible explanations of the changes in mRNA expression of markers of 
chondrogenesis also rely on MS-444 specifically inhibiting HuR.  It is worth 
considering that MS-444 was initially discovered as an inhibitor of myosin light 
chain kinase, a regulatory enzyme in smooth muscle contraction (Nakanishi et 
al., 1995). While all MS-444 experiments in this project were carried out on the 
chondrogenic cell line ATDC5, it can still be possible that in the complex 
environment of the cell MS-444 could also affect other targets besides HuR. 
Further experiments would need to address this issue and look for off target 
effects of MS-444 treatment in cells. One such experiment that would address 
whether MS-444 is specific in its suggested mode of action at inhibiting HuR 
would be to treat cells that overexpress HuR with various concentrations of MS-
444 and for varying amounts of time. Alternatively, Hoechst staining can be 
used to examine nucleus morphology. HuR plays a pivotal role in tumorigenesis, 
for example over-expression of HuR provides cancer cells with anti-apoptotic 
features (Abdelmohsen et al., 2010), therefore cancer cells can be utilised and 
treated with MS-444 to examine effects on processes influenced by HuR 
expression including apoptosis. Previous studies have also examined whether 
MS-444-mediated COX2 mRNA dysregulation occurred through disruption of 
HuR/COX2 mRNA association via ribonucleoprotein immunoprecipitation (RNP-
IP) (Blanco et al., 2016). RNP-IP involves the immunoprecipitation of whole miR-
silencing complexes that is capable of directly analysing miRNA and RNA 
binding protein function in a specific cellular context (Hassan et al., 2010). This 
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level of analysis would be a useful next step in providing validation and insights 
into the specificity of MS-444-mediated HuR inhibition in ATDC5 cells. 
5.3.2 Primary chondrocytes 
While chondrocyte cell lines are extremely useful in the study of chondrocyte 
differentiation, they cannot be entirely substituted for primary chondrocyte 
cultures. Primary chondrocyte cultures have been developed to identify 
mechanisms involved in chondrocyte hypertrophic differentiation and cartilage 
matrix mineralisation and have become increasingly important since the 
generation of transgenic and floxed mouse models, providing a means to study 
gain- and loss-of-function approaches during chondrogenesis and endochondral 
ossification (Chen et al. 2007). 
While we attempted to generate only pups that contained the Cre recombinase 
allele for experimental conditions, we were unable to distinguish between 
breeding mice that were homozygous or heterozygous for the Cre transgene via 
genotyping. It is therefore a limitation of this study that some pups used for the 
tamoxifen primary chondrocyte experimental conditions may not be positive 
for Cre, therefore generating a mixed population of Cre+ and Cre- cells between 
biological replicates. 
In these experiments, HuR was knocked down in isolated primary murine 
chondrocytes using two approaches: either through activation of the 
endogenous CreERT2luc expressed via the Acan promoter (tamoxifen treatment) 
or via delivery of active Cre via an adenovirus. Treatment of primary 
chondrocytes with tamoxifen caused HuR expression to decrease significantly 
by 48 hours (Figure 5.6A), while chondrocytes treated with Cre adenovirus also 
resulted in a knockdown of HuR but in a more stable and continuous manner 
than with tamoxifen (Figure 5.9A). This result was encouraging, however 
unfortunately only one biological replicate of Cre adenoviral treatment in 
primary articular chondrocytes could be performed due to available mice and 
time limitations. Further biological replicates are clearly necessary to validate 
and confirm this observation; as such no conclusions can be drawn from Cre 
adenoviral treated cell experiments. Additionally, in Figure 5.8, FACS analysis 
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showed the optimum MOI of eGFP in primary articular cartilage to be 200. This, 
however, can be lowered for subsequent experiments as the increase in the 
percent of cells expressing eGFP was not exponential. Virus toxicity is a concern 
with adenoviral vector delivery, therefore if a lower MOI gives a similar 
expression of viral expression it is worth considering the cost and benefit of a 
lower MOI to the cells. Future plans include increasing the n number of these 
experiments in order to assess the effect of HuR knock-down via Cre adenovirus 
on markers of chondrocytes.  
Interestingly in the tamoxifen treated cells, we observe the same trend of a 
decrease in MMP13 and Runx2 expression levels as previously observed in MS-
444 treated ATDC5 cells. Sox9 and Runx2 can interact in cells, with Sox9 
inhibiting the activation of Runx2 by inducing a dose-dependent degradation of 
Runx2 via the promotion of Bapx1 (bagpipe homeobox protein homolog 1) and 
in turn slowing chondrocyte hypertrophy (Cheng and Genever 2010). In 
response, Runx2 can also inhibit Sox9 transactivity. MMP13 is also a 
downstream target of Runx2; with an increase in MMP13 expression as a result 
of an increase in Runx2 expression during osteoarthritis. MMP13 expression is 
also diminished in Runx2-deficient mice (Inada et al. 1999, Wang et al. 2004). 
This may potentially explain some of the results observed in Chapter 3 in which 
HuR knockout during embryonic development lead to a delay in bone 
mineralisation. Runx2 is a transcription factor involved in the regulation of 
hypertrophic chondrocyte differentiation and is essential in bone formation 
(Kim et al. 1999). Skeletal analysis of heterozygous Runx2-deficient murine 
embryos revealed an absence of mineralised bone tissue resulting from a lack 
of endochondral ossification (Otto et al. 1997). If a downregulation of HuR in 
vitro results in a reduction of Runx2, also resulting in a reduction of MMP13, 
then this potentially may be occurring in vivo were ablation of HuR in 
chondrocyte- and skeletal- specific manners may result in a reduction of Runx2, 
which in turn may lead to a delay in chondrocyte hypertrophy and ultimately a 
delay in bone formation. This may also explain a lack of phenotypic differences 
between chondrocyte-specific HuRfl/flAcanA1-CreERT2+ mice that have 
undergone DMM surgery and their HuRfl/flAcanA1-CreERT2- counterparts, as 
Runx2 is a critical gene in the progression of osteoarthritis. Bapx1 is also 
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regulated by Ihh, which we hypothesised in Chapter 3 may be stabilised, along 
with PTHrP, by HuR in normal articular chondrocytes. As HuR acts to stabilise its 
target mRNAs in the cytoplasm, it would be expected that a knockdown of HuR 
would result in an increase in the turnover of affected mRNAs in chondrocytes. 
As such, we speculate that a downregulation of Runx2 is probably due to HuR 
acting on an intermediate factor which regulates Runx2 expression. 
Transcriptome-wide studies, including microarray analysis and RNAseq 
examining the control of gene expression in both chondrocytes from healthy vs 
osteoarthritic cartilage and in chondrocytes that have undergone changes in 
their physiological conditions, have led to the identification of the processes 
and mechanisms involved in the control of chondrocyte gene expression 
(Aigner et al. 2004; Sato et al. 2006; Peffers et al. 2014). Further transcriptomic 
analysis would be necessary in order to strengthen the findings presented in 
this thesis. Currently, there have been no transcriptome-wide studies 
investigating the targets of HuR during chondrogenesis, endochondral 
ossification and osteoarthritis progression. Microarray and RNA-seq analysis 
performed on various other cell types during HuR knockdown have not 
identified any differentially expressed markers of chondrocytes. In particular we 
would like to carry out RNAseq on the RNA from Cre adenoviral treated primary 
articular chondrocytes. RNAseq sequences the entire transcriptome in a high-
throughput and quantitative manner to provide precise measurements of the 
levels of transcripts, which in turn would identify genes targeted by HuR, and 
potential mechanisms of action. 
A limitation of the in vitro studies in this project is the lack of validation that in 
vitro experiments have succeeded in reducing HuR protein levels, or 
cytoplasmic protein levels when using MS-444. This is something that needs to 
be further characterised. However, previous work in our laboratory carried out 
by Dr Simon Tew has provided evidence that a reduction in the mRNA of HuR 
also leads to a quick reduction in the protein levels of HuR in human 
mesenchymal stem cells (Figure 5.10).  
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Figure 5.10. Both HuR mRNA and protein levels are knocked down after siRNA 
treatment in human mesenchymal stem cells. Human mesenchymal stem cells 
were treated with siRNAs targeting the expression of the RNA binding proteins TTP, 
KSRP and HuR. HuR siRNA was the only RNA binding protein whos mRNA (A) and 
protein (B) expression levels were reduced in a strong and rapid manner (A n=3 
experimental replicates each in triplicate, B n=2 biological replicates). (Unpublished 
data). 
 
When transfecting these cells with siRNAs targeting the expression of the RNA 
binding proteins TTP, KSRP and HuR, only the latter was able to consistently 
knockdown HuR protein levels after either 3 or 6 days (Figure 5.10B). The HuR 
siRNA significantly reduced HuR mRNA levels within 24 hours and this reduced 
level was maintained for several days (Figure 5.10A). This fast and efficient 
knock-down is indicative of a short-lived protein. In support of this, other 
studies have reported strong and rapid knock-down of HuR during in vitro via 
siRNA silencing experiments (Al-Ahmadi et al., 2013; Lebedeva et al., 2011). 
Whilst these results suggest that HuR knock-down would also be efficient in the 
cell culture systems utilised in this project, it is worth noting that these 
experiments were performed on different cell types and in different species to 
those used in this project and also the difference in technologies between 
siRNA silencing, adenoviral gene delivery and tamoxifen-mediated 
recombination. In its current state, this study needs validation of HuR protein 
knock-down in vitro in order to validate the findings presented. 
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The regulation of gene expression and protein function occurs at multiple levels 
via multiple signalling pathways (Jonason et al. 2009). Post-transcriptional 
modification regulates mRNA translation and stability, a process controlled by 
miRNAs and RNA binding proteins interacting with the 3’ AU-rich UTR of target 
mRNAs (Tew and Clegg 2010). The mechanistic details of the function of key 
regulators of post-transcriptional regulation, including RNA binding proteins 
and miRNAs, are still poorly understood and limited studies have examined 
post-transcriptional regulation in relation to cartilage biology.  
Our group has been interested in the post-transcriptional control of 
chondrocyte genes and have recently reported that a number of mRNAs exhibit 
altered decay rates in chondrocytes from osteoarthritis patients compared to 
those from healthy individuals (Tew et al. 2014). It has also been reported that 
siRNA-mediated knockdown of RNA binding proteins also led to alterations in 
mRNA decay rates and changes in chondrocyte gene expression levels 
(McDermott et al. 2016). The distribution of HuR was also examined in murine 
embryos, were it was observed that levels of HuR were reduced in hypertrophic 
chondrocytes and in those adjacent to the perichondrium, regions implicated in 
long bone growth and mineralisation. The condensing mesenchyme of the 
future digits of developing E13.5 embryos also displayed a ‘checkerboard’ 
appearance of HuR distribution (McDermott et al. 2016). 
HuR-null embryos exhibit embryonic lethality as a result of defects in the 
placenta (Katsanou et al. 2009). It was also reported that conditional knockout 
of HuR driven by Sox2-Cre overcomes this lethality but results in a 
developmental phenotype that includes a severe skeletal dysplasia. Long bones 
were shortened and showed minimal ossification zones in the scapulae, femurs 
and tibia. Mutant embryos also displayed syndactyly in both forelimbs and 
hindlimbs and fusion in the digits. Craniofacial ossification was also delayed in 
mutant embryos (Katsanou et al. 2009). Taken together, these studies 
suggested a role for HuR in the post-transcriptional regulation of skeletal 
development. 
This project set out to investigate the role of HuR in the skeleton of developing 
and adult mice. Two HuR knockout mouse models were developed to gain 
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insights about the physiological role of the HuR protein during skeletal 
development. In Chapter 3 cartilage-specific and skeletal-specific HuR knockout 
mice were generated for the first time, and used to demonstrate a role for HuR 
in endochondral ossification and limb patterning during embryonic 
development. After observing cartilage and bone development via whole-
mount staining and CT analysis, it was found that HuR knockout during 
embryonic development resulted in a phenotype that affects cartilage 
development in the limbs, ribs and craniofacial structures as a result of severely 
dysregulated chondrogenesis and a delay in mineralisation. Histological analysis 
also revealed that the morphology and organisation of chondrocytes was also 
altered and, taken together, this data suggests HuR plays an important role in 
skeletal development, particularly during endochondral ossification. There are 
limitations to any project, particularly those that include in vivo work. 
One limitation to this study is the type of controls used to compare against 
experimental conditions. Many new mouse alleles are generated when a 
neomycin-resistance selection cassette (neo cassette) is included in the 
construction of a floxed allele for Cre-loxP conditional knockout experiments. 
Retention of the neo cassette often reduces gene expression, sometimes 
causing hypomorphic phenotypes or increasing the expression of the transgene 
(Dorà et al., 2016). HuR floxed mice were generated using a neo cassette in the 
generation of the floxed allele. In this project, HuRfl/fl Cre- mice were used as 
controls. In hindsight, this is not a full control as does not take into account any 
effects, if any, caused by the floxed alleles. It has previously been found that 
some floxed alleles that retain the neo cassette are not equivalent to wild-type 
alleles. For example, Pax6 is an important developmental gene with important 
roles in the development of the eye. A previous study reported that 
homozygous Pax6fl/fl and heterozygous Pax6fl/+ mice were viable, fertile and 
phenotypically indistinguishable from wild-type mice, however detailed 
investigation of the eye had not been carried out (Simpson et al., 2009). A 
subsequent analysis reported that while homozygous Pax6fl/fl and heterozygous 
Pax6fl/+ mice had no overt qualitative eye abnormalities, morphometric analysis 
identified Pax6fl/fl mice to have thicker corneas that are also smaller in diameter 
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(Dorà et al., 2016). This study also revealed that eye phenotypes in Pax6fl/- 
compound heterozygotes had displayed more severe eye abnormalities than 
those in Pa6+/- heterozygous, suggesting that the Pax6fl allele is not equivalent 
to the wild-type Pax6+ allele (Dorà et al., 2016). In order to be draw conclusions 
on the negative effects of HuR knockout on skeletal development, controls such 
as HuRWTCre+ would be needed to elucidate any phenotypic effects that might 
arise as a result of the floxed alleles. 
Another potential problem with using the Cre/loxP system is the potential 
toxicity of Cre expression to cells. Several reports indicate that Cre recombinase 
might lead to toxic effects as a consequence of Cre targeting sites in genomic 
DNA that share limited homology with the loxP sequence, thereby inducing mis-
recombination, DNA damage and an alteration in the normal proliferation rate 
(Forni et al., 2006). Most strains in which Cre is expressed seem to develop 
normally and do not show any overt signs of Cre toxicity, however in vitro 
studies on cells lacking exogenous loxP sites have shown that Cre recombinase 
can cause decreased growth, chromosomal aberrations and cytopathic effects 
(Loonstra et al., 2001; Pfeifer et al., 2001). It has been suggested that Cre 
toxicity results from long-term expression of high levels of the enzyme and 
therefore, in this study, additional controls of Aggrecan-CreERT2 and Prx1-Cre 
mice with no other transgenic alterations (ie. no flox sites) should have been 
included as controls.  
There were also many issues that arose during this project in relation to the use 
of mouse models. In particular, a Home Office project licence issue arose half 
way through this project which resulted in a legal requirement to cull all 
experimental mice and drastically reduce the numbers of our colonies. This 
occurred at a crucial time when HuRfl/flAcanA1-CreERT2luc+ mice had been 
staggered into an aging study. As a result a large part of the study, where 
tamoxifen treated HuRfl/flAcanA1-CreERT2luc+ and control mice were being aged 
to identify any long term effects of HuR knockout on the pathology of the knee 
joints, had to be cut short. As a result of the staggered breeding, mice were also 
not of the same age at the time of culling. Due to having to reduce the number 
of mice in the colonies we also lost valuable time when we were eventually able 
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to re-breed our mice as the process to increase our numbers took 
approximately 6 months. On top of this the embryonic development aspect of 
this project required many timed matings to be set up, with more than 60% of 
these resulting in no pregnancy or a dramatically reduced litter size. A 
consideration that is often overlooked when using in vivo models is the effect of 
human interaction on the mice. While many environmental conditions within 
our animal facility are tightly regulated, noise is not a factor that is controlled, 
yet has been shown to increase physiological distress in mice (Lauer et al., 
2009). During the total length of this project the animal unit has had two large 
construction sites within close proximity that has caused noticeable vibrations 
and sound pressures into the facility. It has also been shown that excessive 
noise by construction equipment leads to an in increase in still births and a 
reduction in litter sizes in mice, which may provide an explanation for the small 
litter sizes and the high number of unsuccessful pregnancies observed during 
this project (Rasmussen et al., 2009; Reynolds et al., 2010). 
Previous studies have investigated the role of post-transcriptional regulation in 
osteoarthritis (Tew et al. 2014). RNA binding proteins play a crucial role in post-
transcriptional regulation and our laboratory has recently identified gene 
regulation following knockdown of the RNA binding proteins HuR and TTP in 
human chondrocytes (McDermott et al. 2016). Genes regulated included those 
coding for the matrix degrading extracellular proteinases MMP13 and 
ADAMTS5. It was therefore decided to explore the role of HuR during 
osteoarthritis disease progression. Data from Chapter 4, in which osteoarthritis 
was induced via DMM surgery in HuRfl/flAcanA1-CreERT2 mice generated in 
Chapter 3, suggested there is no statistically significant change between Cre+ 
and Cre- mice but there was an increased mean osteoarthritis score with 
increased variability. It is worth noting that the surgical work carried out in this 
project was a pilot study with the aim of carrying out a fully powered study at a 
later date. A biologically relevant response to DMM in knockout mice vs. 
controls would be an increase in the average score of 1. Based on the 
preliminary findings in this project (SD = 0.81) and assuming a power of 0.8 and 
a type I error of 0.05 then 11 animals would be needed for each sample group. 
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The work presented here has provided the basis for a larger study which is now 
currently being carried out in our lab with a larger sample size.  
In order to investigate the molecular mechanisms underpinning the defects in 
skeletal development that were found in the limb and cartilage specific HuR 
knockout embryos, in vitro assays utilising both the murine chondrogenic cell 
line ATDC5 and primary murine chondrocytes were developed in Chapter 5. This 
in vitro data suggests that HuR expression might be required for the 
appropriate regulation of a number of known chondrocyte marker genes 
including the master transcription factor Sox9, Runx2 and Mmp13, of which the 
latter two are known to be critically involved in the regulation of chondrocyte 
hypertrophy and endochondral ossification. This data is complemented by the 
severe skeletal dysplasia we see in HuR knockout embryos, were a delay in 
endochondral ossification and mineralisation is observed, alongside a 
disorganised structure to chondrocyte morphology. However, it is worth noting 
the limitations that exist with the in vitro work carried out in this project.  
MS-444 is a small molecular weight inhibitor of HuR; however it was initially 
discovered as an inhibitor of myosin light chain kinase activity (Nakanishi et al., 
1995). This paper reported that 10µM of MS-444 was enough to inhibit the 
enzyme activity by 50% (IC50) and worked by inhibiting Ca2+ and calmodulin-
dependent activity of smooth muscle myosin light chain kinase (Nakanishi et al., 
1995). MS-444 was then reported as a small molecular weight inhibitor of HuR 
and was shown to interfere with HuR binding to its target mRNAs and influence 
cytoplasmic localisation of HuR (Meisner et al. 2007). Prior to this, MS-444 was 
described as an anticancer agent (Tatsuta et al., 1997) and Meisner therefore 
proposed that the anti-tumorigenic, anti-angiogenic and the anti-inflammatory 
effects of MS-444 were due (in part) to its strong role as a HuR inhibitor 
(Miesner et al. 2007). It can therefore be a possibility that in the complex 
environment of the cell, MS-444 also affects other targets besides HuR. An 
important outstanding question is whether MS-444s effect on the regulation of 
known markers of chondrogenesis including Mmp13, Sox9 and RunX2 is directly 
due to the inhibition of HuR. 
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Another limitation, as previously discussed in chapter 5, is that we cannot be 
certain that all primary chondrocytes used for tamoxifen knockdown of HuR 
express Cre recombinase (Fig 5.6). Due to the nature of transgenics when 
utilising Cre recombinase, it is not possible to identify mice that are 
homozygous for Cre using standard genotyping techniques. The standard 
procedure to produce mice that are homozygous for Cre recombinase is to 
track the genotype of breeding for progenies that are all subsequently Cre 
positive. This is a long process and, for this study, was not attainable due to the 
majority of other experiments requiring mice heterozygous for Cre 
recombinase. In order to overcome this limitation in future work, transgenic 
mice would need to be lineage tracked and only mice resulting from confirmed 
Cre homozygotes be used for experiments requiring Cre recombinase in all 
cells. 
By utilising transgenic technology, we have been able to develop novel 
chondrocyte- and skeletal- specific HuR knockout mice and use these for 
temporal and spatial in vivo examination of the roles HuR plays in both 
embryonic development and in adult mice during osteoarthritis. We have also 
utilised tissue culture techniques in order to assess the mechanisms on which 
HuR is acting at the molecular level. In this project, we have identified potential 
molecular mechanisms by which HuR affects chondrogenesis and skeletal 
development. It was, however, not in the scope of this study to identify all of 
the genes that HuR may regulate in chondrocytes and this still requires further 
investigation. In order to shed more light on the complex role of HuR in 
chondrogenesis, it would be useful to perform analysis such as RNAseq as this 
would identify changes in the transcriptome. 
This work has provided strong evidence that HuR plays a vital role in the 
regulation of chondrogenesis and has opened the door for further investigation 
of HuR, particularly in the regulation of endochondral ossification and skeletal 
bone development. In particular, our group is currently working on CRISPR/Cas9 
(Clustered Regularly Interspaced Short Palindromic Repeats/associated protein-
9 nuclease) genomic editing of HuR in vitro. CRISPR/Cas9 is a simple yet highly 
efficient and versatile system and allows precise gene editing. By generating 
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HuR deleted chondrocytic cell lines the specific mechanisms HuR influences in 
chondrocytes can be determined using transcriptomic analysis. Further work 
into HuR’s role in embryonic development and in the progression of 
osteoarthritis presented in Chapters 3 and 4, respectively, is also currently 
ongoing to improve the numbers generated from this project.  
Polyadenylation, as previously described in Chapter 1, is the addition of the 
poly(A) tail to the 3’ end of newly synthesised mRNA and is essential for gene 
expression (Millevoi and Vagner, 2010). Transcriptome-wide studies have 
reported that most genes contain multiple poly(A) signals and are subject to 
alternative polyadenylation, an important post-transcriptional process that has 
been implicated in a variety of developmental and disease processes (Elkon et 
al., 2013; Shi, 2012; Tian et al., 2005).  For example, E2F transcription factors 
has been shown to contribute to global 3’ UTR shortening during proliferation, 
which can activate oncogenes in mammalian cells thereby contributing to 
tumorigenesis (Elkon et al., 2012; Mayr and Bartel, 2009). Interestingly HuR has 
been reported to influence alternative polyadenylation (Zhu et al., 2007; Al-
Ahmadi et al., 2009), specifically in Drosophila where HuR inhibits RNA 
processing at proximal polyadenylation sites resulting in extra-long 3’UTRs as a 
result of recruitment by paused polymerase II (Oktaba et al., 2015). It would 
therefore be an interesting next step to examine how HuRs role in influencing 
alternative polyadenylation might affect chondrocyte gene expression, since 
the presence of ARE alternative forms allows differentiation regulation of 
mRNA decay. 
Improving our understanding of cartilage biology is the basis on which 
treatments are developed for people suffering with degenerative joint disease. 
Such treatments would vastly improve their quality of life and lower the 
economic burden associated with age-related joint disease.   
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8 Appendix 
 
 
 
 
Supplementary Figure 1. PCR housekeeping gene primer validation. GeNorm 
output depicting β-Actin as the best housekeeping gene for qRT-PCR in ATDC5 cells. 
 
 
